Datasets:
ChatDOC
/
OCRFlux-pubtabnet-single

Dataset card Data Studio Files Community
image_name
stringlengths
68
68
type
stringclasses
2 values
gt_table
stringlengths
116
12.6k
c2348be8fabcae24b83cd514b35c196d61e0a99f3a635e1347cafcf3729c3a88.png
complex
<table><tr><td>Variables</td><td>No. of study (<i>n</i> = 28)</td><td>Coefficient (95% CI)</td><td><i>P</i> value</td></tr><tr><td colspan="4">Univariate meta-regression</td></tr><tr><td>Year of publication</td><td>28</td><td>0.03 (&#8722;0.03&#8211;0.08)</td><td>0.288</td></tr><tr><td>Male% in sample</td><td>28</td><td>0.001 (&#8722;0.01&#8211;0.02)</td><td>0.862</td></tr><tr><td>Sample size</td><td>28</td><td>0.00 (&#8722;0.00&#8211;0.00)</td><td>0.435</td></tr><tr><td>Study location</td><td></td><td></td><td></td></tr><tr><td>Inland</td><td>19</td><td>Reference</td><td></td></tr><tr><td>Coastal</td><td>9</td><td>&#8722;0.35 (&#8722;0.84&#8211;0.14)</td><td>0.153</td></tr><tr><td>Study region</td><td></td><td></td><td>0.054</td></tr><tr><td>South</td><td>5</td><td>Reference</td><td></td></tr><tr><td>Central</td><td>6</td><td>0.54 (&#8722;0.15&#8211;1.22)</td><td>0.119</td></tr><tr><td>North</td><td>17</td><td>0.71 (0.14&#8211;1.30)</td><td>0.017</td></tr><tr><td>Study period</td><td></td><td></td><td></td></tr><tr><td>2006&#8211;2012</td><td>18</td><td>Reference</td><td></td></tr><tr><td>1990&#8211;2005</td><td>10</td><td>&#8722;0.11 (&#8722;0.60&#8211;0.38)</td><td>0.656</td></tr><tr><td>Study setting</td><td></td><td></td><td>0.451</td></tr><tr><td>Rural and urban</td><td>4</td><td>Reference</td><td></td></tr><tr><td>Urban</td><td>21</td><td>0.39 (&#8722;0.29&#8211;1.06)</td><td>0.251</td></tr><tr><td>Rural</td><td>3</td><td>0.51 (&#8722;0.44&#8211;1.47)</td><td>0.278</td></tr><tr><td>Diagnostic criteria</td><td></td><td></td><td></td></tr><tr><td>15 &#956;mol/L</td><td>25</td><td>Reference</td><td></td></tr><tr><td>Others</td><td>3</td><td>0.16 (&#8722;0.60&#8211;0.92)</td><td>0.671</td></tr><tr><td>Methods of Hcy measurement</td><td></td><td></td><td>0.798</td></tr><tr><td>FPIA</td><td>5</td><td>Reference</td><td></td></tr><tr><td>ECA</td><td>9</td><td>&#8722;0.10 (&#8722;0.81&#8211;0.62)</td><td>0.783</td></tr><tr><td>HPLC</td><td>8</td><td>0.07 (&#8722;0.66&#8211;0.80)</td><td>0.846</td></tr><tr><td>Others</td><td>6</td><td>0.22 (&#8722;0.55&#8211;1.00)</td><td>0.555</td></tr><tr><td colspan="3">Multivariate meta-regression</td><td>0.0511</td></tr><tr><td>Year of publication</td><td>28</td><td>0.04 (&#8722;0.01&#8211;0.09)</td><td>0.242</td></tr><tr><td>Study location</td><td></td><td></td><td></td></tr><tr><td>Inland</td><td>19</td><td>Reference</td><td></td></tr><tr><td>Coastal</td><td>9</td><td>&#8722;0.16 (&#8722;0.70&#8211;0.38)</td><td>0.614</td></tr><tr><td>Study region</td><td></td><td></td><td>0.294</td></tr><tr><td>South</td><td>5</td><td>Reference</td><td></td></tr><tr><td>Central</td><td>6</td><td>0.48 (&#8722;0.25&#8211;1.21)</td><td>0.185</td></tr><tr><td>North</td><td>17</td><td>0.66 (&#8722;0.01&#8211;1.33)</td><td>0.052</td></tr></table>
dd944cdd41844b4a29aab608fd145d6aecc254ff0b4801ec510801f30142c053.png
simple
<table><tr><td></td><td>Al</td><td>Cd</td><td>Cu</td><td>Fe</td><td>Pb</td><td>Zn</td><td>Na</td><td>Ca</td><td>K</td><td>Mg</td><td>DOC</td><td>PH =</td><td>Temp.</td></tr><tr><td>P1</td><td>NS</td><td>*(0.89)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.80)</td><td>*(0.85)</td><td>NS</td></tr><tr><td>P1.1</td><td>NS</td><td>*(0.82)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>P2</td><td>NS</td><td>*(0.82)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.80)</td><td>*(0.86)</td><td>NS</td></tr><tr><td>P3</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>P4</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>P5</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.88)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>P6</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.84)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G1</td><td>*(0.86)</td><td>NS</td><td>*(0.83)</td><td>&#8225;(0.99)</td><td>&#8225;(1.00)</td><td>*(0.80)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.87)</td></tr><tr><td>G2</td><td>*(0.88)</td><td>NS</td><td>*(0.85)</td><td>&#8225;(1.00)</td><td>&#8225; (1.00)</td><td>*(0.82)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.89)</td></tr><tr><td>G3</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.91)</td><td>NS</td><td>NS</td><td>*(0.81)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G4</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.94)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G5</td><td>NS</td><td>*(0.87)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.92)</td><td>NS</td></tr><tr><td>G6</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.94)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G7</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>&#8224;(0.77)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G8</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.94)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G9</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G10</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.93)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G11</td><td>*(0.85)</td><td>NS</td><td>*(0.82)</td><td>&#8225;(0.98)</td><td>&#8225; (1.00)</td><td>&#8224;(0.79)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.86)</td></tr><tr><td>G12</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G13</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.91)</td><td>NS</td><td>*(0.77)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G14</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.92)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G15</td><td>NS</td><td>*(0.89)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.84)</td><td>&#8224;(0.93)</td><td>NS</td></tr><tr><td>G16</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>*(0.78)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G17</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.94)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G18</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.87)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G19</td><td>*(0.86)</td><td>NS</td><td>*(0.83)</td><td>&#8225;(0.99)</td><td>&#8225;(1.00)</td><td>*(0.80)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.88)</td></tr><tr><td>G20</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>&#8224;(0.93)</td><td>NS</td><td>*(0.82)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G21</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.91)</td><td>NS</td><td>*(0.78)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G22</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.85)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G23</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G24</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.90)</td><td>NS</td><td>*(0.77)</td><td>NS</td><td>NS</td><td>NS</td></tr><tr><td>G25</td><td>NS</td><td>*(0.86)</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>NS</td><td>*(0.83)</td><td>&#8224;(0.93)</td><td>NS</td></tr></table>
c318e550fe5305232a697eb7c216ffd0dd63855bb5471993294f8ea05a2ccfd3.png
simple
<table><tr><td> </td><td>3 hours</td><td>24 hours</td><td>7 days</td></tr><tr><td>Pulpdent</td><td>6.3-7.2</td><td>7.1-8.2</td><td>7.4-7.9</td></tr><tr><td>Dycal</td><td>5.8-7.6</td><td>7.2-7.8</td><td>7.4-7.8</td></tr><tr><td>ProRoot MTA</td><td>6.2-7.3</td><td>7.1-7.5</td><td>7.5-7.8</td></tr><tr><td>Negative control </td><td>5.7-7.2</td><td>6.0-7.6</td><td>6.8-7.7</td></tr><tr><td>Positive control</td><td>6.4-7.0</td><td>6.8-7.5</td><td>6.7-7.4</td></tr><tr><td>Deionized water</td><td>6.4-7.4</td><td>6.9-7.2</td><td>6.8-7.5</td></tr></table>
5aef4a9b2225fbf16c7b75afa92028d5e33fb6468b4a7cff3e91798dd04e08a2.png
simple
<table><tr><td></td><td>BMI</td><td>Macrosomia (<i>n</i> =700)</td><td>Control (<i>n</i> =5137)</td><td>OR (95%CI)</td><td><i>P</i></td></tr><tr><td>Male</td><td>Normal</td><td>259(60.66%)</td><td>1,838(69.99%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>99(23.19%)</td><td>459(17.52%)</td><td>1.53(1.19-1.97)</td><td>0.001</td></tr><tr><td></td><td>Obesity</td><td>69(16.15%)</td><td>328(12.49%)</td><td>1.49(1.14-1.99)</td><td>0.007</td></tr><tr><td>Female</td><td>Normal</td><td>183(67.03%)</td><td>1,873(74.56%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>58(21.24%)</td><td>408(16.24%)</td><td>1.45(1.06-1.99)</td><td>0.019</td></tr><tr><td></td><td>Obesity</td><td>32(11.73%)</td><td>231(9.20%)</td><td>1.42(0.95-2.11)</td><td>0.087</td></tr><tr><td>Total</td><td>Normal</td><td>442(63.14%)</td><td>3,711(72.24%)</td><td>-</td><td>-</td></tr><tr><td></td><td>Overweight</td><td>157(22.43%)</td><td>867(16.88%)</td><td>1.52(1.24-1.86)</td><td>0.001</td></tr><tr><td></td><td>Obesity</td><td>101(14.43%)</td><td>559(10.88%)</td><td>1.50(1.19-1.92)</td><td>&lt; 0.001</td></tr></table>
954a163868b0946929d7949d25f6691a80a30afcdbe4234bc5437b366a9214e6.png
simple
<table><tr><td>Group</td><td>Material</td><td>Contrast</td><td>Region of main effect</td><td>Comparison with controls (increased/decreased, location)</td><td>Correlation with memory performance (location, correlating measure)</td></tr><tr><td>Controls</td><td>Words</td><td>Remembered &gt; forgotten</td><td>Left HC</td><td></td><td></td></tr><tr><td></td><td>Pictures</td><td></td><td>Bilateral PHG</td><td></td><td></td></tr><tr><td></td><td>Faces</td><td></td><td>Right HC, A</td><td></td><td></td></tr><tr><td></td><td>Words</td><td>Viewing &gt; fixate</td><td>Left PHG</td><td></td><td></td></tr><tr><td></td><td>Pictures</td><td></td><td>Left PHG</td><td></td><td></td></tr><tr><td></td><td>Faces</td><td></td><td>Bilateral FG</td><td></td><td></td></tr><tr><td>Left TLE</td><td>Words</td><td>Remembered &gt; forgotten</td><td>&#8211;</td><td>Increased, Right PHG</td><td>Right HC, 1/verbal recall</td></tr><tr><td></td><td>Pictures</td><td></td><td>&#8211;</td><td>&#8211;</td><td>&#8211;</td></tr><tr><td></td><td>Faces</td><td></td><td>Right HC, ERC</td><td>Increased, Right ERC</td><td>-</td></tr><tr><td></td><td>Words</td><td>Viewing &gt; fixate</td><td>Right PHG</td><td>Reduced, Left HC</td><td>Left HC, verbal recall</td></tr><tr><td></td><td></td><td></td><td></td><td>Increased, Right PHG</td><td>Right HC, 1/verbal recall</td></tr><tr><td></td><td>Pictures</td><td></td><td>Right PHG</td><td>Reduced, Left HC</td><td>Left HC, verbal learning</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>Right HC, 1/verbal learning</td></tr><tr><td></td><td>Faces</td><td></td><td>Right PHG, FG</td><td>Increased, Right FG</td><td>-</td></tr><tr><td>Right TLE</td><td>Words</td><td>Remembered &gt; forgotten</td><td>Left HC</td><td>Increased, Left HC</td><td>-</td></tr><tr><td></td><td>Pictures</td><td></td><td>Left PHG</td><td>-</td><td>Right HC, figure recall</td></tr><tr><td></td><td>Faces</td><td></td><td>-</td><td>-</td><td>Left HC, 1/figure recall</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td>-</td></tr><tr><td></td><td>Words</td><td>Viewing &gt; fixate</td><td>-</td><td>Increased, Left HC</td><td>-</td></tr><tr><td></td><td>Pictures</td><td></td><td>Left HC</td><td>Increased, Left HC</td><td>Right HC, figure recall</td></tr><tr><td></td><td>Faces</td><td></td><td>Right HC</td><td>-</td><td>-</td></tr></table>
685294ff796045f4976ec8e5194208cbe3518b98272c7b5d06856c69c84eaea6.png
complex
<table><tr><td rowspan="3"></td><td colspan="6">Bivariate associations (<i>n</i> = 3438)</td><td colspan="2">Adjusted odds ratios (<i>n</i> = 3293)</td></tr><tr><td colspan="2">Increased = No</td><td colspan="2">Increased = Yes</td><td>OR</td><td>95% CI<sup>1</sup></td><td>AOR<sup>a</sup></td><td>95% CI<sup>1</sup></td></tr><tr><td>n</td><td>(%)</td><td>n</td><td>(%)</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="9">Site Characteristics</td></tr><tr><td colspan="9"> Site level</td></tr><tr><td>Primary</td><td>1932</td><td>78%</td><td>552</td><td>22%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td>Secondary</td><td>594</td><td>73%</td><td>218</td><td>27%</td><td>1.28</td><td>(1.07, 1.54)**</td><td>1.20</td><td>(0.95, 1.51)</td></tr><tr><td>Tertiary</td><td>94</td><td>66%</td><td>48</td><td>34%</td><td>1.78</td><td>(1.25, 2.56)**</td><td>1.78</td><td>(0.99, 3.19)</td></tr><tr><td colspan="9"> Community outreach with abortion information</td></tr><tr><td>Yes</td><td>763</td><td>75%</td><td>256</td><td>25%</td><td>1.10</td><td>(0.92, 1.90)</td><td>1.26</td><td>(1.03, 1.55)*</td></tr><tr><td>No</td><td>1756</td><td>77%</td><td>538</td><td>23%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td colspan="9">Provider Characteristics</td></tr><tr><td colspan="9"> Fiscal year trained</td></tr><tr><td>FY 2012</td><td>747</td><td>77%</td><td>220</td><td>23%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td>FY 2013</td><td>650</td><td>71%</td><td>271</td><td>29%</td><td>1.44</td><td>(1.17, 1.77)**</td><td>1.56</td><td>(1.24, 1.96)***</td></tr><tr><td>FY 2014</td><td>555</td><td>77%</td><td>162</td><td>23%</td><td>1.01</td><td>(0.80, 1.27)</td><td>0.97</td><td>(0.75, 1.26)</td></tr><tr><td>FY 2015</td><td>654</td><td>80%</td><td>165</td><td>20%</td><td>0.87</td><td>(0.70, 1.10)</td><td>0.81</td><td>(0.63, 1.04)</td></tr><tr><td colspan="9"> Any prior uterine evacuation experience</td></tr><tr><td>Yes</td><td>803</td><td>75%</td><td>273</td><td>25%</td><td>1.13</td><td>(0.95, 1.33)</td><td>0.95</td><td>(0.77, 1.17)</td></tr><tr><td>No</td><td>1788</td><td>77%</td><td>540</td><td>23%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td colspan="9"> Any other Ipas-trained providers at site</td></tr><tr><td>Yes</td><td>803</td><td>77%</td><td>239</td><td>23%</td><td>0.93</td><td>(0.79, 1.11)</td><td>0.95</td><td>(0.76, 1.19)</td></tr><tr><td>No</td><td>1817</td><td>76%</td><td>579</td><td>24%</td><td>Ref</td><td></td><td>Ref</td><td></td></tr><tr><td colspan="9">Provider Support</td></tr><tr><td> Total in-person, post-training contacts (Mean, SD)</td><td>(3.3, 2.2)</td><td></td><td>(3.8, 2.4)</td><td></td><td>1.11</td><td>(1.07, 1.15)***</td><td>1.17</td><td>(1.11, 1.22)***</td></tr><tr><td> Total non-in-person, post-training contacts (Mean, SD)</td><td>(2.3, 2.0)</td><td></td><td>(2.3, 1.8)</td><td></td><td>1.01</td><td>(0.97, 1.05)</td><td>0.95</td><td>(0.91, 1.00)</td></tr></table>
0a7001bc46bd0f3a8bb0c22fe1875cf7e578d22102cc403097afa1d0e1550ae2.png
complex
<table><tr><td rowspan="2">Culture</td><td colspan="9">MIC mode (&#956;g/ml)<sup>a</sup></td></tr><tr><td>Carb</td><td>Cpz</td><td>Gent<sup>b</sup></td><td>Kan<sup>b</sup></td><td>Levo</td><td>Nor</td><td>Rif</td><td>Tet</td><td>Vanc</td></tr><tr><td><i>M. smegmatis</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>pH 5.6</td><td></td><td>50</td><td></td><td>2.0</td><td></td><td>4.0</td><td>6.3</td><td></td><td></td></tr><tr><td>pH 6.6</td><td></td><td>50</td><td></td><td>2.0</td><td></td><td>2.0</td><td>25</td><td></td><td></td></tr><tr><td>pH 7.6</td><td></td><td>50</td><td></td><td>1.0</td><td></td><td>2.0</td><td>25</td><td></td><td></td></tr><tr><td>pH 6.6 + DNP</td><td></td><td>50</td><td></td><td>2.0</td><td></td><td>2.0</td><td>13</td><td></td><td></td></tr><tr><td><i>S. aureus</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>pH 6</td><td></td><td></td><td></td><td>50</td><td></td><td>3.1</td><td></td><td></td><td>13</td></tr><tr><td>pH 7</td><td></td><td></td><td></td><td>13</td><td></td><td>1.6</td><td></td><td></td><td>13</td></tr><tr><td>pH 8</td><td></td><td></td><td></td><td>3.1</td><td></td><td>1.6</td><td></td><td></td><td>13</td></tr><tr><td>pH 7 + DNP</td><td></td><td></td><td></td><td>200</td><td></td><td>0.4</td><td></td><td></td><td>13</td></tr><tr><td><i>E. coli</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>pH 6</td><td>6.3</td><td></td><td></td><td>13</td><td></td><td>125</td><td></td><td></td><td></td></tr><tr><td>pH 7</td><td>6.3</td><td></td><td></td><td>6.3</td><td></td><td>63</td><td></td><td></td><td></td></tr><tr><td>pH 8</td><td>6.3</td><td></td><td></td><td>1.6</td><td></td><td>31</td><td></td><td></td><td></td></tr><tr><td>pH 7 + DNP</td><td>13</td><td></td><td></td><td>6.3</td><td></td><td>125</td><td></td><td></td><td></td></tr><tr><td><i>P. aeruginosa</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>pH 6</td><td></td><td></td><td>3.1</td><td></td><td>0.2</td><td></td><td></td><td>13</td><td></td></tr><tr><td>pH 7</td><td></td><td></td><td>1.6</td><td></td><td>0.2</td><td></td><td></td><td>13</td><td></td></tr><tr><td>pH 8</td><td></td><td></td><td>0.4</td><td></td><td>0.1</td><td></td><td></td><td>13</td><td></td></tr><tr><td>pH 7 + DNP</td><td></td><td></td><td>1.6</td><td></td><td>0.2</td><td></td><td></td><td>13</td><td></td></tr></table>
6e5420cae87782003a8f0aac01c0ffbbf576abf519412a28c510fa5ce65e73d7.png
simple
<table><tr><td>Solution Set</td><td>Health Status Level</td><td>Health Description</td><td>Maintenance Level</td></tr><tr><td><i>A</i><sub>1</sub></td><td>Health (<i>HS</i>)</td><td>healthy condition</td><td>No maintenance</td></tr><tr><td><i>A</i><sub>2</sub></td><td>Subhealth (<i>SHS</i>)</td><td>normal range</td><td>Preventive maintenance</td></tr><tr><td><i>A</i><sub>3</sub></td><td>failure edge (<i>FES</i>)</td><td>fault edge</td><td>Corrective maintenance</td></tr><tr><td><i>A</i><sub>4</sub></td><td>Failure (<i>FS</i>)</td><td>fault condition</td><td>Immediate maintenance</td></tr></table>
3e0dd84e56d784cbef967230b34e1d2244b0174ec1953e02ec16c349e6db938b.png
simple
<table><tr><td>Reference</td><td>Study</td><td># Cases</td><td># Controls</td><td>Outcomes</td><td>Comment</td></tr><tr><td>[214]</td><td>Nurses' Health Study</td><td>3,483</td><td></td><td>&#8595;folate intake + alcohol = &#8593;risk of breast cancer (OR = 0.55, P-trend = 0.001)</td><td>Folate intake not associated with overall risk of breast cancer</td></tr><tr><td>[215]</td><td>Canadian National Breast Screening Study</td><td>1,336</td><td>5,382</td><td>&#8595;folate intake + alcohol = &#8593;risk of breast cancer (OR = 0.34, P-trend = 0.004)</td><td>Folate intake not associated with overall risk of breast cancer</td></tr><tr><td>[216]</td><td>Prospective study in USA with postmenopausal women</td><td>1,586</td><td></td><td>Among drinkers, &#8595;folate intake = &#8593;breast cancer risk (OR = 1.59)</td><td>No association in overall cohort</td></tr><tr><td>[125]</td><td>Shanghai Breast Cancer Study, China</td><td>1,321</td><td>1,382</td><td>&#8593;folate intake = &#8595; risk (OR = 0.71, P-trend = 0.05); &#8593;folate, &#8593;methionine, &#8593;B<sub>6</sub>, &#8593;B<sub>12 </sub>= &#8595;risk (OR = 0.47, P-trend = 0.01)</td><td>No alcohol, no supplements, unprocessed, unfortified foods</td></tr><tr><td>[217]</td><td>Nurses' Health Study II, study of premenopausal women</td><td>714</td><td></td><td>Vitamin A protective (OR = 0.28); Vitamins C, E, and folate not associated with risk.</td><td></td></tr><tr><td>[118]</td><td>Nurses' Health Study</td><td>712</td><td>712 matched</td><td>&#8593;plasma folate = &#8595;risk (OR = 0.73, P-trend = 0.06). For women who drank alcohol, &#8593;plasma folate even more protective, OR = 0.11.</td><td>&#8593;plasma B<sub>6 </sub>and plasma B<sub>12 </sub>were also protective</td></tr><tr><td>[218]</td><td>Prospective study in USA with postmenopausal women</td><td>1,823, 308 with family history (FH)</td><td></td><td>FH- +Alcohol = &#8593;risk (OR = 1.40) FH- + Alcohol + &#8593;folate = normal risk; FH+ &#8595;folate = &#8593;risk for drinkers (OR = 2.21) and non-drinkers (OR = 2.39); FH+ +Alcohol + &#8593;folate = &#8593;risk (OR = 1.67); FH+ + &#8593;folate = normal risk</td><td>Women with family history of breast cancer can reduce risk by increasing folate intake and not drinking.</td></tr></table>
d26a996ead4a9f860b0ac2117a4d0df673f38859470cc69741456a8002cd1348.png
simple
<table><tr><td></td><td>Formulations</td><td>Crystalline Phase (wt%)</td><td>Amorphous Phase (wt%)</td></tr><tr><td></td><td>Pure Ca/Mg-rich glass</td><td>66</td><td>34</td></tr><tr><td>1</td><td>H62C + fillers</td><td>88</td><td>12</td></tr><tr><td>2</td><td>H62C + fillers + 10 wt% glass</td><td>98</td><td>2</td></tr><tr><td>3</td><td>MK + fillers</td><td>92</td><td>8</td></tr><tr><td>4</td><td>MK + fillers + 10 wt% glass</td><td>96</td><td>4</td></tr></table>
ed09eb3deb26865c3ec6a9bc0546460dedaf845f5cc89defc350ad610ab3e532.png
complex
<table><tr><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence &#8805;3%</td><td colspan="2">Number of HIV-negative people and people living in sub-national areas with incidence &#8805;1.5%</td></tr><tr><td>Characteristics</td><td>Estimates</td><td>Characteristics</td><td>Estimates</td></tr><tr><td>Women:&#8226; 15&#8211;19 years old&#8226; 20&#8211;24 years old</td><td>140,000770,000</td><td>Women: &#8226; 15&#8211;19 years old &#8226; 20&#8211;24 years old</td><td>2.2 million2.4 million</td></tr><tr><td>Men:&#8226; 15&#8211;19 years old&#8226; 20&#8211;24 years old</td><td>040,000</td><td>Men: &#8226; 15&#8211;19 years old &#8226; 20&#8211;24 years old</td><td>01.2 million</td></tr><tr><td colspan="2">Countries: Kenya, Lesotho, Mozambique, South Africa, Swaziland.</td><td colspan="2">Countries: Kenya, Lesotho, Mozambique, South Africa, Swaziland, Zimbabwe and Uganda.</td></tr></table>
cadb149b967cfbdb22d7012409450a19750afa2669b82358ec9e96f2668dc1cb.png
complex
<table><tr><td>Groups</td><td>Specific Diseases (ICD-10 Coding) [Number of GPs Mentioning It]</td></tr><tr><td rowspan="2">ICD-10 E86 Volume depletion/ E87 Other disorders of fluid, electrolyte and acid-base balance [22/24]</td><td>E86 Volume depletion OR T67.3 Heat exhaustion due to water depletion [18]</td></tr><tr><td>E87 Other disorders of fluid, electrolyte and acid-base balance OR T67.4 Heat exhaustion due to salt depletion [4]</td></tr><tr><td rowspan="3">Circulatory diseases, ICD10-I00-I99 [15/24]</td><td>I99 Other and unspecified disorders of circulatory system [9]: usually naming circulatory collapse and circulatory dysregulation</td></tr><tr><td>I95 Hypotension [4]</td></tr><tr><td>Other [3]: I74 Arterial embolism and thrombosis [1], I64 Stroke, not specified as hemorrhage or infarction [1], I49.9 Cardiac arrhythmia, unspecified [1]</td></tr><tr><td>T67 Effects of heat and light [8/24]</td><td>T67.6 Heat fatigue, transient [5]; T67.0 Heatstroke and sunstroke [3]; T67.5 Heat exhaustion, unspecified [2], T67.1 Heat syncope [2]; T76.7 Heat edema [1]</td></tr><tr><td rowspan="2">Infectious diseases, ICD10-A00-B99 [7/24]</td><td>A00&#8211;A09 Intestinal infectious diseases [6]</td></tr><tr><td>Other [3]: B37.2 Candidiasis of skin and nail [1], L00&#8211;L08 Infections of the skin and subcutaneous tissue [2], N39.0 Urinary tract infection, site not specified [1]</td></tr><tr><td rowspan="2">Organic mental disorders, ICD-F00-F09 [5/24]</td><td>Disorientation, cognitive or emotional impairment [4] (in line with F05&#8211;F07 *)</td></tr><tr><td>Aggravation of dementia [2] (F00&#8211;F003)</td></tr><tr><td>Others [5/24]</td><td>N17 Acute renal failure [2]; J98.9 Respiratory disorder, unspecified [1]; L55 Sunburn [1]; Injuries from fall [3]</td></tr></table>
d12c007adbb33e8dcbb12d51af149017e3c865233bc9d517c7413855a4448cd3.png
complex
<table><tr><td>Question</td><td><i>n</i> (%)</td></tr><tr><td colspan="2">Do customers talk about experiences of trying to quit smoking?</td></tr><tr><td> Yes many do</td><td>30 (73)</td></tr><tr><td> Yes some do</td><td>9 (22)</td></tr><tr><td> No</td><td>1 (2)</td></tr><tr><td> No response</td><td>1 (2)</td></tr><tr><td colspan="2">Do customers ask for advice about quitting?</td></tr><tr><td> Yes</td><td>37 (90)</td></tr><tr><td> No</td><td>3 (7)</td></tr><tr><td> No response</td><td>1 (2)</td></tr><tr><td colspan="2">What kind of information do you give to customers? (multiple responses permitted)</td></tr><tr><td> Product information</td><td>38 (93)</td></tr><tr><td> Smoking cessation advice</td><td>17 (41)</td></tr><tr><td> Information how to cut down regular cigarettes</td><td>36 (88)</td></tr><tr><td> Other</td><td>9 (22)</td></tr><tr><td colspan="2">Where do you access this information? (Open question) </td></tr><tr><td> Online</td><td>22 (54)</td></tr><tr><td> In-house training</td><td>6 (15)</td></tr><tr><td> Personal experience</td><td>10 (24)</td></tr><tr><td> Manufacturers' guidelines</td><td>3 (7)</td></tr><tr><td colspan="2">How confident are you about offering smoking cessation advice to customers that ask for it?</td></tr><tr><td> Not at all</td><td>0 (0)</td></tr><tr><td> Not too confident</td><td>2 (5)</td></tr><tr><td> Quite confident</td><td>15 (37)</td></tr><tr><td> Very confident</td><td>16 (39)</td></tr><tr><td> No response</td><td>8 (20)</td></tr><tr><td colspan="2">Do you think it would be a good idea to deliver smoking cessation advice with training in your shop?</td></tr><tr><td> Yes</td><td>19 (46)</td></tr><tr><td> No</td><td>4 (10)</td></tr><tr><td> Not sure</td><td>17 (41)</td></tr><tr><td> No response</td><td>1 (2)</td></tr><tr><td colspan="2">Do you think customers would be interested in accessing this in-store smoking cessation service?</td></tr><tr><td> Yes</td><td>17 (41)</td></tr><tr><td> No</td><td>9 (22)</td></tr><tr><td> Not sure</td><td>15 (37)</td></tr><tr><td colspan="2">Which type of in-store cessation service do you think might work best? (<i>n</i> = 19 - staff who think service is a good idea)</td></tr><tr><td> Support from a training member of staff</td><td>14 (74)</td></tr><tr><td> Face-to-face support from an external advisor</td><td>1 (5)</td></tr><tr><td> A text or email-based support service</td><td>0 (0)</td></tr><tr><td> No response</td><td>4 (21)</td></tr></table>
10015d547525ade978c4af77e398bca20d172c9a6fe2374f3dc8c30d3c87eb9e.png
simple
<table><tr><td>Characteristics of patients</td><td>100</td></tr><tr><td>Phototype</td><td> </td></tr><tr><td>I</td><td>0 (0%)</td></tr><tr><td>II</td><td>72 (72%)</td></tr><tr><td>III</td><td>28 (28%)</td></tr><tr><td>IV</td><td>0 (0%)</td></tr><tr><td>V</td><td>0 (0%)</td></tr><tr><td>Skin hydration</td><td> </td></tr><tr><td>dry skin</td><td>56 (56%)</td></tr><tr><td>normal skin</td><td>10 (10%)</td></tr><tr><td>sensible skin</td><td>34 (34%)</td></tr></table>
9d3323a6d0549482da837403adc88b5f94fa1425b895f2058709ae46772cc02d.png
complex
<table><tr><td></td><td colspan="2">Rate ratio (95% CI<sup>a</sup>)</td><td>Intervention effect ratio<sup>b</sup></td></tr><tr><td></td><td colspan="2">(intervention period relative to baseline)</td><td>(95% CI<sup>a</sup>)</td></tr><tr><td>Outcome variable</td><td>Intervention</td><td>Control</td><td></td></tr><tr><td>ISH presentations and self-inflicted death events</td><td>0.91 (0.81&#8211;1.02)</td><td>0.85 (0.76&#8211;0.95)</td><td>1.07 (0.82&#8211;1.40)</td></tr><tr><td>ISH presentations only</td><td>0.91 (0.80&#8211;1.02)</td><td>0.85 (0.75&#8211;0.95)</td><td>1.07 (0.82&#8211;1.40)</td></tr><tr><td>Self-inflicted death events only</td><td>1.17 (0.84&#8211;1.65)</td><td>1.01 (0.77&#8211;1.31)</td><td>1.18 (0.51&#8211;2.70)</td></tr></table>
fde9cf400773a15f5ece6e735ddf31d8f5c7e96422d41137807e520cbebbfa54.png
simple
<table><tr><td>Sample</td><td>Conc.(&#956;g/ml)</td><td>No of brine shrimps taken</td><td>No of brine shrimps killed</td><td>LC<sub>50 </sub>(&#956;g/ml)</td></tr><tr><td></td><td>1000</td><td>10</td><td>10 &#177; 0</td><td></td></tr><tr><td></td><td>100</td><td>10</td><td>10 &#177; 0</td><td></td></tr><tr><td></td><td>10</td><td>10</td><td>10 &#177; 0</td><td></td></tr><tr><td>CSA</td><td>7.5</td><td>10</td><td>10 &#177; 0</td><td>2.3 &#177; 0.16</td></tr><tr><td></td><td>5</td><td>10</td><td>9.67 &#177; 0.58</td><td></td></tr><tr><td></td><td>2.5</td><td>10</td><td>06 &#177; 1</td><td></td></tr><tr><td></td><td>1.25</td><td>10</td><td>03 &#177; 1</td><td></td></tr><tr><td></td><td>1000</td><td>10</td><td>10 &#177; 0</td><td></td></tr><tr><td></td><td>100</td><td>10</td><td>10 &#177; 0</td><td></td></tr><tr><td></td><td>10</td><td>10</td><td>9.8 &#177; 0.76</td><td></td></tr><tr><td>CST</td><td>7.5</td><td>10</td><td>7 &#177; 0.5</td><td>5.23 &#177; 0.34</td></tr><tr><td></td><td>5</td><td>10</td><td>5 &#177; 0.5</td><td></td></tr><tr><td></td><td>2.5</td><td>10</td><td>2.9 &#177; 0.36</td><td></td></tr><tr><td></td><td>1.25</td><td>10</td><td>1 &#177; 0.14</td><td></td></tr></table>
109ca5a012ed58355f8165eed4846417cbab537b86d8f9bd213d543aba170f04.png
simple
<table><tr><td>Responses (verbatim)</td><td>Number of health workers (n=10)</td><td>Percentage (%)</td></tr><tr><td>We usually ask if they had finished the treatment</td><td>1</td><td>10</td></tr><tr><td>When they come we check the container, most have finishedbut others did not finish due to nausea and vomiting. Thosewho did not finish we educate them</td><td>1</td><td>10</td></tr><tr><td>We repeat Hb test</td><td>1</td><td>10</td></tr><tr><td>Through statistics records</td><td>1</td><td>10</td></tr><tr><td>We interview, the questions are like how is the progress, ifthey are complying; and if they have problems they usuallytell us</td><td>1</td><td>10</td></tr><tr><td>We ask mothers to accompany teenagers and ask the motherabout compliance</td><td>1</td><td>10</td></tr><tr><td>We give them 28 day supply, if after 4 weeks they still havesupplements we know they are not complying</td><td>1</td><td>10</td></tr><tr><td>You give them health education, if they understand you aresure they are going to comply</td><td>1</td><td>10</td></tr><tr><td>We only hear from them if they complain with side effects, ifno complain they are complying</td><td>1</td><td>10</td></tr><tr><td>Usually ask questions and check Hb levels</td><td>1</td><td>10</td></tr></table>
4818504169a449d071be3077b00a15f4b848aa83a5ed98cd5b888e2d6463ab79.png
complex
<table><tr><td colspan="2">Phantom configuration</td><td>True sphere/background ratio</td><td colspan="3">SPECT alone</td><td colspan="3">SPECT-CT</td></tr><tr><td colspan="2"> </td><td> </td><td>Isocontour (%)</td><td>Measured volume (cm<sup>3</sup>)</td><td>Error (%)</td><td>Isocontour (%)</td><td>Measured volume (cm<sup>3</sup>)</td><td>Error (%)</td></tr><tr><td rowspan="5">18,5 MBq/sphere</td><td>Cylinder 1</td><td>&#8212;</td><td>1%</td><td>7087</td><td>5,52</td><td>2%</td><td>6521</td><td>&#8722;2,90</td></tr><tr><td>Sphere 1</td><td>2.8</td><td>31%</td><td>207</td><td>276,36</td><td>48%</td><td>57,2</td><td>4,00</td></tr><tr><td>Sphere 2</td><td>7.6</td><td>13%</td><td>104,5</td><td>397,62</td><td>28%</td><td>24,4</td><td>16,19</td></tr><tr><td>Sphere 3</td><td>9.6</td><td>19%</td><td>27,4</td><td>71,25</td><td>29%</td><td>16,9</td><td>5,62</td></tr><tr><td>Sphere 4</td><td>19.6</td><td>8%</td><td>29,2</td><td>265,00</td><td>19%</td><td>10,9</td><td>36,25</td></tr><tr><td rowspan="5">37 MBq/sphere</td><td>Cylinder 1</td><td>&#8212;</td><td>2%</td><td>6180</td><td>&#8722;7,98</td><td>1%</td><td>6700</td><td>&#8722;0,24</td></tr><tr><td>Sphere 1</td><td>6</td><td>7%</td><td>169,7</td><td>208,55</td><td>34%</td><td>53,56</td><td>&#8722;2,62</td></tr><tr><td>Sphere 2</td><td>17</td><td>3%</td><td>113,7</td><td>441,43</td><td>23%</td><td>24,34</td><td>15,90</td></tr><tr><td>Sphere 3</td><td>23.4</td><td>3%</td><td>119,78</td><td>648,63</td><td>27%</td><td>14,9</td><td>&#8722;6,88</td></tr><tr><td>Sphere 4</td><td>43.8</td><td>4%</td><td>53,48</td><td>568,50</td><td>33%</td><td>9,8</td><td>22,50</td></tr><tr><td rowspan="5">55,5 MBq/sphere</td><td>Cylinder 1</td><td>&#8212;</td><td>1%</td><td>6737</td><td>0,31</td><td>1%</td><td>6737</td><td>0,31</td></tr><tr><td>Sphere 1</td><td>9.9</td><td>10%</td><td>159,3</td><td>189,64</td><td>35%</td><td>55,7</td><td>1,27</td></tr><tr><td>Sphere 2</td><td>29.6</td><td>4%</td><td>85</td><td>304,76</td><td>25%</td><td>22,7</td><td>8,10</td></tr><tr><td>Sphere 3</td><td>38.6</td><td>7%</td><td>51,5</td><td>221,88</td><td>36%</td><td>15,5</td><td>&#8722;3,13</td></tr><tr><td>Sphere 4</td><td>73.1</td><td>6%</td><td>44,1</td><td>451,25</td><td>36%</td><td>12</td><td>50,00</td></tr><tr><td rowspan="5">74 MBq/sphere</td><td>Cylinder 1</td><td>&#8212;</td><td>1%</td><td>6565</td><td>&#8722;2,10</td><td>1</td><td>6565</td><td>&#8722;2,10</td></tr><tr><td>Sphere 1</td><td>16</td><td>15%</td><td>99,5</td><td>80,91</td><td>32%</td><td>56</td><td>1,82</td></tr><tr><td>Sphere 2</td><td>45</td><td>6%</td><td>54,1</td><td>157,62</td><td>23%</td><td>23,7</td><td>12,86</td></tr><tr><td>Sphere 3</td><td>57</td><td>5%</td><td>42,8</td><td>167,50</td><td>25%</td><td>17,4</td><td>8,75</td></tr><tr><td>Sphere 4</td><td>114</td><td>2%</td><td>35,8</td><td>347,50</td><td>20%</td><td>8,7</td><td>8,75</td></tr><tr><td>55 MBq</td><td>Cylinder 2</td><td>&#8212;</td><td>17%</td><td>887</td><td>14,60</td><td>27%</td><td>801</td><td>3,49</td></tr><tr><td>116 MBq</td><td>Cylinder 2</td><td>&#8212;</td><td>19%</td><td>855</td><td>10,47</td><td>29%</td><td>775</td><td>0,13</td></tr><tr><td>72 MBq</td><td>Cylinder 3</td><td>&#8212;</td><td>21%</td><td>520</td><td>9,94</td><td>27%</td><td>481</td><td>1,69</td></tr></table>
51f5aa6588e8e8b1a683b3d28d0d434053c56bd54caab6796c8fe0586dcb9ea6.png
complex
<table><tr><td rowspan="2">Clinical parameters</td><td>Total</td><td>Male patients</td><td>Female patients</td><td><i>p</i>-value</td></tr><tr><td>Median(25th&#8211;75th)</td><td>Median(25th&#8211;75th)</td><td>Median(25th&#8211;75th)</td><td></td></tr><tr><td>Age(years)</td><td>47.5 &#177; 11.94</td><td>50.19 &#177; 12.43</td><td>45.04 &#177; 11.17</td><td>0.15</td></tr><tr><td>BMI(Kg/m<sup>2</sup>)</td><td>28.94 &#177; 4.21</td><td>28.65 &#177; 4.90</td><td>29.2 &#177; 3.56</td><td>0.67</td></tr><tr><td colspan="5">Lab data</td></tr><tr><td> OPG(pmol/l)</td><td>3.5(2.9&#8211;4)</td><td>3.4(2.9&#8211;4.3)</td><td>3.6(2.8&#8211;3.9)</td><td>0.61</td></tr><tr><td> sRANKL(pmol/l)</td><td>0.2(0.1&#8211;0.3)</td><td>0.2(0.1&#8211;0.3)</td><td>0.2(0.1&#8211;0.3)</td><td>0.85</td></tr><tr><td> BUN(mg/dl)</td><td>15.2(12.98&#8211;17.38)</td><td>15.8(14.15&#8211;18.45)</td><td>14(11.8&#8211;16.3)</td><td>0.02</td></tr><tr><td> Creatinie (mg/dl)</td><td>0.9(0.8&#8211;1.1)</td><td>1.1(1&#8211;1.25)</td><td>0.8(0.8&#8211;0.9)</td><td>&#8804; 0.001</td></tr><tr><td> Uric acid (mg/dl)</td><td>5.45(4.03&#8211;6.3)</td><td>6.3(5.65&#8211;7.25)</td><td>4.4(3.3&#8211;5.3)</td><td>&#8804; 0.001</td></tr><tr><td> Ca(mg/dl)</td><td>9.6(8.9&#8211;9.98)</td><td>9.7(8.95&#8211;10.05)</td><td>9.5(8.9&#8211;9.9)</td><td>0.2</td></tr><tr><td> P(mg/dl)</td><td>3.4(3.13&#8211;4.18)</td><td>3.3(3&#8211;4)</td><td>3.6(3.3&#8211;4.2)</td><td>0.19</td></tr><tr><td> Urine volume(ml/24 h)</td><td>1350(900&#8211;2237.5)</td><td>1650(950&#8211;2237.5)</td><td>1150(825&#8211;2250)</td><td>0.39</td></tr><tr><td> Urine creatinine(mg/24 h)</td><td>1227(949.5&#8211;1624)</td><td>1538(1150&#8211;1789.5)</td><td>1011(725&#8211;1273.5)</td><td>0.003</td></tr><tr><td> Urine uric acid(mg/24 h)</td><td>593(405&#8211;804.5)</td><td>786(436&#8211;865.25)</td><td>547(390&#8211;760.5)</td><td>0.14</td></tr><tr><td> Urine calcium (mg/24 h)</td><td>209.5(150&#8211;327)</td><td>193.5(152.5&#8211;285)</td><td>232(105&#8211;340.5)</td><td>0.9</td></tr><tr><td> Urine phosphorus (mg/24 h)</td><td>741.5(592.5&#8211;958)</td><td>832(663.75&#8211;1163.5)</td><td>671(484.5&#8211;814.5)</td><td>0.04</td></tr><tr><td> PTH(pg/ml)</td><td>32.9(24.65&#8211;42.83)</td><td>36.1(27.1&#8211;41.8)</td><td>31.1(20.7&#8211;61.4)</td><td>0.5</td></tr><tr><td> Vitamin D(nmol/l)</td><td>36.8(25.45&#8211;61.10)</td><td>40(27.1&#8211;56.7)</td><td>31.55(20.5&#8211;64.45)</td><td>0.41</td></tr><tr><td> Urine citrate (mg/24 h)</td><td>493(267&#8211;740)</td><td>427(277&#8211;674)</td><td>592(225&#8211;756.25)</td><td>0.3</td></tr><tr><td> Na(mEq/l)</td><td>137.4(136.8&#8211;138.35)</td><td>137.3(136.75&#8211;138)</td><td>137.5(136.8&#8211;139)</td><td>0.5</td></tr><tr><td> eGFR (ml/minute)</td><td>102.48(82.27&#8211;119.33)</td><td>101.98(79.14&#8211;117.83)</td><td>103.62(82.43&#8211;125.85)</td><td>0.71</td></tr><tr><td> kidney stone disease duration (year)</td><td>3.5(1, 11)</td><td>3.25(1&#8211;8.88)</td><td>4.5(1&#8211;11.5)</td><td>0.66</td></tr></table>
7792ca7fd46dcc08c4014c7ba12b3ddcd250d6a6824dc9df90daacc25746aaa0.png
simple
<table><tr><td>Instruments</td><td>Categories</td><td>Variables</td></tr><tr><td>Baseline questionnaire</td><td>Demographic characteristics</td><td>Age; Sex; Nationality; Education; Occupation; Marriage; Family income of last year; Health insurance, etc.</td></tr><tr><td></td><td>Family history</td><td>Liver, renal and other disease history of family members.</td></tr><tr><td></td><td>Medical history and concurrent disease</td><td>Previous hepatitis history; Previous hepatitis virus tests results. Diagnosis and duration of past renal, visional, auditive and other chronic disease history; Allergic history; Concurrent chronic diseases.</td></tr><tr><td></td><td>TB diagnosis and previous treatment</td><td>Definitive diagnosis of TB; Diagnosis time; Diagnosis agency; Anti-TB treatment history; Anti-tuberculosis induced ADEs occurrence history.</td></tr><tr><td></td><td>Current drug usage information</td><td>Product name; Production NO; Dose; Method and cost of anti-tuberculosis drugs and other concurrent using drugs.</td></tr><tr><td>Physical, laboratory examination</td><td>Physical examinations</td><td>Height; Weight.</td></tr><tr><td></td><td>Blood routine test</td><td>Erythrocyte count (10<sup>12</sup>/L); Leukocyte count (10<sup>9</sup>/L); Hemoglobin concentration (g/L); Platelet count (10<sup>9</sup>/L).</td></tr><tr><td></td><td>Urine routine test</td><td>PH value; Urine protein; Erythrocyte count; Leukocyte count; Urinary cylinder count.</td></tr><tr><td></td><td>Liver and renal function test</td><td>Alanine aminotransferase (ALT, U/L); Aspartate aminotransferase (AST, U/L); Total bilirubin (TBIL, &#956;mol/L); Blood urea nitrogen (BUN, mmol/L).</td></tr><tr><td></td><td>Hepatitis B virus marker</td><td>HBsAg test.</td></tr><tr><td>Medication record</td><td>Anti-TB drugs</td><td>Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of anti-TB drugs, including RHZES and other supplementary anti-TB drugs.</td></tr><tr><td></td><td>Liver protective drugs</td><td>Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of drugs used for preventing ATLI.</td></tr><tr><td></td><td>Other drugs</td><td>Name, commercial name, manufacturer, production number, usage, dosage, starting and ending time of other drugs used during the anti-TB therapy, for example, antihypertensive drugs, hypoglycaemic drugs, etc.</td></tr></table>
4886d12e7a47871f56c4593213bd01e1787097b607a9702317acdc69a5749b2b.png
complex
<table><tr><td colspan="3">model</td><td colspan="2">traditional method</td></tr><tr><td></td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>Sensitivity (%)</td><td>Specificity (%)</td></tr><tr><td>&#8804; T2</td><td>84.1</td><td>96.1</td><td>41.3</td><td>96.3</td></tr><tr><td>T3</td><td>81.8</td><td>89.7</td><td>27.3</td><td>69</td></tr><tr><td>T4</td><td>95.2</td><td>94.6</td><td>85.7</td><td>61.2</td></tr></table>
9f0a4568cc3ce8df77ff277082048411da130e8a3afbe14b0b19f282966f025b.png
complex
<table><tr><td></td><td></td><td colspan="3">Within population a</td><td colspan="3">Between populations b</td></tr><tr><td>Chr</td><td>Site</td><td>Pop. c</td><td><i>&#960;</i></td><td>Tajima&#8217;s <i>D</i></td><td>MAF</td><td><i>F<sup>U</sup></i></td><td><i>F<sup>W</sup></i></td></tr><tr><td>A</td><td>0-fold</td><td>RG</td><td>0.0012</td><td>&#8722;0.8397</td><td>0.1222</td><td>0.1516</td><td>0.1709</td></tr><tr><td></td><td></td><td>FR</td><td>0.0010</td><td>&#8722;0.2586</td><td></td><td></td><td></td></tr><tr><td></td><td>4-fold</td><td>RG</td><td>0.0154</td><td>&#8722;0.1069</td><td>0.1653</td><td>0.1684</td><td>0.1743</td></tr><tr><td></td><td></td><td>FR</td><td>0.0119</td><td>0.1116</td><td></td><td></td><td></td></tr><tr><td></td><td>SI d</td><td>RG</td><td>0.0145</td><td>&#8722;0.1380</td><td>0.1630</td><td>0.1677</td><td>0.1766</td></tr><tr><td></td><td></td><td>FR</td><td>0.0113</td><td>0.1413</td><td></td><td></td><td></td></tr><tr><td>X</td><td>0-fold</td><td>RG</td><td>0.0012</td><td>&#8722;1.1907</td><td>0.1073</td><td>0.1653</td><td>0.2924</td></tr><tr><td></td><td></td><td>FR</td><td>0.0005</td><td>&#8722;0.2293</td><td></td><td></td><td></td></tr><tr><td></td><td>4-fold</td><td>RG</td><td>0.0166</td><td>&#8722;0.4679</td><td>0.1367</td><td>0.1903</td><td>0.2879</td></tr><tr><td></td><td></td><td>FR</td><td>0.0068</td><td>0.1412</td><td></td><td></td><td></td></tr><tr><td></td><td>SI d</td><td>RG</td><td>0.0160</td><td>&#8722;0.4561</td><td>0.1379</td><td>0.2033</td><td>0.3173</td></tr><tr><td></td><td></td><td>FR</td><td>0.0061</td><td>0.3414</td><td></td><td></td><td></td></tr></table>
166d86de823b4a70dc4bdb30de3040a4bbb209dab013442c014dddaab581e442.png
complex
<table><tr><td>Age</td><td>Sex</td><td>Start [g]</td><td>Final eu [g]</td><td>Final hyper [g]</td><td>Final hypo [g]</td></tr><tr><td rowspan="2">Adult</td><td>Males</td><td>40.2 &#177; 5.0</td><td>45.8 &#177; 3.7 **</td><td>40.1 &#177; 4.1</td><td>35.6 &#177; 2.0 *</td></tr><tr><td>Females</td><td>28.0 &#177; 1.4<sup>&#8224;&#8224;&#8224;&#8224;</sup></td><td>30.5 &#177; 3.1<sup>&#8224;&#8224;</sup></td><td>34.3 &#177; 2.2 ***</td><td>27.0 &#177; 1.6</td></tr><tr><td rowspan="2">Old</td><td>Males</td><td>39.0 &#177; 5.2</td><td>41.3 &#177; 3.7</td><td>36.9 &#177; 5.3</td><td>34.0 &#177; 3.1 *</td></tr><tr><td>Females</td><td>30.3 &#177; 3.5<sup>&#8224;&#8224;&#8224;&#8224;</sup></td><td>32.8 &#177; 3.2<sup>&#8224;&#8224;&#8224;&#8224;</sup></td><td>33.7 &#177; 4.4<sup>&#8224;</sup></td><td>28.7 &#177; 1.7<sup>&#8224;&#8224;&#8224;&#8224;</sup></td></tr></table>
78a336a6d156c6f81dd7866e01275c7f22eddc591fa7c720ea295f7fd6a8ce40.png
complex
<table><tr><td>Variables</td><td>Frequency (%)</td></tr><tr><td colspan="2">Sex</td></tr><tr><td> Male</td><td>363 (58.8)</td></tr><tr><td> Female</td><td>254 (41.2)</td></tr><tr><td colspan="2">Age (years, <i>n</i> = 569)</td></tr><tr><td> 15&#8211;19</td><td>75 (13.2)</td></tr><tr><td> 20&#8211;24</td><td>451 (79.3)</td></tr><tr><td>&#8805; 25</td><td>43 (7.3)</td></tr><tr><td colspan="2">Religion</td></tr><tr><td> Orthodox</td><td>540 (87.5)</td></tr><tr><td> Muslim</td><td>29 (4.7)</td></tr><tr><td> Protestant</td><td>44 (7.1)</td></tr><tr><td> Other</td><td>4 (0.7)</td></tr><tr><td colspan="2">Region</td></tr><tr><td> Tigray</td><td>37 (6.0)</td></tr><tr><td> Amhara</td><td>274 (44.4)</td></tr><tr><td> Oromia</td><td>59 (9.6)</td></tr><tr><td> SNNP</td><td>31 (5.0)</td></tr><tr><td> Addis Ababa</td><td>136 (22.0)</td></tr><tr><td> Other<sup>a</sup></td><td>8 (1.34)</td></tr><tr><td colspan="2">Income Category (in birr)</td></tr><tr><td> &#8804; 500</td><td>306 (68.8)</td></tr><tr><td> 501&#8211;1000</td><td>92 (20.7)</td></tr><tr><td> &#8805; 1001</td><td>47 (10.6)</td></tr><tr><td colspan="2">Mother&#8217;s Educational Status</td></tr><tr><td> Not Educated</td><td>277 (44.9)</td></tr><tr><td> Primary school</td><td>134 (21.7)</td></tr><tr><td> Diploma</td><td>55 (8.9)</td></tr><tr><td> Degree and above</td><td>67 (10.9)</td></tr><tr><td colspan="2">Father&#8217;s Educational Status</td></tr><tr><td> Not Educated</td><td>213 (34.5)</td></tr><tr><td> Secondary school</td><td>71 (11.5)</td></tr><tr><td> Diploma</td><td>56 (9.1)</td></tr><tr><td> Degree and above</td><td>126 (20.4)</td></tr><tr><td colspan="2">Preparatory School</td></tr><tr><td> Public</td><td>547(88.7)</td></tr><tr><td> Private</td><td>63 (10.2)</td></tr><tr><td> NGO</td><td>7 (1.1)</td></tr></table>
8322d9ac2aa619f6922c94006f51d08a1ffa538c33e3d9d89e2f0d0e7a5f0a61.png
complex
<table><tr><td>Group</td><td>N</td><td colspan="2">Pain intensity</td><td colspan="2">Facial Swelling</td><td colspan="2">Mouth Opening</td></tr><tr><td></td><td></td><td>D1</td><td>D2</td><td>D1</td><td>D2</td><td>D1</td><td>D2</td></tr><tr><td>Group I</td><td>50</td><td>0.62 &#177; 0.6*</td><td>0.5 &#177; 0.51*</td><td>30.9 &#177; 1.6*</td><td>31.0 &#177; 1.58*</td><td>36.0 &#177; 11.2</td><td>38.1 &#177; 10.05</td></tr><tr><td>Group II</td><td>50</td><td>1.64 &#177; 0.9*</td><td>1.3 &#177; 0.62*</td><td>31.7 &#177; 1.6*</td><td>32.04 &#177; 1.5*</td><td>39.2 &#177; 11.3</td><td>36.0 &#177; 10.02</td></tr></table>
83e3248167d11f2b24b5f7072efae6acdb3543dda2fda4c1b16503788dbe75ba.png
complex
<table><tr><td rowspan="2"></td><td colspan="3">Population(CT <i>n</i> = 327, HPV <i>n</i> = 324)</td><td colspan="3">Vaccinees(CT <i>n</i> = 248, HPV <i>n</i> = 245)</td><td colspan="3">Non vaccinees(CT <i>n</i> = 77, HPV n = 77)</td><td rowspan="2">p-value</td></tr><tr><td>n</td><td>pr</td><td>sd</td><td>n</td><td>pr</td><td>sd</td><td>n</td><td>pr</td><td>sd</td></tr><tr><td>CT</td><td>15</td><td>4.6</td><td>1.2</td><td>10</td><td>4.0</td><td>1.3</td><td>5</td><td>6.5</td><td>2.8</td><td>0.360</td></tr><tr><td>HPV global</td><td>95<sup>a</sup></td><td>29.5</td><td>2.5</td><td>70</td><td>28.6</td><td>2.9</td><td>25</td><td>32.5</td><td>5.4</td><td>0.567</td></tr><tr><td>HPV vaccine</td><td>9<sup>b</sup></td><td>2.8</td><td>0.9</td><td>6</td><td>2.4</td><td>1.0</td><td>3</td><td>3.9</td><td>2.2</td><td>0.451</td></tr></table>
0c4e2bfb773edfd2bac46eccb3c1c5168d682e3a80373819c6f98cf87f741a34.png
complex
<table><tr><td>SIMD quintile &amp; domain</td><td>Mean score out of 10 &amp; (SD)</td><td>Developmentally vulnerable</td><td>Developmentally at risk</td><td colspan="2">On track</td></tr><tr><td> </td><td> </td><td>In the lowest 10%</td><td>Between the 10th and the 25th percentile</td><td>Between the 25th and 50th percentile</td><td>Above the 50% percentile</td></tr><tr><td> </td><td> </td><td>%</td><td>%</td><td>%</td><td>%</td></tr><tr><td>1: Most deprived</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>PHWB</td><td>8.45 (1.67)</td><td>25.6</td><td>12.8</td><td>28.2</td><td>33.3</td></tr><tr><td>SC</td><td>8.18 (1.97)</td><td>20.6</td><td>8.8</td><td>35.3</td><td>35.3</td></tr><tr><td>EM</td><td>7.94 (1.52)</td><td>15.8</td><td>21.1</td><td>28.9</td><td>34.2</td></tr><tr><td>L&amp;CD</td><td>8.36 (1.70)</td><td>18.9</td><td>18.9</td><td>45.9</td><td>16.2</td></tr><tr><td>C&amp;GK</td><td>7.77 (2.66)</td><td>17.9</td><td>17.9</td><td>64.1</td><td>0</td></tr><tr><td>2: Deprived</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>PHWB</td><td>8.55 (1.38)</td><td>22.4</td><td>18.1</td><td>25.4</td><td>34.1</td></tr><tr><td>SC</td><td>8.27 (1.91)</td><td>14.4</td><td>19.1</td><td>29.8</td><td>36.7</td></tr><tr><td>EM</td><td>8.21 (1.44)</td><td>13.9</td><td>16.5</td><td>25.1</td><td>44.6</td></tr><tr><td>L&amp;C</td><td>8.46 (1.93)</td><td>19.0</td><td>11.1</td><td>43.5</td><td>26.4</td></tr><tr><td>C&amp;GK</td><td>7.97 (2.47)</td><td>18.1</td><td>16.8</td><td>65.1</td><td>0</td></tr><tr><td>3: Average</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>PHWB</td><td>8.86 (1.31)</td><td>14.6</td><td>14.6</td><td>26.5</td><td>44.2</td></tr><tr><td>SC</td><td>8.65 (1.73)</td><td>11.9</td><td>12.4</td><td>23.3</td><td>52.4</td></tr><tr><td>EM</td><td>8.27 (1.36)</td><td>11.9</td><td>19.0</td><td>17.3</td><td>51.8</td></tr><tr><td>L&amp;C</td><td>8.90 (1.61)</td><td>10.5</td><td>14.3</td><td>34.3</td><td>41.0</td></tr><tr><td>C&amp;GK</td><td>8.26 (2.33)</td><td>15.9</td><td>14.2</td><td>69.9</td><td>0</td></tr><tr><td>4: Affluent</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>PHWB</td><td>9.04 (1.28)</td><td>12.8</td><td>8.6</td><td>25.6</td><td>53.0</td></tr><tr><td>SC</td><td>8.77 (1.63)</td><td>8.6</td><td>12.6</td><td>25.7</td><td>53.1</td></tr><tr><td>EM</td><td>8.36 (1.26)</td><td>9.7</td><td>18.1</td><td>20.8</td><td>51.4</td></tr><tr><td>L&amp;C</td><td>8.99 (1.51)</td><td>8.8</td><td>8.3</td><td>53.5</td><td>29.5</td></tr><tr><td>C&amp;GK</td><td>8.58 (2.11)</td><td>9.4</td><td>12.1</td><td>78.6</td><td>0</td></tr><tr><td>5: Most affluent</td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>PHWB</td><td>9.09 (1.05)</td><td>6.7</td><td>17.9</td><td>25.1</td><td>50.3</td></tr><tr><td>SC</td><td>8.89 (1.42)</td><td>6.3</td><td>15.0</td><td>26.3</td><td>52.5</td></tr><tr><td>EM</td><td>8.45 (1.17)</td><td>7.3</td><td>14.6</td><td>23.0</td><td>55.1</td></tr><tr><td>L&amp;C</td><td>9.34 (0.93)</td><td>1.8</td><td>10.7</td><td>42.6</td><td>45.0</td></tr><tr><td>C&amp;GK</td><td>8.78 (1.93)</td><td>5.6</td><td>15.0</td><td>79.4</td><td>0</td></tr></table>
b6df4ee5d1e9b2ef1d7ae214a9ff72ded721e89e6e80c753b8bced7e7cbeff91.png
complex
<table><tr><td></td><td></td><td></td><td colspan="7">Age group</td></tr><tr><td></td><td>Label reason for encounter</td><td>Total N (%)</td><td>0&#8211;4 N (%)</td><td>5&#8211;14 N (%)</td><td>15&#8211;24 N (%)</td><td>25&#8211;44 N (%)</td><td>45&#8211;64 N (%)</td><td>65&#8211;74 N (%)</td><td>75+ N (%)</td></tr><tr><td>1</td><td>Symptoms or complaints of sinus (including pain)<sup>a</sup></td><td>2001 (24.5)</td><td>7 (4.6)</td><td>60 (11.8)</td><td>196 (21.8)</td><td>1131 (29.7)</td><td>417 (22.7)</td><td>133 (20.9)</td><td>57 (18.3)</td></tr><tr><td>2</td><td>Upper respiratory infection (common cold)</td><td>1000 (12.3)</td><td>16 (10.5)</td><td>60 (11.8)</td><td>126 (14.0)</td><td>464 (12.2)</td><td>243 (13.3)</td><td>54 (8.5)</td><td>37 (11.9)</td></tr><tr><td>3</td><td>Headache<sup>b</sup></td><td>994 (12.2)</td><td>6 (3.9)</td><td>84 (16.5)</td><td>148 (16.4)</td><td>457 (12.0)</td><td>192 (10.5)</td><td>66 (10.4)</td><td>41 (13.2)</td></tr><tr><td>4</td><td>Cough</td><td>947 (11.6)</td><td>38 (24.8)</td><td>100 (19.6)</td><td>90 (10.0)</td><td>333 (8.7)</td><td>211 (11.5)</td><td>121 (19.1)</td><td>54 (17.4)</td></tr><tr><td>5</td><td>Sinusitis, acute or chronic<sup>c</sup></td><td>784 (9.6)</td><td>3 (2.0)</td><td>9 (1.8)</td><td>69 (7.7)</td><td>429 (11.3)</td><td>218 (11.9)</td><td>43 (6.8)</td><td>13 (4.2)</td></tr><tr><td>6</td><td>Fever</td><td>386 (4.7)</td><td>35 (22.9)</td><td>60 (11.8)</td><td>31 (3.4)</td><td>141 (3.7)</td><td>70 (3.8)</td><td>30 (4.7)</td><td>19 (6.1)</td></tr><tr><td>7</td><td>Symptoms or complaints of throat</td><td>237 (2.9)</td><td>2 (1.3)</td><td>13 (2.5)</td><td>43 (4.8)</td><td>88 (2.3)</td><td>64 (3.5)</td><td>20 (3.1)</td><td>7 (2.3)</td></tr><tr><td>8</td><td>Medication/prescription/injection</td><td>218 (2.7)</td><td>1 (0.7)</td><td>4 (0.8)</td><td>10 (1.1)</td><td>115 (3.0)</td><td>71 (3.9)</td><td>13 (2.0)</td><td>4 (1.3)</td></tr><tr><td>9</td><td>Sneezing/nasal congestion</td><td>211 (2.6)</td><td>4 (2.6)</td><td>17 (3.3)</td><td>36 (4.0)</td><td>81 (2.1)</td><td>37 (2.0)</td><td>26 (4.1)</td><td>10 (3.2)</td></tr><tr><td>10</td><td>General weakness/tiredness</td><td>181 (2.2)</td><td>8 (5.2)</td><td>20 (3.9)</td><td>21 (2.3)</td><td>73 (1.9)</td><td>29 (1.6)</td><td>17 (2.7)</td><td>13 (4.2)</td></tr></table>
5c18f0eacb373e8a86edc05703436f37a050a40f9804450d0a614d81f8cb16e0.png
complex
<table><tr><td>Fixed effects</td><td>Coefficient value</td><td>Standard error</td><td>Degrees of freedom</td><td><i>P</i>-value<sup>a</sup></td></tr><tr><td>Intercept</td><td>44.917</td><td>0.776</td><td>57</td><td>&lt;.0001</td></tr><tr><td>D530c vs. D-SPECT</td><td>&#8722;26.300</td><td>1.049</td><td>12</td><td>&lt;.0001</td></tr><tr><td>A-SPECT vs. D-SPECT</td><td>&#8722;37.779</td><td>1.021</td><td>12</td><td>&lt;.0001</td></tr><tr><td>Slope for the D-SPECT</td><td>&#8722;1.747</td><td>0.072</td><td>57</td><td>&lt;.0001</td></tr><tr><td>Slope for the D530c</td><td>0.277</td><td>0.043</td><td>57</td><td>&lt;.0001</td></tr><tr><td>Slope for the A-SPECT</td><td>&#8722;0.022</td><td>0.007</td><td>57</td><td>0.0016</td></tr><tr><td>Random effects</td><td>Standard deviation</td><td colspan="3">Standard deviation adjustment per camera</td></tr><tr><td>Intercept</td><td>1.42</td><td>D-SPECT</td><td>D530c</td><td>A-SPECT</td></tr><tr><td>Residual</td><td>0.497</td><td>1</td><td>0.706</td><td>0.108</td></tr></table>
ae0daed60ee0841112989cbad65fc06877266d67d324b17a0ab493cfab0a7aee.png
complex
<table><tr><td>Combination*</td><td>Patients</td><td>Controls</td><td><i>P</i></td><td>OR; 95% CI; <i>P</i></td><td>OR; 95% CI; <i>P</i>**</td></tr><tr><td>Men</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T-A-G-C</td><td>45.03%</td><td>44.23%</td><td>0.807</td><td colspan="2">Reference group</td></tr><tr><td>G-G-G-C</td><td>24.38%</td><td>27.06%</td><td>0.394</td><td>0.90; 0.74&#8211;1.11; 0.345</td><td>0.90; 0.74&#8211;1.11; 0.344</td></tr><tr><td>T-A-A-T</td><td>13.98%</td><td>13.46%</td><td>0.815</td><td>1.05; 0.75&#8211;1.46; 0.787</td><td>1.05; 0.75&#8211;1.46; 0.785</td></tr><tr><td>G-G-A-T</td><td>7.92%</td><td>6.18%</td><td>0.254</td><td>1.29; 0.85&#8211;1.96; 0.227</td><td>1.29; 0.85&#8211;1.96; 0.225</td></tr><tr><td>G-A-G-C</td><td>4.50%</td><td>5.63%</td><td>0.509</td><td>0.84; 0.57&#8211;1.25; 0.391</td><td>0.84; 0.57&#8211;1.25; 0.397</td></tr><tr><td>Women</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>T-A-G-C</td><td>48.44%</td><td>49.20%</td><td>0.888</td><td colspan="2">Reference group</td></tr><tr><td>G-G-G-C</td><td>22.75%</td><td>25.00%</td><td>0.251</td><td>0.91; 0.66&#8211;1.25; 0.560</td><td>0.91; 0.66&#8211;1.25; 0.549</td></tr><tr><td>T-A-A-T</td><td>18.30%</td><td>10.53%</td><td>&lt; 0.001</td><td>1.83; 1.20&#8211;2.80; 0.005</td><td>1.84; 1.20&#8211;2.81; 0.005</td></tr><tr><td>G-G-A-T</td><td>6.96%</td><td>5.73%</td><td>0.124</td><td>1.39; 0.74&#8211;2.58; 0.304</td><td>1.40; 0.75&#8211;2.62; 0.288</td></tr><tr><td>T-A-G-T</td><td>1.24%</td><td>5.21%</td><td>0.001</td><td>0.34; 0.15&#8211;0.77; 0.010</td><td>0.33; 0.15&#8211;0.76; 0.010</td></tr></table>
5a88d4067919a456a9fb4b714a0b86ae1f8d83eb6752415aafd16c3bc4cc1bb0.png
complex
<table><tr><td> </td><td>Continuous level (1/day)</td><td>p-value</td><td colspan="4">Level of soy consumption<sup>b</sup></td></tr><tr><td> </td><td> </td><td> </td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>Total soy</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Median intake, svg/wk</td><td> </td><td> </td><td>0.0</td><td>4.5</td><td>13.5</td><td>24.2</td></tr><tr><td>Median AOM, yr<sup>c</sup></td><td> </td><td> </td><td>12.6</td><td>12.4</td><td>12.5</td><td>12.6</td></tr><tr><td>Relative risk</td><td>0.99 (0.91, 1.07)</td><td>0.770</td><td>1.00 Ref</td><td>0.96 (0.66, 1.40)</td><td>0.95 (0.64, 1.41)</td><td>1.19 (0.79, 1.80)</td></tr><tr><td>Meat alternatives</td><td> </td><td> </td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Median intake, svg/wk</td><td> </td><td> </td><td>0.0</td><td>2.5</td><td>8.0</td><td>14.5</td></tr><tr><td>Median AOM, yr<sup>c</sup></td><td> </td><td> </td><td>12.5</td><td>12.5 (12.5)</td><td>12.8 (12.7)</td><td>12.5</td></tr><tr><td>Relative risk</td><td>1.01 (0.90, 1.13)</td><td>0.838</td><td>1.00 Ref</td><td>0.92 (0.62, 1.36)</td><td>1.02 (0.70, 1.48)</td><td>1.07 (0.70, 1.65)</td></tr><tr><td> </td><td> </td><td> </td><td>Non-consumers</td><td colspan="2">Low-moderate</td><td>High</td></tr><tr><td>Tofu/Traditional soy</td><td> </td><td> </td><td> </td><td colspan="2"> </td><td> </td></tr><tr><td>Median intake, svg/wk</td><td> </td><td> </td><td>0.0</td><td colspan="2">1.0</td><td>4.8</td></tr><tr><td>Median AOM, yr<sup>c</sup></td><td> </td><td> </td><td>12.5</td><td colspan="2">12.6</td><td>12.4</td></tr><tr><td>Relative Risk</td><td>0.90 (0.70, 1.16)</td><td>0.401</td><td>1.00 Ref</td><td colspan="2">0.93 (0.68, 1.26)</td><td>1.00 (0.72, 1.40)</td></tr><tr><td>Soy beverages</td><td> </td><td> </td><td> </td><td colspan="2"> </td><td> </td></tr><tr><td>Median intake, svg/wk</td><td> </td><td> </td><td>0.0</td><td colspan="2">1.5</td><td>8.5</td></tr><tr><td>Median AOM, yr<sup>c</sup></td><td> </td><td> </td><td>12.6</td><td colspan="2">12.4</td><td>12.6</td></tr><tr><td>Relative Risk</td><td>0.98 (0.84, 1.14)</td><td>0.759</td><td>1.00 Ref</td><td colspan="2">1.07 (0.79, 1.46)</td><td>1.12 (0.82, 1.54)</td></tr></table>
ddbc4173dbf82afe6b348421eda2016ff41b5d1efa680becf5d4b59689589936.png
simple
<table><tr><td></td><td>No PORT <i>N</i> (%)</td><td></td><td>PORT <i>N</i> (%)</td><td></td><td><i>P</i> value</td></tr><tr><td>Number of patients</td><td>3211</td><td></td><td>2093</td><td></td><td></td></tr><tr><td>Year of diagnosis, median (range)</td><td>2007 (1988&#8211;2012)</td><td></td><td>2006 (1988&#8211;2012)</td><td></td><td></td></tr><tr><td>Age, median (interquartile range)</td><td>67 (59&#8211;75)</td><td></td><td>63 (56&#8211;70)</td><td></td><td>&lt; 0.05 (&#967;<sup>2</sup> test)</td></tr><tr><td>Sex</td><td></td><td></td><td></td><td></td><td>0.312</td></tr><tr><td> Male</td><td>1599</td><td>(49.8)</td><td>1072</td><td>(51.2)</td><td></td></tr><tr><td> Female</td><td>1612</td><td>(50.2)</td><td>1021</td><td>(48.8)</td><td></td></tr><tr><td>Race or ethnicity</td><td></td><td></td><td></td><td></td><td>0.038</td></tr><tr><td> White</td><td>2638</td><td>(82.2)</td><td>1679</td><td>(80.2)</td><td></td></tr><tr><td> Black</td><td>286</td><td>(8.9)</td><td>231</td><td>(11.0)</td><td></td></tr><tr><td> Others</td><td>287</td><td>(8.9)</td><td>183</td><td>(8.7)</td><td></td></tr><tr><td>Cancer stage</td><td></td><td></td><td></td><td></td><td>&lt; 0.001</td></tr><tr><td> Localized</td><td>451</td><td>(14.0)</td><td>210</td><td>(10.0)</td><td></td></tr><tr><td> Regional</td><td>2167</td><td>(67.5)</td><td>1695</td><td>(81.0)</td><td></td></tr><tr><td> Distant</td><td>581</td><td>(18.1)</td><td>181</td><td>(8.6)</td><td></td></tr><tr><td> Unstaged</td><td>12</td><td>(0.4)</td><td>7</td><td>(0.3)</td><td></td></tr><tr><td>Tumor location</td><td></td><td></td><td></td><td></td><td>&lt; 0.001</td></tr><tr><td> Head of pancreas</td><td>2239</td><td>(69.7)</td><td>1559</td><td>(74.5)</td><td></td></tr><tr><td> Body or tail of pancreas</td><td>561</td><td>(17.5)</td><td>330</td><td>(15.8)</td><td></td></tr><tr><td> Other</td><td>411</td><td>(12.8)</td><td>204</td><td>(9.7)</td><td></td></tr><tr><td>Tumor differentiation</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Poorly differentiated or undifferentiated</td><td>1111</td><td>(34.6)</td><td>652</td><td>(31.2)</td><td>0.001</td></tr><tr><td> Well or moderately differentiated</td><td>1828</td><td>(56.9)</td><td>1294</td><td>(61.8)</td><td></td></tr><tr><td> Unknown</td><td>272</td><td>(8.5)</td><td>147</td><td>(7.0)</td><td></td></tr><tr><td>Total number of LN, median (range)</td><td>12</td><td>(0&#8211;69)</td><td>12</td><td>(0&#8211;72)</td><td></td></tr><tr><td>Number of PLN, median (range)</td><td>1</td><td>(0&#8211;32)</td><td>1</td><td>(0&#8211;34)</td><td></td></tr><tr><td>LNR (mean &#177; SD)</td><td>0.18 &#177; 0.23</td><td></td><td>0.17 &#177; 0.22</td><td></td><td></td></tr><tr><td>Lymph node status</td><td></td><td></td><td></td><td></td><td>&lt; 0.001</td></tr><tr><td> Not examined</td><td>231</td><td>(7.2)</td><td>74</td><td>(3.5)</td><td></td></tr><tr><td> pN0</td><td>1118</td><td>(34.8)</td><td>699</td><td>(33.4)</td><td></td></tr><tr><td> pN1</td><td>1862</td><td>(58.0)</td><td>1320</td><td>(63.1)</td><td></td></tr><tr><td>Median overall survival, months 95% CI</td><td>14.0 (13.3&#8211;14.7)</td><td></td><td>19.0 (18.2&#8211;19.8)</td><td></td><td>&lt; 0.001</td></tr><tr><td>Cancer-specific survival, months 95% CI</td><td>15.0 (14.2&#8211;15.8)</td><td></td><td>20.0 (19.1&#8211;20.9)</td><td></td><td>&lt; 0.001</td></tr><tr><td>Other-cause survival, months 95% CI</td><td>163.0 (129.5&#8211;196.5)</td><td></td><td>196.0 (160.2&#8211;231.8)</td><td></td><td>&lt; 0.001</td></tr></table>
bebcee0596d3e5f056979f1919c38d8f111f066e86189cfc793e8924434909ca.png
complex
<table><tr><td></td><td>Workpiece</td><td>Upper Punch</td><td>Die</td><td>Lower Punch</td></tr><tr><td>Properties</td><td>Elastic-plastic</td><td colspan="3">Rigid</td></tr><tr><td>Material</td><td>C1010</td><td>SKH55</td><td>WC</td><td>SKH9</td></tr><tr><td>Mesh number</td><td>35,000</td><td colspan="3">30,000</td></tr><tr><td>Hardness</td><td>HRC38</td><td>HRC66</td><td>HRC77</td><td>HRC61</td></tr></table>
1dbd93b934da2eba36e984ffe821734c4433794fa22b04446a1a68f647cad0c0.png
simple
<table><tr><td>ID</td><td>No-Attr BE</td><td>Sex BE</td><td>Age BE</td><td>Ped BE</td><td>All-Attr BE</td><td>All-Attr BE+CE</td><td>SSABE</td><td>SSABEG</td></tr><tr><td>rs6442089</td><td>74</td><td>72</td><td>74</td><td>66</td><td>35</td><td>55</td><td>57</td><td>24</td></tr><tr><td>rs1060407</td><td>76</td><td>66</td><td>58</td><td>50</td><td>18</td><td>41</td><td>46</td><td>13</td></tr><tr><td>13rs3772219</td><td>2</td><td>2</td><td>6</td><td>20</td><td>52</td><td>44</td><td>9</td><td>13</td></tr><tr><td>rs1131356</td><td>20</td><td>28</td><td>13</td><td>25</td><td>60</td><td>67</td><td>41</td><td>29</td></tr><tr><td>rs4679394</td><td>22</td><td>21</td><td>6</td><td>4</td><td>0</td><td>0</td><td>6</td><td>2</td></tr><tr><td>rs4683602</td><td>10</td><td>7</td><td>28</td><td>7</td><td>0</td><td>0</td><td>16</td><td>16</td></tr><tr><td>rs16851435</td><td>34</td><td>34</td><td>44</td><td>0</td><td>0</td><td>0</td><td>19</td><td>14</td></tr><tr><td>rs304079</td><td>4</td><td>6</td><td>8</td><td>16</td><td>38</td><td>32</td><td>19</td><td>21</td></tr><tr><td>rs373572</td><td>7</td><td>4</td><td>14</td><td>17</td><td>16</td><td>24</td><td>19</td><td>28</td></tr><tr><td>rs2322142</td><td>21</td><td>24</td><td>33</td><td>55</td><td>70</td><td>34</td><td>36</td><td>33</td></tr></table>
5ffa163eafeda7639f9440f584928de6a99b22c98eb4966b34b09fd27d416b3f.png
simple
<table><tr><td>LogMAR BCVA</td><td>Phacotrab group</td><td>Phaco group</td><td><i>P</i> Value</td></tr><tr><td>Mean preoperative &#177; SD</td><td>1.21 &#177; 0.49</td><td>1.23 &#177; 0.43</td><td>0.93*</td></tr><tr><td>Mean postoperative &#177; SD (6 mos)</td><td>0.82 &#177; 0.44</td><td>0.80 &#177; 0.38</td><td>0.91*</td></tr><tr><td>Mean postoperative &#177; SD (12 mos)</td><td>0.82 &#177; 0.41</td><td>0.80 &#177; 0.39</td><td>0.85*</td></tr><tr><td><i>P</i> Value</td><td>0.003*</td><td>&lt;0.001*</td><td></td></tr></table>
6a3f9042a23dd48a469b1d53eeb85201e0763c12fa01f90a122ca66857c24dbb.png
complex
<table><tr><td>ROI</td><td>BMD ratios in the bisphosphonates group</td><td>BMD ratios in the control group</td><td>WMD</td><td colspan="2">[95 % CI]</td><td><i>P</i> of chi-square</td><td><i>I</i><sup>2</sup></td><td>Selected model</td><td><i>P</i> for overall effect</td></tr><tr><td>1</td><td>97.556</td><td>90.840</td><td>6.364</td><td>2.122</td><td>10.606</td><td>0</td><td>92 %</td><td>Random-effect model</td><td>0.003</td></tr><tr><td>2</td><td>96.275</td><td>93.488</td><td>2.479</td><td>1.886</td><td>3.072</td><td>0.564</td><td>0 %</td><td>Fixed-effect model</td><td>&lt;0.001</td></tr><tr><td>3</td><td>97.041</td><td>95.413</td><td>1.309</td><td>0.824</td><td>1.794</td><td>0.673</td><td>0 %</td><td>Fixed-effect model</td><td>&lt;0.001</td></tr><tr><td>4</td><td>100.207</td><td>98.036</td><td>2.349</td><td>0.505</td><td>4.193</td><td>0.003</td><td>78 %</td><td>Random-effect model</td><td>0.013</td></tr><tr><td>5</td><td>97.528</td><td>97.172</td><td>&#8722;0.619</td><td>&#8722;1.120</td><td>&#8722;0.119</td><td>0.138</td><td>46 %</td><td>Fixed-effect model</td><td>0.015</td></tr><tr><td>6</td><td>95.641</td><td>92.724</td><td>2.177</td><td>1.598</td><td>2.756</td><td>0.552</td><td>0 %</td><td>Fixed-effect model</td><td>&lt;0.001</td></tr><tr><td>7</td><td>91.099</td><td>84.457</td><td>6.634</td><td>0.655</td><td>12.612</td><td>0.001</td><td>95 %</td><td>Random-effect model</td><td>0.030</td></tr></table>
cccff30ca213a757efe11de814de8a1843123923d3372b7a66a8fcaa32e1861d.png
simple
<table><tr><td></td><td>Normal</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td></tr><tr><td>Motor</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <i>Median nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DML (ms)</td><td>&#8804; 3,9</td><td>2,8</td><td>3</td><td></td><td>3,8</td><td>5</td><td></td></tr><tr><td>NCV (m/s)</td><td>&#8805; 50</td><td>53</td><td>50</td><td>n.d.</td><td>46,2</td><td>56</td><td>n.d.</td></tr><tr><td>Amplitude (mV)</td><td>&#8805; 6</td><td>11,4</td><td>14,2</td><td></td><td>n.d.</td><td>11</td><td></td></tr><tr><td> <i>Peroneal nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DML (ms)</td><td>&#8804; 4,8</td><td>7,6</td><td>4</td><td></td><td>5,3</td><td></td><td></td></tr><tr><td>NCV (m/s)</td><td>&#8805; 42</td><td>37</td><td>45</td><td>not recordable</td><td>47,8</td><td>not recordable</td><td>not recordable</td></tr><tr><td>Amplitude (mV)</td><td>&#8805; 4</td><td>0,8</td><td>8,4</td><td></td><td>2</td><td></td><td></td></tr><tr><td> <i>Tibial nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>DML (ms)</td><td>&#8804; 5,1</td><td>6,2</td><td>4,2</td><td>7,1</td><td></td><td></td><td></td></tr><tr><td>NCV (m/s)</td><td>&#8805; 41</td><td>31</td><td>36</td><td>38</td><td>n.d.</td><td>not recordable</td><td>not recordable</td></tr><tr><td>Amplitude (mV)</td><td>&#8805; 5</td><td>0,6</td><td>0,4</td><td>0,4</td><td></td><td></td><td></td></tr><tr><td>Sensory</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> <i>Median nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>NCV (m/s)</td><td>&#8805; 47</td><td>60</td><td>54</td><td>n.d.</td><td>57,7</td><td>45</td><td>n.d.</td></tr><tr><td>Amplitude (mV)</td><td>&#8805; 7</td><td>13,4</td><td>11</td><td></td><td>n.d.</td><td>20</td><td></td></tr><tr><td> <i>Sural nerve</i></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>NCV (m/s)</td><td>&#8805; 41</td><td>34</td><td>not recordable</td><td>30</td><td>56,5</td><td>32</td><td>not recordable</td></tr><tr><td>Amplitude (mV)</td><td>&#8805; 10</td><td>7,2</td><td></td><td>1</td><td>n.d.</td><td>6</td><td></td></tr></table>
9ca2d13fcef9ff4fe0175c44d3923d50e93c96444d9e82ce38a2b78fe6290479.png
simple
<table><tr><td></td><td>Males</td><td>P</td><td>Females</td><td>P</td></tr><tr><td></td><td>(n = 24)</td><td></td><td>(n = 20)</td><td></td></tr><tr><td>Model R</td><td>0.28</td><td>0.80</td><td>0.79</td><td>0.004</td></tr><tr><td>Standardised coefficients (Beta)</td><td></td><td></td><td></td><td></td></tr><tr><td>BMI</td><td>&#8722;0.06</td><td>0.88</td><td>1.06</td><td>0.008</td></tr><tr><td>Diet (1.5 g/d ALA vs. 9.5 g/d ALA)</td><td>0.02</td><td>0.94</td><td>0.63</td><td>0.003</td></tr><tr><td>Age</td><td>&#8722;0.15</td><td>0.56</td><td>&#8722;0.47</td><td>0.029</td></tr><tr><td>Weight</td><td>&#8722;0.15</td><td>0.68</td><td>&#8722;0.70</td><td>0.055</td></tr></table>
3599d918e2c832664ed6fc680d6e1ae85228867646328ac69a6754cea4efda3b.png
simple
<table><tr><td>Variable</td><td>&#946;</td><td>p</td><td>OR</td><td>95% CI</td></tr><tr><td>Marital status</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Single</td><td>0.859</td><td>0.031</td><td>2.36</td><td>1.081 &#8211; 5.150</td></tr><tr><td>All others</td><td> </td><td> </td><td>1</td><td> </td></tr><tr><td>Migrant</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Yes</td><td>0.403</td><td>0.002</td><td>1.497</td><td>1.156 &#8211; 1.937</td></tr><tr><td>No</td><td> </td><td> </td><td>1</td><td> </td></tr><tr><td>Religion</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Catholic</td><td>0.312</td><td>0.034</td><td>1.366</td><td>1.024 &#8211; 1.823</td></tr><tr><td>All others</td><td> </td><td> </td><td>1</td><td> </td></tr><tr><td>Income (n&#176; of minimal wages)</td><td>0.054</td><td>0.026</td><td>1.056</td><td>1.007 &#8211; 1.107</td></tr></table>
7fd6c503bfa681cc30487e53a0c0096aeb6a0d2a6e8fa7bfde49bc887c1c838f.png
simple
<table><tr><td>Factor</td><td>OR (95% CI)<sup>b</sup></td><td><i>P </i>value<sup>c</sup></td></tr><tr><td>Ultrasound examination</td><td>53.7 (28.6 to 83.5)</td><td>&lt; 0.001</td></tr><tr><td>NT-proBNP</td><td>14.3 (8.1 to 29.4)</td><td>&lt; 0.001</td></tr><tr><td>Orthopnea</td><td>6.9 (1.9 to 18.39</td><td>&lt; 0.001</td></tr><tr><td>Rales</td><td>5.1 (1.5 to 12.8)</td><td>0.014</td></tr><tr><td>Troponin T</td><td>2.1 (1.3 to 4.6)</td><td>0.018</td></tr><tr><td>petCO<sub>2</sub></td><td>7.6 (2.9 to 19.6)</td><td>&lt; 0.001</td></tr><tr><td>HF medications</td><td>2.7 (1.3 to 5.1)</td><td>0.031</td></tr><tr><td>Asthma/COPD medications</td><td>0.12 (0.03 to 0.42)</td><td>0.028</td></tr><tr><td>Previous HF</td><td>7.4 (2.3 to 20.4)</td><td>&lt; 0.001</td></tr><tr><td>Fever</td><td>0.17 (0.06 to 0.49)</td><td>0.017</td></tr></table>
1bc70f623053499b37e6af1f77df82e3a004c9e129dd80fca58de8297f167a3c.png
complex
<table><tr><td>Expression</td><td>Gene</td><td>Meningioma (%)</td><td>Schwannoma (%)</td></tr><tr><td rowspan="3">Downregulation</td><td><i>FOS</i></td><td>90</td><td>65</td></tr><tr><td><i>ICAM1</i></td><td>71</td><td>61</td></tr><tr><td><i>FLY1</i></td><td>78</td><td>48</td></tr><tr><td>Upregulation</td><td><i>ITCAV</i></td><td>66</td><td>61</td></tr></table>
604affeaa20dd229d69c3c1c3066db6135f89d683ecbd6342602d1081ae7305d.png
complex
<table><tr><td>Cluster number</td><td><i>x, y, z</i>a</td><td>Peak intensity</td><td>Cluster sizeb</td><td>Regionc</td><td>Brodmann's area</td></tr><tr><td colspan="6">Taking the Declive as ROI</td></tr><tr><td>1</td><td>&#8722;30, 3, &#8722;18</td><td>3.649</td><td>142</td><td>L Superior Temporal Gyrus/Inferior Parietal Lobe</td><td>41, 42, 44, 45</td></tr><tr><td>2</td><td>12, &#8722;72, 27</td><td>&#8722;3.462</td><td>125</td><td>R Medial Frontal Gyrus</td><td>7</td></tr><tr><td>3</td><td>&#8722;21, &#8722;27, 60</td><td>3.764</td><td>189</td><td>L Precentral Gyrus</td><td>4, 6</td></tr><tr><td colspan="6">Taking the Precentral Gyrus as ROI</td></tr><tr><td>1</td><td>0, 27, &#8722;21</td><td>&#8722;5.278</td><td>136</td><td>Orbital Frontal Gyrus</td><td>8, 9</td></tr><tr><td>2</td><td>3, 27, 39</td><td>4.077</td><td>497</td><td>Superior Frontal Gyrus/Medial Frontal Gyrus</td><td>4, 6, 8, 9</td></tr><tr><td colspan="6">Taking the Striatum as ROI</td></tr><tr><td>1</td><td>9, 0, 54</td><td>3.632</td><td>151</td><td>R Anterior Cingulate Cortex</td><td>6, 23, 24</td></tr><tr><td rowspan="2">2</td><td rowspan="2">39, &#8722;24, 48</td><td rowspan="2">3.884</td><td rowspan="2">185</td><td>R Middle Frontal Gyrus</td><td rowspan="2">4</td></tr><tr><td>R Inferior Frontal Gyrus</td></tr><tr><td>3</td><td>&#8722;24, 6, 51</td><td>3.749</td><td>197</td><td>L Postcentral Gyrus</td><td>1, 2, 3</td></tr></table>
ecf8c58995a39e208d4a6707191083e6523cd0f056d2c3cfdea5a721d45af4d1.png
simple
<table><tr><td>Time of assessment</td><td><i>n</i></td><td>Mean</td><td>Median</td><td>Minimum</td><td>Maximum</td><td>SD</td><td><i>P</i>-value*</td></tr><tr><td>Preoperative</td><td>30</td><td>4.1</td><td>4.0</td><td>2.0</td><td>8.3</td><td>1.4</td><td></td></tr><tr><td>3-5 days</td><td>30</td><td>3.3</td><td>3.1</td><td>1.8</td><td>4.9</td><td>0.8</td><td></td></tr><tr><td>1 month</td><td>30</td><td>3.0</td><td>2.9</td><td>2.0</td><td>4.6</td><td>0.7</td><td>0.019</td></tr><tr><td>6 months</td><td>30</td><td>3.0</td><td>3.1</td><td>1.1</td><td>5.0</td><td>0.8</td><td></td></tr><tr><td>1 year</td><td>30</td><td>3.1</td><td>3.2</td><td>1.5</td><td>5.4</td><td>0.8</td><td></td></tr></table>
ec6a0fb110cfbef19502385aeab5acee22ddd2e1c437887d19820b081da1e6ac.png
complex
<table><tr><td>Time Light</td><td colspan="2">Morning</td><td colspan="2">Mid-day</td><td colspan="2">Evening</td><td colspan="2">Total</td></tr><tr><td></td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td><td>Bright</td><td>Dim</td></tr><tr><td>Baseline start</td><td>21.23 (6.08) 13</td><td>21.00 (4.47) 15</td><td>18.73 (2.91) 15</td><td>19.50 (4.43) 16</td><td>18.54 (5.63) 13</td><td>17.00 (4.27) 16</td><td>19.46 (5.01) 41</td><td>19.50 (4.56) 40</td></tr><tr><td>End of baseline week</td><td>21.77 (5.85) 13</td><td>20.33 (4.53) 15</td><td>18.93 (3.41) 15</td><td>19.63 (4.83) 16</td><td>18.62 (5.61) 13</td><td>17.89 (5.09) 9</td><td>19.73 (5.07) 41</td><td>19.50 (4.74) 40</td></tr><tr><td>After wake therapy</td><td>21.67 (5.68) 9</td><td>19.43 (6.73) 14</td><td>18.00 (5.31) 12</td><td>18.00 (5.85) 13</td><td>16.60 (5.97) 10</td><td>17.14 (4.14) 7</td><td>18.61 (5.82) 31</td><td>18.41 (5.85) 34</td></tr><tr><td>Treatment Week 1</td><td>20.00 (5.55) 13</td><td>19.33 (7.69) 15</td><td>18.20 (4.06) 15</td><td>16.94 (3.99) 16</td><td>15.08 (8.41) 13</td><td>15.11 (5.11) 9</td><td>17.78 (6.35) 41</td><td>17.43 (5.95) 40</td></tr><tr><td>Treatment Week 2</td><td>20.08 (6.22) 13</td><td>18.60 (7.60) 15</td><td>16.21 (5.69) 14</td><td>14.38 (5.30) 16</td><td>14.75 (8.07) 12</td><td>12.33 (5.45) 9</td><td>17.05 (6.87) 39</td><td>15.50 (6.65) 40</td></tr><tr><td>Treatment Week 3</td><td>18.85 (6.50) 13</td><td>18.50 (6.44) 14</td><td>15.00 (5.41) 15</td><td>14.81 (5.97) 16</td><td>13.23 (6.66) 13</td><td>13.00 (7.05) 9</td><td>15.66 (6.45) 41</td><td>15.72 (6.61) 39</td></tr><tr><td>Treatment Week 4</td><td>17.38 (6.96) 13</td><td>18.67 (7.79) 15</td><td>14.07 (6.06) 15</td><td>13.81 (5.60) 16</td><td>11.77 (7.00) 13</td><td>12.22 (6.53) 9</td><td>14.39 (6.88) 41</td><td>15.28 (7.07) 40</td></tr><tr><td>Two-Week follow-up</td><td>16.25 (7.96) 12</td><td>16.00 (7.72) 11</td><td>13.69 (5.41) 13</td><td>11.85 (5.80) 14</td><td>11.80 (6.66) 10</td><td>12.13 (8.41) 8</td><td>14.03 (6.77) 35</td><td>13.30 (7.18) 33</td></tr><tr><td>Four-Week follow-up</td><td>17.25 (6.54) 8</td><td>14.00 (9.03) 9</td><td>12.77 (5.69) 13</td><td>13.08 (5.27) 13</td><td>13.55 (6.25) 11</td><td>10.25 (8.40) 8</td><td>14.16 (6.18) 32</td><td>12.60 (7.29) 30</td></tr><tr><td>3-Month follow-up</td><td>14.00 (9.47) 8</td><td>18.14 (9.58) 7</td><td>15.91 (5.26) 11</td><td>11.21 (5.74) 14</td><td>16.29 (6.97) 7</td><td>11.60 (9.63) 5</td><td>15.42 (6.99) 26</td><td>13.15 (7.97) 26</td></tr></table>
f794d8db5dd08b08841bfe71dc9ce0262d7d83cfb4e9517a599d7f3057334248.png
simple
<table><tr><td>Typer</td><td>Overall</td><td>HLA-A</td><td>HLA-B</td><td>HLA-C</td></tr><tr><td>Optitype (4-digit)</td><td>0.09</td><td>0.08</td><td>0.08</td><td>0.11</td></tr><tr><td>Polysolver (8-digit)</td><td>0.08</td><td>0.08</td><td>0.02</td><td>0.14</td></tr><tr><td>Polysolver (4-digit)</td><td>0.12</td><td>0.12</td><td>0.09</td><td>0.15</td></tr></table>
f23ef114ab13a3f943e239c711422674c854675cf7dd46e74375ffaa9f753d2c.png
simple
<table><tr><td>Characteristics</td><td>New-onset CAE (<i>n</i> = 35)</td><td>Control (<i>n</i> = 33)</td><td><i>P</i> value</td></tr><tr><td>Age (years), mean &#177; SD (range)</td><td>7.3 &#177; 1.3 (5&#8211;10)</td><td>6.8 &#177; 1.1 (5&#8211;9)</td><td>0.14</td></tr><tr><td>Gender (boys/girls)</td><td>14/21</td><td>18/15</td><td>0.23</td></tr><tr><td>Age at onset, years (SD)</td><td>6.7 (1.3)</td><td>N/A</td><td>N/A</td></tr><tr><td>Duration of epilepsy (time to diagnosis), months (SD)</td><td>7 (7)</td><td>N/A</td><td>N/A</td></tr></table>
692dbe42043b20ec2a9d3909bc522b96fd6b9774da8a25c8616b7439f1a62cdc.png
simple
<table><tr><td></td><td>2007</td><td>2008</td><td>2009</td><td>2010</td></tr><tr><td>Total number of insured persons</td><td>4 048 709</td><td>3 931 988</td><td>3 906 411</td><td>3 954 172</td></tr><tr><td>Age in years (mean)</td><td>43.0</td><td>43.5</td><td>43.7</td><td>43.7</td></tr><tr><td>Sex (men &amp; women)</td><td>47.1 % &amp; 52.9 %</td><td>47.0 % &amp; 53.0 %</td><td>47.1 % &amp; 52.9 %</td><td>47.2 % &amp; 52.8 %</td></tr><tr><td>Number of persons insured permanently over the respective year (study population)</td><td>3 538 793</td><td>3 483 739</td><td>3 459 461</td><td>3 492 326</td></tr><tr><td>Proportion of the included study population compared to total number of insured persons (%)</td><td>87.4 %</td><td>88.6 %</td><td>88.6 %</td><td>88.3 %</td></tr><tr><td>Age in years (mean)</td><td>44.4</td><td>44.8</td><td>40.0</td><td>45.0</td></tr><tr><td>Sex (men &amp; women)</td><td>46.2 % &amp; 53.8 %</td><td>46.3 % &amp; 53.7 %</td><td>46.4 % &amp; 53.6 %</td><td>46.4 % &amp; 53.6 %</td></tr></table>
ca44d3ff0e5523624c2690d04f0f8353876f507167e77c55eaf8c6726c3a24b2.png
complex
<table><tr><td>Age group (years)</td><td colspan="2"><i>Haemophilus influenzae</i> type b (invasive)</td><td colspan="2">Measles</td><td colspan="2">Meningococcal disease(invasive)</td><td colspan="2">Mumps</td><td colspan="2">Pertussis</td><td colspan="2">Pneumococcal disease(invasive)</td><td colspan="2">Rubella</td><td colspan="2">Tetanus</td></tr><tr><td> </td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td><td>n</td><td>Rate</td></tr><tr><td>0&#8211;4</td><td>3</td><td>0.6</td><td>12</td><td>2.4</td><td>14</td><td>2.8</td><td>7</td><td>1.4</td><td>400</td><td>80.8</td><td>69</td><td>13.9</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>5&#8211;9</td><td>0</td><td>0.0</td><td>4</td><td>0.9</td><td>0</td><td>0</td><td>8</td><td>1.7</td><td>636</td><td>134.6</td><td>11</td><td>2.3</td><td>1</td><td>0.2</td><td>0</td><td>0</td></tr><tr><td>10&#8211;14</td><td>0</td><td>0.0</td><td>6</td><td>1.3</td><td>3</td><td>0.7</td><td>3</td><td>0.7</td><td>518</td><td>115.2</td><td>5</td><td>1.1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>15&#8211;19</td><td>0</td><td>0.0</td><td>15</td><td>3.2</td><td>3</td><td>0.7</td><td>9</td><td>1.9</td><td>122</td><td>26.3</td><td>9</td><td>1.9</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>20&#8211;24</td><td>0</td><td>0.0</td><td>11</td><td>2.2</td><td>1</td><td>0.2</td><td>7</td><td>1.4</td><td>86</td><td>17.0</td><td>6</td><td>1.2</td><td>1</td><td>0.2</td><td>0</td><td>0</td></tr><tr><td>25&#8211;29</td><td>0</td><td>0.0</td><td>8</td><td>1.5</td><td>0</td><td>0.0</td><td>1</td><td>0.2</td><td>82</td><td>15.2</td><td>12</td><td>2.2</td><td>3</td><td>0.6</td><td>0</td><td>0</td></tr><tr><td>30&#8211;34</td><td>1</td><td>0.2</td><td>6</td><td>1.1</td><td>2</td><td>0.4</td><td>10</td><td>1.8</td><td>128</td><td>23.6</td><td>11</td><td>2.0</td><td>0</td><td>0</td><td>1</td><td>0.2</td></tr><tr><td>35&#8211;39</td><td>0</td><td>0.0</td><td>4</td><td>0.8</td><td>0</td><td>0.0</td><td>9</td><td>1.8</td><td>128</td><td>25.6</td><td>20</td><td>4.0</td><td>2</td><td>0.4</td><td>0</td><td>0</td></tr><tr><td>40&#8211;44</td><td>0</td><td>0.0</td><td>1</td><td>0.2</td><td>1</td><td>0.2</td><td>2</td><td>0.4</td><td>175</td><td>33.3</td><td>18</td><td>3.4</td><td>1</td><td>0.2</td><td>0</td><td>0</td></tr><tr><td>45&#8211;49</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>3</td><td>0.6</td><td>145</td><td>29.9</td><td>38</td><td>7.8</td><td>2</td><td>0.4</td><td>0</td><td>0</td></tr><tr><td>50&#8211;54</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>1</td><td>0.2</td><td>4</td><td>0.8</td><td>125</td><td>25.0</td><td>30</td><td>6.0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>55&#8211;59</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>1</td><td>0.2</td><td>4</td><td>0.9</td><td>122</td><td>26.4</td><td>41</td><td>8.9</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>60&#8211;64</td><td>1</td><td>0.2</td><td>0</td><td>0</td><td>1</td><td>0.2</td><td>4</td><td>1.0</td><td>127</td><td>31.0</td><td>46</td><td>11.2</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>65&#8211;69</td><td>1</td><td>0.3</td><td>0</td><td>0</td><td>3</td><td>0.8</td><td>3</td><td>0.8</td><td>103</td><td>27.9</td><td>49</td><td>13.3</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>70&#8211;74</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>1</td><td>0.4</td><td>2</td><td>0.7</td><td>80</td><td>29.5</td><td>34</td><td>12.5</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>75&#8211;79</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>2</td><td>1.0</td><td>2</td><td>1.0</td><td>68</td><td>33.0</td><td>31</td><td>15.0</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>80&#8211;84</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0.7</td><td>48</td><td>31.2</td><td>32</td><td>20.8</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>85+</td><td>0</td><td>0.0</td><td>0</td><td>0</td><td>3</td><td>1.9</td><td>0</td><td>0</td><td>37</td><td>23.1</td><td>54</td><td>33.8</td><td>0</td><td>0</td><td>0</td><td>0</td></tr></table>
100859bd75ea00d882b8083884a1e07c4bd55c1cb1b9643f988e994b34696dc7.png
complex
<table><tr><td>Outcome</td><td><i>ID</i></td><td><i>GH</i></td><td><i>PE</i></td><td><i>HEELP</i></td><td><i>FGR</i></td><td><i>PL</i></td><td><i>Abruptio</i></td><td><i>Previa</i></td><td><i>DIC</i></td></tr><tr><td></td><td colspan="9">Cases with single mutation Pearson correlation 2-tailed significance</td></tr><tr><td rowspan="3"> AT III deficiency</td><td>0</td><td>2</td><td>6</td><td>0</td><td>2</td><td>0</td><td>0</td><td>0</td><td>2</td></tr><tr><td>-0.035</td><td>-0.034</td><td>0.131</td><td>0.002</td><td>0.012</td><td>-0.042</td><td>0.052</td><td>-0.050</td><td>0.138</td></tr><tr><td>0.541</td><td>0.551</td><td>0.022</td><td>0.972</td><td>0.837</td><td>0.468</td><td>0.366</td><td>0.383</td><td>0.016</td></tr><tr><td rowspan="3"> Protein S deficiency</td><td>0</td><td>0</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>-0.024</td><td>-0.055</td><td>-0.028</td><td>-0.041</td><td>-0.016</td><td>-0.028</td><td>-0.043</td><td>-0.034</td><td>-0.015</td></tr><tr><td>0.679</td><td>0.337</td><td>0.623</td><td>0.481</td><td>0.786</td><td>0.623</td><td>0.450</td><td>0.555</td><td>0.794</td></tr><tr><td rowspan="3"> APCR</td><td>1</td><td>4</td><td>0</td><td>3</td><td>12</td><td>3</td><td>11</td><td>4</td><td>0</td></tr><tr><td>-0.028</td><td>-0.066</td><td>-0.034</td><td>-0.048</td><td>0.010</td><td>-0.034</td><td>0.159</td><td>-0.041</td><td>-0.018</td></tr><tr><td>0.622</td><td>0.253</td><td>0.558</td><td>0.402</td><td>0.868</td><td>0.558</td><td>0.005</td><td>0.481</td><td>0.756</td></tr><tr><td rowspan="3"> Hyper-HCY</td><td>0</td><td>3</td><td>0</td><td>2</td><td>6</td><td>0</td><td>2</td><td>2</td><td>0</td></tr><tr><td>0.046</td><td>-0.016</td><td>-0.050</td><td>0.089</td><td>0.110</td><td>-0.050</td><td>-0.026</td><td>-0.060</td><td>-0.026</td></tr><tr><td>0.424</td><td>0.785</td><td>0.386</td><td>0.122</td><td>0.056</td><td>0.386</td><td>0.647</td><td>0.298</td><td>0.122</td></tr><tr><td rowspan="3"> C677T MTHFR (+/+)</td><td>1</td><td>4</td><td>1</td><td>2</td><td>9</td><td>2</td><td>3</td><td>4</td><td>0</td></tr><tr><td>-0.061</td><td>0.039</td><td>-0.084</td><td>-0.041</td><td>0.131</td><td>-0.084</td><td>-0.023</td><td>-0.041</td><td>0.044</td></tr><tr><td>0.286</td><td>0.493</td><td>0.144</td><td>0.478</td><td>0.022</td><td>0.144</td><td>0.695</td><td>0.477</td><td>0.448</td></tr><tr><td rowspan="3"> A1298C MTHFR (+/+)</td><td>0</td><td>2</td><td>0</td><td>0</td><td>3</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>-0.032</td><td>-0.041</td><td>-0.038</td><td>0.033</td><td>0.070</td><td>0.146</td><td>-0.017</td><td>-0.046</td><td>-0.020</td></tr><tr><td>0.576</td><td>0.476</td><td>0.506</td><td>0.563</td><td>0.224</td><td>0.011</td><td>0.762</td><td>0.425</td><td>0.725</td></tr><tr><td rowspan="3"> G20210A PTR (+/+)</td><td>0</td><td>0</td><td>0</td><td>1</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>-0.027</td><td>-0.063</td><td>-0.032</td><td>0.016</td><td>-0.002</td><td>-0.032</td><td>0.009</td><td>0.108</td><td>-0.017</td></tr><tr><td>0.638</td><td>0.275</td><td>0.576</td><td>0.775</td><td>0.971</td><td>0.576</td><td>0.872</td><td>0.059</td><td>0.767</td></tr><tr><td rowspan="3"> G1691A factor V (+/+)</td><td>0</td><td>1</td><td>0</td><td>0</td><td>1</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>-0.038</td><td>-0.089</td><td>-0.046</td><td>-0.065</td><td>0.029</td><td>-0.046</td><td>0.102</td><td>-0.001</td><td>-0.024</td></tr><tr><td>0.505</td><td>0.122</td><td>0.428</td><td>0.257</td><td>0.611</td><td>0.428</td><td>0.077</td><td>0.985</td><td>0.675</td></tr><tr><td rowspan="3"> PAI-1 (5G/5G) (+/+)</td><td>1</td><td>3</td><td>0</td><td>1</td><td>2</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>0.005</td><td>-0.035</td><td>-0.054</td><td>-0.016</td><td>0.018</td><td>-0.054</td><td>-0.054</td><td>0.007</td><td>-0.029</td></tr><tr><td>0.934</td><td>0.54</td><td>0.350</td><td>0.779</td><td>0.755</td><td>0.350</td><td>0.348</td><td>0.906</td><td>0.620</td></tr></table>
cb05b29acc232d814175512e3bff78de24544b2ffb0226d8f252d30c697df300.png
simple
<table><tr><td>BehaviouralCorrelate</td><td>Brain region</td><td>Cerebral hemisphere</td><td>Cluster size (voxels)</td><td>p value</td></tr><tr><td>Combined groups</td><td>Anterior TL, OFC</td><td>R</td><td>107,453</td><td>0.02</td></tr><tr><td>bvFTD only</td><td>Anterior TL, OFC</td><td>Bilateral</td><td>318,805</td><td>0.01</td></tr><tr><td>bvFTD &gt; svPPA</td><td>Parahippocampal, fusiform gyri</td><td>L</td><td>61,222</td><td>0.03</td></tr></table>
58da377859bba45d004d89b5cc5e08d3fd6557d0b2505e77e6a7d9b3fa838d28.png
complex
<table><tr><td></td><td colspan="2">Baseline</td><td colspan="2">Day 1</td><td colspan="2">Day 3</td><td colspan="2">Day 7</td></tr><tr><td></td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td><td>PHARLAP</td><td>Control</td></tr><tr><td>V<sub>T</sub>, mls</td><td>519 &#177; 56</td><td>501 &#177; 30</td><td>463 &#177; 42</td><td>563 &#177; 65</td><td>586 &#177; 58</td><td>511 &#177; 55</td><td>528 &#177; 76</td><td>579 &#177; 78</td></tr><tr><td>RR, bpm</td><td>21 &#177; 2</td><td>21 &#177; 1</td><td>22 &#177; 2</td><td>20 &#177; 2</td><td>19 &#177; 2</td><td>24 &#177; 2</td><td>22 &#177; 2</td><td>22 &#177; 2</td></tr><tr><td>FiO<sub>2</sub></td><td>0.48 &#177; 0.06</td><td>0.57 &#177; 0.06</td><td>0.4 &#177; 0.04</td><td>0.5 &#177; 0.04</td><td>0.5 &#177; 0.07</td><td>0.55 &#177; 0.06</td><td>0.5 &#177; 0.07</td><td>0.5 &#177; 0.09</td></tr><tr><td>PEEP,cm H<sub>2</sub>O</td><td>11.8 &#177; 0.7</td><td>14.2 &#177; 1.2</td><td>15 &#177; 1*</td><td>10 &#177; 0.5</td><td>12.1 &#177; 1.5</td><td>9.3 &#177; 1.4</td><td>8.5 &#177; 1.8</td><td>7.8 &#177; 2.0</td></tr><tr><td>Pplateau, cmH<sub>2</sub>O</td><td>28.4 &#177; 1.5</td><td>29 &#177; 1.5</td><td>27.6 &#177; 1.5</td><td>26.9 &#177; 1.4</td><td>24.2 &#177; 2.4</td><td>24 &#177; 2.1</td><td>21 &#177; 2.9</td><td>20. &#177; 3.4</td></tr><tr><td>Arterial pH</td><td>7.34 &#177; 0.02</td><td>7.36 &#177; 0.02</td><td>7.36 &#177; 0.01</td><td>7.35 &#177; 0.01</td><td>7.38 &#177; 0.03</td><td>7.44 &#177; 0.03</td><td>7.42 &#177; 0.03</td><td>7.42 &#177; 0.04</td></tr><tr><td>PaCO<sub>2</sub>, mmHg</td><td>49 &#177; 5</td><td>46 &#177; 5</td><td>45 &#177; 3</td><td>46 &#177; 3</td><td>47.6 &#177; 3.7</td><td>44 &#177; 3.5</td><td>43.3 &#177; 4</td><td>56.5 &#177; 5</td></tr></table>
d696a03d712cc441f2cec2f9eaac9df0b2cef8a1ae21c308aa48e93d6d290114.png
simple
<table><tr><td>Variable</td><td>C</td><td>F</td></tr><tr><td>Glucose (mg/dl)</td><td>83.6 &#177; 4.5</td><td>98.5 &#177; 10.5*</td></tr><tr><td>Triglycerides (mg/dl)</td><td>123.4 &#177; 49.0</td><td>268.3 &#177; 35.1*</td></tr><tr><td>Total cholesterol (mg/dl)</td><td>91.7 &#177; 9.6</td><td>96.3 &#177; 15.5</td></tr><tr><td>HDL cholesterol (mg/dl)</td><td>42.7 &#177; 5.3</td><td>43.5 &#177; 6.9</td></tr><tr><td>LDL cholesterol (mg/dl)</td><td>62.8 &#177; 3.9</td><td>65.4 &#177; 1.3</td></tr><tr><td>AST/ALT ratio</td><td>1.08 &#177; 0.4</td><td>2.8 &#177; 0.8*</td></tr><tr><td>SOD (U/ml)</td><td>1.7 &#177; 0.4</td><td>1.5 &#177; 0.6</td></tr><tr><td>Catalase (U/ml)</td><td>42.2 &#177; 10.4</td><td>68.4 &#177; 6.8*</td></tr><tr><td>TBARS (&#956;M)</td><td>16.5 &#177; 2.0</td><td>22.2 &#177; 4.4*</td></tr></table>
33e02c7b3edb89dbba51c754138d1be212423f90d99d82be3508dadc28852ba1.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">Normal versus normal-tension glaucoma</td></tr><tr><td>AUROC (SE)</td><td>Sn/Sp (Sp &gt; 90%)</td></tr><tr><td>OCT-A whole image vessel density</td><td>0.950 (0.027)</td><td>82.14/92.00</td></tr><tr><td>OCT-A inside disc vessel density</td><td>0.931 (0.034)</td><td>78.57/92.00</td></tr><tr><td>OCT-A peripapillary vessel density</td><td>0.830 (0.056)<sup>&#8727;</sup></td><td>60.71/92.00</td></tr><tr><td>LSFG MBR<sub>A</sub></td><td>0.793 (0.065)<sup>&#8727;&#8224;</sup></td><td>60.71/92.00</td></tr><tr><td>LSFG MBR<sub>V</sub></td><td>0.601 (0.079)<sup>&#8727;&#8224;&#8225;</sup></td><td>21.43/92.00</td></tr><tr><td>LSFG MBR<sub>T</sub></td><td>0.601 (0.079)<sup>&#8727;&#8224;&#8225;</sup></td><td>28.57/92.00</td></tr><tr><td>GCC thickness</td><td>0.970 (0.021)<sup>&#8225;</sup></td><td>92.86/92.00</td></tr><tr><td>RNFL thickness</td><td>0.906 (0.039)</td><td>75.00/96.00</td></tr></table>
1e18001564d3955d571d4c8d5551a29160a94560bc67feb87a90e84e998202d5.png
complex
<table><tr><td>Variables</td><td>Overall</td><td>Somalian</td><td>Ethiopian</td><td>Eritrean</td><td>Gambian</td><td><i>P</i>-value</td></tr><tr><td>N</td><td>36,366</td><td>24,253</td><td>5631</td><td>4483</td><td>1999</td><td></td></tr><tr><td colspan="7">Age distribution, %</td></tr><tr><td> 0&#8211;14</td><td>38.1</td><td>41.2</td><td>34.1</td><td>28.5</td><td>33.7</td><td>&lt;0.001</td></tr><tr><td> 15&#8211;44</td><td>52.2</td><td>50.8</td><td>56.0</td><td>56.1</td><td>49.9</td><td>&lt;0.001</td></tr><tr><td> 45&#8211;64</td><td>8.8</td><td>7.0</td><td>9.6</td><td>14.5</td><td>16.2</td><td>&lt;0.001</td></tr><tr><td> &#8805; 64</td><td>0.8</td><td>0.9</td><td>0.4</td><td>0.9</td><td>0.2</td><td>&lt;0.001</td></tr><tr><td>Age, mean (SD)</td><td>22.8 (16.0)</td><td>21.5 (15.8)</td><td>24.0 (15.5)</td><td>27.3 (16.7)</td><td>25.0 (16.5)</td><td></td></tr><tr><td> Women, %</td><td>47.0</td><td>47.0</td><td>46.5</td><td>48.7</td><td>44.4</td><td>0.11</td></tr><tr><td> Urban settlement, %</td><td>83.3</td><td>81.9</td><td>86.6</td><td>82.6</td><td>92.0</td><td>&lt;0.001</td></tr><tr><td colspan="7">Marital status, %:</td></tr><tr><td> Unmarried</td><td>64.4</td><td>65.0</td><td>63.1</td><td>63.7</td><td>61.4</td><td>&lt;0.001</td></tr><tr><td> Married</td><td>24.5</td><td>23.8</td><td>27.7</td><td>27.0</td><td>19.2</td><td>&lt;0.001</td></tr><tr><td> Others (divorced, separated or widow)</td><td>11.1</td><td>11.2</td><td>9.2</td><td>9.3</td><td>19.4</td><td>&lt;0.001</td></tr><tr><td>Income, mean [Norwegian crownes]</td><td>75,827</td><td>53,731</td><td>126,980</td><td>118,213</td><td>104,721</td><td>&lt;0.001</td></tr><tr><td colspan="7">Employment status, %</td></tr><tr><td> Outside work force</td><td>67.9</td><td>73.3</td><td>55.3</td><td>58.7</td><td>58.5</td><td>&lt;0.001</td></tr><tr><td> Employed</td><td>26.0</td><td>19.9</td><td>40.9</td><td>38.0</td><td>35.8</td><td>&lt;0.001</td></tr><tr><td> Self-employed</td><td>0.7</td><td>0.6</td><td>0.8</td><td>0.7</td><td>1.9</td><td>&lt;0.001</td></tr><tr><td> Unemployed</td><td>3.3</td><td>4.0</td><td>1.9</td><td>1.7</td><td>2.4</td><td>&lt;0.001</td></tr><tr><td> Social welfare beneficiaries</td><td>1.8</td><td>2.2</td><td>1.0</td><td>0.9</td><td>1.4</td><td>&lt;0.001</td></tr><tr><td colspan="7">Immigrants, reasons of migration, %:</td></tr><tr><td> Labour</td><td>0.1</td><td>0.1</td><td>0.4</td><td>0.1</td><td>0.4</td><td>&lt;0.001</td></tr><tr><td> Refugee</td><td>35.3</td><td>37.9</td><td>29.7</td><td>43.4</td><td>1.0</td><td>&lt;0.001</td></tr><tr><td> Family reunification</td><td>25.1</td><td>28.8</td><td>19.7</td><td>11.5</td><td>25.6</td><td>&lt;0.001</td></tr><tr><td> Others</td><td>2.2</td><td>0.9</td><td>7.5</td><td>1.5</td><td>3.4</td><td>&lt;0.001</td></tr><tr><td> Reason not specified</td><td>37.3</td><td>32.3</td><td>42.7</td><td>43.5</td><td>69.6</td><td>&lt;0.001</td></tr><tr><td> Length of stay in Norway, mean (SD)</td><td>7.63 (7.15)</td><td>6.61 (5.39)</td><td>8.51 (9.07)</td><td>9.33 (9.71)</td><td>13.74 (8.77)</td><td>&lt;0.001</td></tr><tr><td colspan="7">Immigrants background, %</td></tr><tr><td> Immigrant</td><td>69.0</td><td>71.2</td><td>64.4</td><td>71.8</td><td>48.6</td><td>&lt;0.001</td></tr><tr><td> Born in Norway with immigrant parent</td><td>23.3</td><td>26.3</td><td>14.2</td><td>20.4</td><td>18.7</td><td>&lt;0.001</td></tr><tr><td> Born out of Norway with one parent a Norwegian</td><td>0.3</td><td>0.0</td><td>1.5</td><td>0.4</td><td>0.3</td><td>&lt;0.001</td></tr><tr><td> Born in Norway with one parent a Norwegian</td><td>5.1</td><td>2.4</td><td>7.1</td><td>5.0</td><td>32.4</td><td>&lt;0.001</td></tr><tr><td> Born out of Norway with both parent Norwegian</td><td>2.3</td><td>0.0</td><td>12.8</td><td>2.4</td><td>0.0</td><td>&lt;0.001</td></tr><tr><td> Norwegian nationality, %</td><td>56.5</td><td>54.2</td><td>58.2</td><td>55.4</td><td>81.5</td><td>&lt;0.001</td></tr><tr><td colspan="7">Use of health care services, mean (SD)</td></tr><tr><td> Number of consultations with GP in 2008</td><td>2.42 (3.38)</td><td>2.48 (3.41)</td><td>2.29 (3.30)</td><td>2.33 (3.45)</td><td>2.14 (3.01)</td><td>&lt;0.001</td></tr><tr><td> Number of consultations at ER in 2008</td><td>0.24 (0.67)</td><td>0.27 (0.72)</td><td>0.22 (0.61)</td><td>0.14 (0.48)</td><td>0.19 (0.53)</td><td>&lt;0.001</td></tr></table>
922c912575c93673611f05923569ccfee0e6f5964fd6454ba8078474db1f4a41.png
complex
<table><tr><td colspan="3">Private Hospital</td><td colspan="3">National Data</td></tr><tr><td>YEAR</td><td>No. of Malaria cases</td><td><i>Plasmodium falciparum</i></td><td>YEAR</td><td>No. of Malaria Cases</td><td><i>Plasmodium falciparum</i></td></tr><tr><td>2006July -December</td><td>60</td><td>31</td><td>2006</td><td>928</td><td>36</td></tr><tr><td>2007</td><td>35</td><td>15</td><td>2007</td><td>182</td><td>2</td></tr><tr><td>2008Jan - July</td><td>18</td><td>10</td><td>2008</td><td>248</td><td>0</td></tr></table>
d9f171a2b38ec65077f359c951decc08350027207c3bdf695925503577bbd30c.png
simple
<table><tr><td></td><td>Group I (Harvesting)</td><td>Group II (Preserving)</td><td><i>p</i> value*</td></tr><tr><td>Patients</td><td>61 (10 M &amp; 51 F)</td><td>43 (1 M &amp; 42 F)</td><td></td></tr><tr><td>Age (years)</td><td>14.0 (11 ~ 19)</td><td>13.8 (10 ~ 18)</td><td>0.71</td></tr><tr><td>Median f/u length (months)</td><td>60 (24 ~ 128)</td><td>73 (24 ~ 107)</td><td></td></tr><tr><td>Level fused</td><td>10.6 &#177; 1.7</td><td>10.0 &#177; 1.9</td><td>0.06</td></tr><tr><td>Duration of surgery (minutes)</td><td>216 &#177; 47</td><td>224 &#177; 50</td><td>0.40</td></tr><tr><td>Implants inserted (numbers)</td><td>13.3 &#177; 2.2</td><td>13.3 &#177; 2.0</td><td>0.97</td></tr><tr><td>Blood loss (ml)</td><td>983 &#177; 446</td><td>824 &#177; 361</td><td>0.048</td></tr><tr><td>Peri-OP blood transfusion (units)</td><td>6.0 &#177; 3.3</td><td>5.1 &#177; 3.0</td><td>0.13</td></tr><tr><td>Hospitalization length (days)</td><td>7.4 &#177; 1.0</td><td>6.8 &#177; 0.8</td><td>0.003</td></tr></table>
66bc6fc6054cd40c1964590de4f98f9a2833f2c7662d668a037d1d90c02c0931.png
simple
<table><tr><td>Station</td><td>Sampling date</td><td>Water depth (m)</td><td>Water temperature (&#176;C)</td><td>Salinity (psu)</td><td>Flow velocity (mm s<sup>-1</sup>)</td></tr><tr><td>H1</td><td>Oct 25, 2012</td><td>3.8</td><td>16.0</td><td>25.0</td><td>129 &#177; 70</td></tr><tr><td>A3</td><td>Apr 3, 2013</td><td>3.4</td><td>19.1</td><td>19.4</td><td>818 &#177; 172</td></tr><tr><td>A5</td><td>Apr 4, 2013</td><td>7.3</td><td>19.2</td><td>30.1</td><td>713 &#177; 498</td></tr></table>
6b8920a09668a0bd57571665db872c5e27e9edc5ea9e2a79a94f52799984c58b.png
simple
<table><tr><td>Health education mode</td><td>Medical and health information from friends&#8217; moments, group chats, public account sharing (open to all)</td><td>Normal health education information from the doctor in charge of you</td><td>Personalized health education information from the doctor in charge of you</td><td>Personalized health education information from the doctor in charge of you, and reminders for you (for example, referred to you, @ you, private letter to you)</td></tr><tr><td>Score</td><td>61.40</td><td>70.15</td><td>74.15</td><td>76.42</td></tr></table>
21ab1152b997a5b6d34a538497fd19652a1095920065ab7652e0fd206ce77634.png
complex
<table><tr><td rowspan="2">CMs modalities</td><td colspan="5">Level of need</td></tr><tr><td>No %</td><td>Low %</td><td>Moderate %</td><td>High %</td><td>Some %</td></tr><tr><td>Herbal medicines</td><td>10</td><td>31</td><td>47</td><td>13</td><td>90 </td></tr><tr><td>Vitamins, minerals, trace elements</td><td>7</td><td>35</td><td>46</td><td>13</td><td>93</td></tr><tr><td>Nutritional supplements</td><td>10</td><td>34</td><td>46</td><td>11</td><td>90</td></tr><tr><td>Homeopathic preparations</td><td>45</td><td>36</td><td>15</td><td>4</td><td>55</td></tr><tr><td>Aromatherapy products</td><td>50</td><td>37</td><td>10</td><td>4</td><td>50</td></tr><tr><td>Dietary interventions</td><td>12</td><td>27</td><td>43</td><td>18</td><td>88</td></tr></table>
0dee07e353c264e4652c02cf14e32339e601cfd5293b39932a565dfa1be16c0c.png
simple
<table><tr><td>Factor</td><td>mean&#177; SD</td><td>Min</td><td>Max</td></tr><tr><td>Age (years)</td><td>53.04&#177;4.53</td><td>42</td><td>60</td></tr><tr><td>Axial length (mm)</td><td>24.60&#177;0.68</td><td>23.2</td><td>26.1</td></tr><tr><td>Operation time (min)</td><td>6.35&#177;0.86</td><td>5</td><td>9</td></tr><tr><td>EFT (sec)</td><td>6.36&#177;1.66</td><td>3</td><td>10</td></tr><tr><td>Central ECD (cells/mm<sup>2</sup>)</td><td>2542.9&#177;194.03</td><td>2004</td><td>2897</td></tr><tr><td>ECD (temporal)</td><td>2547.7&#177;248.03</td><td>2145</td><td>3238</td></tr><tr><td>ECD (superior)</td><td>2748.9&#177;206.9</td><td>2245</td><td>3254</td></tr><tr><td>ECD (superotemporal)</td><td>2751.3&#177;231.01</td><td>2321</td><td>3345</td></tr></table>
c9834475112f983bde71c9067a274c8366f7ab769bbe61f35a71a59cfd7b06b6.png
complex
<table><tr><td></td><td colspan="2">1st Line</td><td colspan="2">Maintenance</td><td></td><td></td><td></td><td></td></tr><tr><td></td><td>Mean</td><td>95% CI</td><td>Mean</td><td>95% CI</td><td>Diff.</td><td>95% CI</td><td><i>F</i>-value</td><td><i>p</i>-value</td></tr><tr><td>Dyspnoea</td><td>23.0</td><td>19.9-26.0</td><td>21.2</td><td>0.0-45.4</td><td>1.73</td><td>&#8722;22.6-26.1</td><td>0.230</td><td>0.632</td></tr><tr><td>Coughing</td><td>31.1</td><td>27.8-34.4</td><td>26.7</td><td>21.4-32.0</td><td>4.4</td><td>&#8722;1.8-10.6</td><td>1.943</td><td>0.165</td></tr><tr><td>Haemoptysis</td><td>2.8</td><td>1.1-4.5</td><td>&lt;0.1</td><td>0.0-10.5</td><td>2.8</td><td>&#8722;7.8-13.4</td><td>0.273</td><td>0.603</td></tr><tr><td>Sore mouth</td><td>8.0</td><td>5.5-10.4</td><td>7.0</td><td>2.9-11.1</td><td>1.0</td><td>&#8722;3.7-5.8</td><td>0.183</td><td>0.670</td></tr><tr><td>Dysphagia</td><td>9.1</td><td>6.8-11.4</td><td>6.1</td><td>1.7-10.6</td><td>3.0</td><td>&#8722;2.0-8.0</td><td>1.408</td><td>0.237</td></tr><tr><td>Peripheral neuropathy</td><td>14.9</td><td>11.8-18.0</td><td>18.8</td><td>13.7-23.9</td><td>&#8722;3.9</td><td>&#8722;9.9-2.0</td><td>1.711</td><td>0.192</td></tr><tr><td>Alopecia</td><td>10.2</td><td>7.3-13.0</td><td>21.7</td><td>16.6-26.8</td><td>&#8722;11.5</td><td>&#8722;17.4- -5.7</td><td>15.116</td><td>&lt;0.001</td></tr><tr><td>Pain in chest</td><td>13.2</td><td>10.8-15.7</td><td>8.0</td><td>4.3-11.7</td><td>5.3</td><td>0.8-9.7</td><td>5.437</td><td>0.022</td></tr><tr><td>Pain in arm or shoulder</td><td>18.1</td><td>14.8-21.3</td><td>19.6</td><td>14.6-24.7</td><td>&#8722;1.6</td><td>&#8722;7.6-4.4</td><td>0.266</td><td>0.607</td></tr><tr><td>Pain in other parts</td><td>24.9</td><td>21.0-28.9</td><td>25.2</td><td>18.3-32.0</td><td>&#8722;0.2</td><td>&#8722;8.1-7.6</td><td>0.004</td><td>0.951</td></tr><tr><td>Taste Alterations<sup>a</sup></td><td>19.7</td><td>16.1-23.2</td><td>31.4</td><td>24.3-38.4</td><td>&#8722;11.7</td><td>&#8722;19.6- -3.7</td><td>8.442</td><td>0.004</td></tr><tr><td>Skin Toxicity<sup>a</sup></td><td>18.1</td><td>15.0-21.3</td><td>16.9</td><td>12.0-21.8</td><td>1.2</td><td>&#8722;4.6-7.0</td><td>0.179</td><td>0.673</td></tr></table>
c690f669e4929b22c6404ec6ff0c8274c4e53cb80e25268191157847c2f91bce.png
complex
<table><tr><td rowspan="2"> </td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td rowspan="2">P<sup>*</sup></td></tr><tr><td>Healthy children</td><td>Ambulant sick children</td><td>Non ambulant sick children</td></tr><tr><td> </td><td><i>n = 126</i></td><td><i>n = 99</i></td><td><i>n = 36</i></td><td> </td></tr><tr><td> </td><td><i>(%</i><sup><i>1</i></sup><i>)</i></td><td><i>(%</i><sup><i>1</i></sup><i>)</i></td><td><i>(%</i><sup><i>1</i></sup><i>)</i></td><td> </td></tr><tr><td>Direct benefits to the parent&#8217;s own child of participating in the study</td><td>85.7</td><td>100.0</td><td>100.0</td><td>0.88</td></tr><tr><td>Benefits to the general population</td><td>93.6</td><td>87.2</td><td>27.6</td><td>0.001</td></tr><tr><td>Low risk to the child of participating in the study</td><td>100.0</td><td>60.8</td><td>70.2</td><td>0.04</td></tr><tr><td>Understanding the study and its regulation</td><td>66.7</td><td>57.4</td><td>13.8</td><td>0.001</td></tr></table>
2a900027960ce72ce20a1b0109c95ebc2e3325e84f14adb2b9a2f7969c16f6eb.png
simple
<table><tr><td>Type of histopathology</td><td><i>n</i> (%)</td></tr><tr><td>Metaplastic carcinoma, spindle cells component</td><td>10 (25.0)</td></tr><tr><td>Metaplastic carcinoma, producing mucin</td><td>3 (7.5)</td></tr><tr><td>Metaplastic carcinoma, liposarcoma component</td><td>2 (5.0)</td></tr><tr><td>Metaplastic carcinoma, squamous cell </td><td>1 (2.5)</td></tr><tr><td>Metaplastic carcinoma, matrix hyaline</td><td>1 (2.5)</td></tr><tr><td>Medullary carcinoma</td><td>13 (32.5)</td></tr><tr><td>Micropapillary carcinoma</td><td>1 (2.5)</td></tr><tr><td>Invasive ductal carcinoma grade 3</td><td>6 (15.0)</td></tr><tr><td>Invasive lobular carcinoma grade 3</td><td>2 (5.0)</td></tr><tr><td>Invasive ductal carcinoma + invasive lobularcarcinoma (mixed)</td><td>1 (2.5)</td></tr></table>
0b61b80b9a77e9ce0bf65890698828250869eab351e582176a28a23573d2aa1d.png
simple
<table><tr><td>Nucleotide no.</td><td>Exon</td><td>Original*</td><td>Mutant</td><td>Amino acid change</td><td>Frequency in Japanese</td></tr><tr><td>590</td><td>IV</td><td>A</td><td>C</td><td>Asn to Thr</td><td>15%</td></tr><tr><td>800</td><td>V</td><td>T</td><td>C</td><td>Leu to Pro</td><td>40%</td></tr></table>
3122a15d01ea5a67484635b27d91652be714f1464e5a6e0a656dff531d394e58.png
simple
<table><tr><td>Head resection volume groups*</td><td>Number of head resections performed</td><td>Non-head resection volume groups</td><td>Number of non-head resections performed</td></tr><tr><td>High volume years</td><td></td><td>High volume years</td><td></td></tr><tr><td>2002</td><td>42</td><td>2000</td><td>28</td></tr><tr><td>2000</td><td>38</td><td>2002</td><td>22</td></tr><tr><td>1998</td><td>33</td><td>1999</td><td>20</td></tr><tr><td>2001</td><td>31</td><td>2001</td><td>19</td></tr><tr><td>1999</td><td>28</td><td>2004</td><td>16</td></tr><tr><td>Medium volume years</td><td></td><td>Medium volume years</td><td></td></tr><tr><td>1997</td><td>23</td><td>2005</td><td>14</td></tr><tr><td>1995</td><td>19</td><td>1991</td><td>14</td></tr><tr><td>2003</td><td>17</td><td>1994</td><td>10</td></tr><tr><td>1993</td><td>14</td><td>1995</td><td>10</td></tr><tr><td>1994</td><td>13</td><td>2003</td><td>11</td></tr><tr><td>Low volume years</td><td></td><td>Low volume years</td><td></td></tr><tr><td>1996</td><td>12</td><td>1996</td><td>9</td></tr><tr><td>2004</td><td>11</td><td>1992</td><td>8</td></tr><tr><td>2005</td><td>8</td><td>1990</td><td>6</td></tr><tr><td>1992</td><td>7</td><td>1993</td><td>6</td></tr><tr><td>1991</td><td>5</td><td>1997</td><td>6</td></tr><tr><td>1990</td><td>5</td><td>1998</td><td>6</td></tr></table>
bda65605da1e46eb2ceb01469655f705d293ffbdb10b4ed16bfeb336f5fd78c9.png
simple
<table><tr><td>PlasmoDB ID</td><td>PlasmoDB annotation</td><td>Motifs</td><td>Key</td><td>Refs</td></tr><tr><td>PPP group</td><td></td><td></td><td></td><td></td></tr><tr><td>PF14_0630</td><td>protein serine/threonine phosphatase</td><td></td><td>A</td><td>42</td></tr><tr><td>PF14_0142</td><td>serine/threonine protein phosphatase, putative</td><td></td><td>B</td><td>45, 46</td></tr><tr><td>PF14_0224</td><td>PP1-like protein serine/threonine phosphatase</td><td></td><td>C</td><td>47, 48</td></tr><tr><td>PFC0595c</td><td>serine/threonine protein phosphatase, putative</td><td></td><td>D</td><td>49</td></tr><tr><td>PF10_0177</td><td>erythrocyte membrane-associated antigen</td><td>HT; SP; API</td><td>E</td><td></td></tr><tr><td>PF08_0129</td><td>protein phosphatase, putative</td><td></td><td>F</td><td>48</td></tr><tr><td>PFI1245c</td><td>Protein phosphatase-beta</td><td></td><td>G</td><td>52</td></tr><tr><td>PFI1360c</td><td>serine/threonine protein phosphatase, putative</td><td></td><td>H</td><td></td></tr><tr><td>MAL13P1.274</td><td>serine/threonine protein phosphatase pfPp5</td><td></td><td>I</td><td>55, 56</td></tr><tr><td>PF13_0222</td><td>RNA lariat debranching enzyme, putative</td><td></td><td>K</td><td></td></tr><tr><td>PFA0390w</td><td>DNA repair exonuclease, putative</td><td></td><td>L</td><td></td></tr><tr><td>PF14_0064</td><td>vacuolar protein sorting 29, putative</td><td></td><td>M</td><td></td></tr><tr><td>PF14_0036</td><td>acid phosphatase, putative</td><td></td><td>J</td><td></td></tr><tr><td>PF14_0660</td><td>hypothetical protein</td><td>SP; API</td><td>O</td><td></td></tr><tr><td>PFL0300c</td><td>phosphoesterase, putative</td><td>SP</td><td>P</td><td></td></tr><tr><td>PF14_0614</td><td>hypothetical protein</td><td>SP</td><td>N</td><td></td></tr><tr><td>PPM group</td><td></td><td></td><td></td><td></td></tr><tr><td>MAL13P1.44</td><td>protein phosphatase 2c-like protein, putative</td><td></td><td>A</td><td></td></tr><tr><td>PFL2365w</td><td>hypothetical protein, conserved</td><td></td><td>B</td><td></td></tr><tr><td>PF14_0523</td><td>Protein phosphatase 2C, putative</td><td></td><td>C</td><td></td></tr><tr><td>PFD0505c</td><td>protein phosphatase 2C</td><td></td><td>D</td><td></td></tr><tr><td>PFE1010w</td><td>protein phosphatase 2c, putative</td><td></td><td>E</td><td></td></tr><tr><td>PF11_0362</td><td>protein phosphatase, putative</td><td></td><td>F</td><td></td></tr><tr><td>PF11_0396</td><td>Protein phosphatase 2C</td><td></td><td>G</td><td>59</td></tr><tr><td>MAL8P1.109</td><td>Protein phosphatase 2C, putative</td><td></td><td>H</td><td></td></tr><tr><td>MAL8P1.108</td><td>protein phosphatase, putative</td><td></td><td>I</td><td></td></tr><tr><td>PF10_0093</td><td>hypothetical protein</td><td></td><td>J</td><td></td></tr><tr><td>PTP group</td><td></td><td></td><td></td><td></td></tr><tr><td>PF14_0524</td><td>protein phosphatase 7 homolog, putative</td><td>API</td><td>A</td><td></td></tr><tr><td>PFC0380w</td><td>dual-specificity protein phosphatase, putative</td><td></td><td>B</td><td>67</td></tr><tr><td>PF11_0139</td><td>protein tyrosine phosphatase, putative</td><td></td><td>C</td><td>68</td></tr><tr><td>PF11_0281</td><td>hypothetical protein</td><td></td><td>D</td><td></td></tr><tr><td>NIF group</td><td></td><td></td><td></td><td></td></tr><tr><td>PFE0795c</td><td>nif-like protein, putative</td><td></td><td>A</td><td></td></tr><tr><td>PF07_0110</td><td>hypothetical protein, conserved</td><td></td><td>B</td><td></td></tr><tr><td>PF10_0124</td><td>hypothetical protein</td><td></td><td>C</td><td></td></tr><tr><td>MAL13P1.275</td><td>NLI interacting factor-like phosphatase, putative</td><td></td><td>D</td><td></td></tr></table>
e34824c23c32e791b71723c285fe6fdec920f18cbde76bb598015fe8a91ac443.png
simple
<table><tr><td>Sample</td><td>Thickness, mm</td><td>Fiber Weight Fraction, %</td><td>Fiber Volume Fraction, %</td></tr><tr><td>PLA</td><td>0.740 &#177; 0.020</td><td>-</td><td>-</td></tr><tr><td>PLA-Flax</td><td>0.698 &#177; 0.016</td><td>38.2 &#177; 1.6</td><td>30.6 &#177; 0.4</td></tr><tr><td>PLA-Jute</td><td>0.750 &#177; 0.021</td><td>44.4 &#177; 0.9</td><td>41.1 &#177; 1.2</td></tr></table>
efdf6c160813738a40b6acd6d396cd02ecdcc06b4c214b6759fa81e74ff9e94c.png
simple
<table><tr><td>Preoperative signs</td><td>Frequency</td></tr><tr><td><i>Reflexes</i></td><td> </td></tr><tr><td>Normal upper extremity reflex</td><td>30, 44.1</td></tr><tr><td>Hyperreflexia of upper extremity</td><td>25, 36.8</td></tr><tr><td>Hyporeflexia of upper extremity</td><td>13, 19.1</td></tr><tr><td>Normal lower extremity reflex </td><td>43, 63.2</td></tr><tr><td>Hyperreflexia in lower extremity </td><td>22, 32.4</td></tr><tr><td>Hyporeflexia in lower extremity</td><td>3, 4.4</td></tr><tr><td><i>Upper extremity muscle power (in one or two dermatomal groups)</i></td><td> </td></tr><tr><td>3/5</td><td>2, 2.9</td></tr><tr><td>4/5 </td><td>48, 70.6 </td></tr><tr><td>5/5 </td><td>18, 26.5</td></tr><tr><td><i>Lower extremity muscle power</i></td><td> </td></tr><tr><td>3/5 </td><td>1, 1.5</td></tr><tr><td>4/5 </td><td>14, 20.6</td></tr><tr><td>5/5 </td><td>53, 77.9</td></tr><tr><td><i>Hoffmann's sign</i></td><td> </td></tr><tr><td>Positive </td><td>25, 36.8</td></tr><tr><td>Negative </td><td>43, 63.2</td></tr><tr><td><i>Babinski sign</i></td><td> </td></tr><tr><td>Upward</td><td>18, 26.5</td></tr><tr><td>Downward </td><td>50, 73.5</td></tr><tr><td><i>Upper extremity hypoesthesia</i></td><td> </td></tr><tr><td>Positive </td><td>40, 58.8</td></tr><tr><td>Negative </td><td>28, 41.2 </td></tr></table>
26ed47ea7353fe8e53ee376aeed2515473f7ff57f57862bfef5693e5c7c3d683.png
complex
<table><tr><td rowspan="2">Gender</td><td rowspan="2">Expert diagnosis</td><td colspan="4">SCAT-B diagnosis (<i>N</i>, %)</td><td>Predictability (%)</td><td>Kappa</td></tr><tr><td>TE</td><td>SE</td><td>SY</td><td>Total</td></tr><tr><td rowspan="3">Males</td><td>TE</td><td>287 (80.2)</td><td>18 (5)</td><td>53 (14.8)</td><td>358 (100)</td><td rowspan="3">489 (61.3)</td><td rowspan="3">.387</td></tr><tr><td>SE</td><td>33 (17.6)</td><td>107 (56.9)</td><td>48 (25.5)</td><td>188 (100)</td></tr><tr><td>SY</td><td>102 (40.5)</td><td>55 (21.8)</td><td>95 (37.7)</td><td>252 (100) </td></tr><tr><td rowspan="3">Females</td><td>TE</td><td>361 (69.3)</td><td>21 (4)</td><td>139 (26.7)</td><td>521 (100)</td><td rowspan="3">767 (54.2)</td><td rowspan="3">.298</td></tr><tr><td>SE</td><td>52 (13.9)</td><td>146 (38.9)</td><td>177 (47.2)</td><td>375 (100)</td></tr><tr><td>SY</td><td>149 (28.7)</td><td>111 (21.3)</td><td>260 (50)</td><td>520 (100)</td></tr></table>
3c0b483afe0e8ec51fcb1c9291088ed1bd1d89659478527b3a2cd2cbb6df5d56.png
complex
<table><tr><td rowspan="2">Characteristic</td><td>Placebo</td><td>Desvenlafaxine</td><td>Desvenlafaxine</td></tr><tr><td>(n = 223)</td><td>10 mg/d (n = 226)</td><td>50 mg/d (n = 224)</td></tr><tr><td>Age, y</td><td>42 &#177; 13</td><td>41 &#177; 14</td><td>43 &#177; 14</td></tr><tr><td>Age group, n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>18-64 y</td><td>215 (96)</td><td>212 (94)</td><td>213 (95)</td></tr><tr><td>&gt;64 y</td><td>8 (4)</td><td>14 (6)</td><td>11 (5)</td></tr><tr><td>Female, n (%)</td><td>139 (62)</td><td>135 (60)</td><td>135 (60)</td></tr><tr><td>Race, n (%)</td><td> </td><td> </td><td> </td></tr><tr><td>White</td><td>176 (79)</td><td>199 (88)</td><td>177 (79)</td></tr><tr><td>Black</td><td>38 (17)</td><td>20 (9)</td><td>37 (17)</td></tr><tr><td>Asian</td><td>4 (2)</td><td>3 (1)</td><td>2 (1)</td></tr><tr><td>Other</td><td>5 (2)</td><td>4 (2)</td><td>8 (4)</td></tr><tr><td>Weight, kg</td><td>87 &#177; 24</td><td>88 &#177; 27</td><td>91 &#177; 26</td></tr><tr><td>Body mass index, kg/m<sup>2</sup></td><td>30 &#177; 7</td><td>31 &#177; 9</td><td>32 &#177; 8</td></tr><tr><td>Baseline HAM-D<sub>17 </sub>score</td><td>23 &#177; 3</td><td>23 &#177; 2</td><td>23 &#177; 3</td></tr><tr><td>Duration of current depressive episode, mo</td><td>34 &#177; 81</td><td>26 &#177; 48</td><td>31 &#177; 76</td></tr></table>
e51cc548cc41a8f0af820f54bfc27eb8b4d232d45b2c7c4cb60c34947f2719d9.png
complex
<table><tr><td colspan="7">Age &lt;65 years (n = 1052)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td>0</td><td>12/137</td><td>1</td><td> </td><td> </td><td>91.5%</td><td>84.7-95.4%</td></tr><tr><td>1</td><td>47/450</td><td>1.44</td><td>0.81-2.56</td><td>0.2133</td><td>90.5%</td><td>86.7-93.3%</td></tr><tr><td>2</td><td>23/253</td><td>1.30</td><td>0.65-2.57</td><td>0.4582</td><td>90.9%</td><td>85.4-94.4%</td></tr><tr><td>3</td><td>22/125</td><td>2.70</td><td>1.35-5.39</td><td>0.0049</td><td>80.3%</td><td>69.6-87.6%</td></tr><tr><td>4</td><td>11/61</td><td>2.68</td><td>1.07-6.70</td><td>0.0346</td><td>82.5%</td><td>69.8-90.2%</td></tr><tr><td>5</td><td>6/26</td><td>7.11</td><td>1.73-29.24</td><td>0.0066</td><td>74.2%</td><td>47.2-88.8%</td></tr><tr><td colspan="7">Age 65+ years (n = 1079)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td>0</td><td>3/53</td><td>1</td><td> </td><td> </td><td>98.1%</td><td>87.4-99.7%</td></tr><tr><td>1</td><td>56/469</td><td>2.24</td><td>1.08-4.64</td><td>0.0300</td><td>88.0%</td><td>83.6-91.2%</td></tr><tr><td>2</td><td>46/259</td><td>2.60</td><td>1.32-5.13</td><td>0.0058</td><td>80.5%</td><td>73.5-85.8%</td></tr><tr><td>3</td><td>30/157</td><td>3.14</td><td>1.48-6.69</td><td>0.0030</td><td>78.2%</td><td>69.0-84.9%</td></tr><tr><td>4</td><td>29/106</td><td>4.07</td><td>1.98-8.37</td><td>0.0001</td><td>67.0%</td><td>54.7-76.6%</td></tr><tr><td>5</td><td>16/35</td><td>21.12</td><td>7.45-59.90</td><td>&lt;0.0001</td><td>48.9%</td><td>26.2-68.3%</td></tr><tr><td colspan="7">All patients (n = 2131)</td></tr><tr><td>Points</td><td>Events</td><td>Hazard ratio</td><td>95% CI</td><td>p*</td><td>10-year survival</td><td>95% CI</td></tr><tr><td>0</td><td>15/190</td><td>1</td><td> </td><td> </td><td>93.4%</td><td>88.3-96.3%</td></tr><tr><td>1</td><td>103/919</td><td>1.73</td><td>1.11-2.69</td><td>0.0149</td><td>89.3%</td><td>86.5-91.5%</td></tr><tr><td>2</td><td>69/512</td><td>2.00</td><td>1.26-3.18</td><td>0.0032</td><td>85.7%</td><td>81.4-89.0%</td></tr><tr><td>3</td><td>52/282</td><td>2.89</td><td>1.77-4.71</td><td>&lt;0.0001</td><td>78.9%</td><td>72.2-84.2%</td></tr><tr><td>4</td><td>40/167</td><td>3.88</td><td>2.25-6.70</td><td>&lt;0.0001</td><td>73.0%</td><td>64.2-80.0%</td></tr><tr><td>5</td><td>22/61</td><td>21.30</td><td>8.95-50.72</td><td>&lt;0.0001</td><td>60.3%</td><td>43.2-73.7%</td></tr></table>
710af7c71595f11c985b8d85e58578932080a71de3f6fddcbe8bd661ded190f2.png
simple
<table><tr><td></td><td>Onset &lt; 20 y.o.</td><td>Onset &gt;40 y.o.</td><td>Abdominal </td><td>C1q &lt; 50%</td></tr><tr><td></td><td>% pts.</td><td>% pts.</td><td>% pts.</td><td>%pts</td></tr><tr><td>Acquired angioedema</td><td>0</td><td>94</td><td>48</td><td>70</td></tr><tr><td>Hereditary angioedema</td><td>12</td><td>3</td><td>87</td><td>&lt; 5</td></tr></table>
90b1091e018aa45a0635987add68c5e344d5acf29d963bee6674cd9ffa2b8a34.png
complex
<table><tr><td></td><td>BudesonideNanodispersion </td><td colspan="2">BudesonideMicrosuspension </td></tr><tr><td>Inhalation Filter (percent of the nominal dose)</td><td colspan="2">14.24 (2.51)</td><td>14.97 (4.3)</td></tr><tr><td>Exhalation Filter (percent of the nominal dose)</td><td colspan="2">14.92 (3.21)</td><td>15.27 (4.48)</td></tr><tr><td>Chamber (percent of the nominal dose)</td><td colspan="2">69.33 (5.08)</td><td>68.36 (8.95)</td></tr><tr><td>Connector (percent of the nominal dose)</td><td colspan="2">1.49 (0.33)</td><td>1.39 (0.20)</td></tr><tr><td>Nebulization time (min)</td><td colspan="2">12.30 (0.37)</td><td>14.85 (0.36)</td></tr></table>
58423c3e7c5925e67f1159f5e44f2ef4b498a09dd251cac1e8ce6e6472a3db43.png
complex
<table><tr><td>Factor</td><td><i>p</i> in univariate regression<sup>*</sup></td><td><i>p</i> in multivariate regression <sup>&#176;</sup></td><td>Odds ratio in multivariate regression [95% CI]</td></tr><tr><td colspan="4">Predictive of complaint specificity</td></tr><tr><td> Age</td><td>0.171</td><td rowspan="2" colspan="2"></td></tr><tr><td> Gender</td><td>0.466</td></tr><tr><td> Previous medical contact</td><td>0.001</td><td>0.001</td><td>1.828 [1.268&#8211;2.636]</td></tr><tr><td colspan="4">Consequences of complaint specificity</td></tr><tr><td> Triage</td><td>0.101</td><td rowspan="3" colspan="2"></td></tr><tr><td> Resuscitation bay</td><td>0.241</td></tr><tr><td> Length of ED stay</td><td>0.748</td></tr><tr><td> Vague diagnosis at ED discharge</td><td>0.012</td><td>0.001</td><td>1.822 [1.159&#8211;2.899]</td></tr><tr><td> Length of hospital stay</td><td>0.029</td><td>0.025</td><td>1.001 [1&#8211;1.002]</td></tr><tr><td> Vague diagnosis at ED discharge</td><td>0.923</td><td colspan="2"></td></tr><tr><td> Mortality</td><td>0.054</td><td>0.087</td><td>1.922 [0.909&#8211;4.065]</td></tr></table>
7e7a8f96a42ccc8ba39d52078ef6734fe3a5a84af5b008508102e3fc0dd03b85.png
complex
<table><tr><td colspan="3">MEN</td><td colspan="3">WOMEN</td></tr><tr><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td><td>FOOD ITEM</td><td>ASSOCIATION</td><td>VIP</td></tr><tr><td><i>Influential for high SOC</i></td><td></td><td></td><td><i>Influential for high SOC</i></td><td></td><td></td></tr><tr><td> Bread</td><td>+</td><td>2.18</td><td> Fruits</td><td>+</td><td>1.83</td></tr><tr><td> Bread and cereals</td><td>+</td><td>1.96</td><td> Vegetables</td><td>+</td><td>1.83</td></tr><tr><td> Rye crisp bread (whole meal)</td><td>+</td><td>1.89</td><td> Liver paste</td><td>+</td><td>1.64</td></tr><tr><td> Fish</td><td>+</td><td>1.76</td><td> Boiled potato</td><td>+</td><td>1.47</td></tr><tr><td> Boiled potato</td><td>+</td><td>1.71</td><td> Rye crisp bread (whole meal)</td><td>+</td><td>1.43</td></tr><tr><td> Berries</td><td>+</td><td>1.51</td><td> Blood foods</td><td>+</td><td>1.32</td></tr><tr><td> Wine</td><td>+</td><td>1.49</td><td> Cereals</td><td>+</td><td>1.29</td></tr><tr><td> Light beer</td><td>+</td><td>1.32</td><td> Oat flake porridge</td><td>+</td><td>1.24</td></tr><tr><td> Vegetables</td><td>+</td><td>1.23</td><td></td><td></td><td></td></tr><tr><td><i>Influential for low SOC</i></td><td></td><td></td><td><i>Influential for low SOC</i></td><td></td><td></td></tr><tr><td> Pizza</td><td>-</td><td>2.41</td><td> Mashed potato</td><td>-</td><td>2.98</td></tr><tr><td> Soft drinks</td><td>-</td><td>2.25</td><td> Sausage as main course</td><td>-</td><td>2.11</td></tr><tr><td> Pasta</td><td>-</td><td>2.14</td><td> Potato salad</td><td>-</td><td>1.98</td></tr><tr><td> Candies</td><td>-</td><td>2.02</td><td> Soft drinks</td><td>-</td><td>1.94</td></tr><tr><td> Sausage as main course</td><td>-</td><td>1.97</td><td> French fries</td><td>-</td><td>1.89</td></tr><tr><td> Hamburgers</td><td>-</td><td>1.94</td><td> Hamburgers</td><td>-</td><td>1.82</td></tr><tr><td> Mashed potato</td><td>-</td><td>1.87</td><td> Beer (high alcohol)</td><td>-</td><td>1.71</td></tr><tr><td> Fried potato</td><td>-</td><td>1.65</td><td> Pizza</td><td>-</td><td>1.68</td></tr><tr><td> Butter for cooking</td><td>-</td><td>1.63</td><td> Sweets</td><td>-</td><td>1.67</td></tr><tr><td> Chips, cheese doodles, nuts</td><td>-</td><td>1.57</td><td> Candies</td><td>-</td><td>1.60</td></tr><tr><td> Potato salad</td><td>-</td><td>1.48</td><td> Rice</td><td>-</td><td>1.50</td></tr><tr><td> Banana</td><td>-</td><td>1.37</td><td> Pancakes</td><td>-</td><td>1.43</td></tr><tr><td> French fries</td><td>-</td><td>1.22</td><td> Syrups</td><td>-</td><td>1.42</td></tr><tr><td> Traditional broth soaked bread</td><td>-</td><td>1.21</td><td> Cookies</td><td>-</td><td>1.39</td></tr><tr><td> Fruit soup</td><td>-</td><td>1.21</td><td> Traditional broth soaked bread</td><td>-</td><td>1.29</td></tr><tr><td> Traditional potato dumpling</td><td>-</td><td>1.20</td><td> Chips, cheese doodles, nuts</td><td>-</td><td>1.29</td></tr></table>
f62f1ef894b06aac69e04edfcb54bdbcb5fbe72dcf6d4b8a765469bf86452c7a.png
complex
<table><tr><td>Anthropometric</td><td><i>p</i></td><td>FFQ Intake</td><td><i>p</i></td><td>Model R-squared</td><td>FFQ&#8212;Plasma Correlation</td><td>Correlation 95% CI</td></tr><tr><td colspan="7">Plasma &#945;-carotene</td></tr><tr><td></td><td></td><td>&#945;-carotene</td><td>&lt;0.001</td><td>0.26</td><td>0.52</td><td>0.35, 0.69</td></tr><tr><td>BMI</td><td>0.004</td><td>&#945;-carotene</td><td>&lt;0.001</td><td>0.34</td><td>0.49</td><td>0.33, 0.64</td></tr><tr><td>BMI</td><td>0.001</td><td></td><td></td><td>0.11</td><td></td><td></td></tr><tr><td colspan="7">Plasma &#946;-carotene</td></tr><tr><td></td><td></td><td>&#946;-carotene</td><td>0.003</td><td>0.21</td><td>0.47 </td><td>0.18, 0.75</td></tr><tr><td></td><td></td><td>Veg Serves</td><td>0.007</td><td>0.17</td><td>0.42</td><td>0.12, 0.71</td></tr><tr><td>BMI</td><td>0.016</td><td>&#946;-carotene</td><td>0.004</td><td>0.31</td><td>0.41</td><td>0.15, 0.68</td></tr><tr><td>Fat mass</td><td>0.013</td><td>Veg Serves</td><td>0.013</td><td>0.25</td><td>0.34</td><td>0.08, 0.61</td></tr><tr><td>BMI</td><td>0.004</td><td></td><td></td><td>0.14</td><td></td><td></td></tr><tr><td>Fat mass</td><td>0.003</td><td></td><td></td><td>0.14</td><td></td><td></td></tr><tr><td colspan="7">Plasma Lycopene</td></tr><tr><td></td><td></td><td>Lycopene</td><td>0.756</td><td>0.00</td><td></td><td></td></tr><tr><td colspan="7">Plasma Lutein/zeaxanthin</td></tr><tr><td></td><td></td><td>Lutein/zeax</td><td>0.041</td><td>0.09</td><td>0.26</td><td>0.01, 0.51</td></tr><tr><td>BMI</td><td>&lt;0.001</td><td>Lutein/zeax</td><td>0.095</td><td>0.20</td><td></td><td></td></tr><tr><td>BMI</td><td>&lt;0.001</td><td></td><td></td><td>0.14</td><td></td><td></td></tr><tr><td colspan="7">Plasma Cryptoxanthin</td></tr><tr><td></td><td></td><td>Cryptoxant</td><td>0.236</td><td>0.08</td><td></td><td></td></tr><tr><td>Fat mass</td><td>0.005</td><td>Supplements</td><td>0.003</td><td>0.35</td><td></td><td></td></tr><tr><td>Fat mass</td><td>&lt;0.001</td><td></td><td></td><td>0.22</td><td></td><td></td></tr></table>
f60defdc1e8d09ea57669fb9a1291ae1f4a238f6ed2c81500a53cf55be848cd0.png
simple
<table><tr><td>Marker name</td><td>Region</td><td>Chr</td><td>Position</td><td>SNP quality</td><td>Alleles (A/B)</td><td>EAF (B allele)</td><td>Effect size for B allele (95% CI)</td><td><i>P</i></td><td>Gene context</td></tr><tr><td>rs377070</td><td>4q27</td><td>4</td><td>123629002</td><td>0.99</td><td>C/G</td><td>0.388</td><td>&#8722;0.070 (&#8722;0.081, &#8722;0.060)</td><td>1.2 &#215; 10<sup>&#8722;36</sup></td><td>IL21--[]--BBS12</td></tr><tr><td>rs3134995</td><td>6p21.32</td><td>6</td><td>32672089</td><td>0.99</td><td>C/T</td><td>0.242</td><td>&#8722;0.065 (&#8722;0.077, &#8722;0.052)</td><td>1.9 &#215; 10<sup>&#8722;24</sup></td><td>HLA-DQB1--[]--HLA-DQA2</td></tr><tr><td>rs5750339</td><td>22q12.3</td><td>22</td><td>37319589</td><td>0.96</td><td>C/G</td><td>0.457</td><td>&#8722;0.052 (&#8722;0.062, &#8722;0.041)</td><td>9.2 &#215; 10<sup>&#8722;21</sup></td><td>[CSF2RB]</td></tr><tr><td>rs55722650</td><td>5q31.1</td><td>5</td><td>131607300</td><td>&gt;0.99</td><td>C/T</td><td>0.41</td><td>&#8722;0.049 (&#8722;0.060, &#8722;0.038)</td><td>4.8 &#215; 10<sup>&#8722;19</sup></td><td>[PDLIM4]</td></tr><tr><td>rs2906856</td><td>12q15</td><td>12</td><td>68390201</td><td>0.99</td><td>C/T</td><td>0.353</td><td>0.039 (0.028, 0.050)</td><td>7.9 &#215; 10<sup>&#8722;12</sup></td><td>DYRK2---[]---IFNG</td></tr><tr><td>rs11751172</td><td>6p21.1</td><td>6</td><td>45552731</td><td>0.99</td><td>C/T</td><td>0.244</td><td>&#8722;0.040 (&#8722;0.053, &#8722;0.028)</td><td>1.1 &#215; 10<sup>&#8722;10</sup></td><td>RUNX2--[]---CLIC5</td></tr><tr><td>rs6754311</td><td>2q21.3</td><td>2</td><td>136707982</td><td>0.97</td><td>C/T</td><td>0.609</td><td>0.039 (0.027, 0.051)</td><td>1.6 &#215; 10<sup>&#8722;10</sup></td><td>[DARS]</td></tr><tr><td>rs143626010</td><td>16p11.2</td><td>16</td><td>28539398</td><td>0.91</td><td>D/I</td><td>0.611</td><td>0.033 (0.021, 0.044)</td><td>1.5 &#215; 10<sup>&#8722;8</sup></td><td>[NPIPL1]</td></tr><tr><td>rs7793919</td><td>7p22.1</td><td>7</td><td>4769030</td><td>0.94</td><td>C/T</td><td>0.435</td><td>0.031 (0.020, 0.042)</td><td>2.8 &#215; 10<sup>&#8722;8</sup></td><td>[FOXK1]</td></tr><tr><td>rs62447171</td><td>7p12.2</td><td>7</td><td>50309890</td><td>&gt;0.99</td><td>A/G</td><td>0.736</td><td>0.034 (0.022, 0.046)</td><td>3.5 &#215; 10<sup>&#8722;8</sup></td><td>C7orf72---[]--IKZF1</td></tr><tr><td>rs3024971</td><td>12q13.3</td><td>12</td><td>57493727</td><td>&gt;0.99</td><td>G/T</td><td>0.896</td><td>0.047 (0.030, 0.065)</td><td>5.9 &#215; 10<sup>&#8722;8</sup></td><td>[STAT6]</td></tr><tr><td>rs3102960</td><td>2p25.1</td><td>2</td><td>8452497</td><td>0.98</td><td>C/T</td><td>0.793</td><td>&#8722;0.036 (&#8722;0.049, &#8722;0.023)</td><td>7.6 &#215; 10<sup>&#8722;8</sup></td><td>[]---ID2</td></tr><tr><td>rs2230624</td><td>1p36.22</td><td>1</td><td>12175658</td><td>0.80</td><td>A/G</td><td>0.988</td><td>0.162 (0.102, 0.222)</td><td>1.1 &#215; 10<sup>&#8722;7</sup></td><td>[TNFRSF8]</td></tr><tr><td>rs9815073</td><td>3q28</td><td>3</td><td>188115682</td><td>0.80</td><td>A/C</td><td>0.657</td><td>&#8722;0.033 (&#8722;0.046, &#8722;0.021)</td><td>1.1 &#215; 10<sup>&#8722;7</sup></td><td>[LPP]</td></tr><tr><td>rs112637405</td><td>4q28.2</td><td>4</td><td>130258336</td><td>0.63</td><td>A/T</td><td>0</td><td>1.946 (1.228, 2.664)</td><td>1.1 &#215; 10<sup>&#8722;7</sup></td><td>C4orf33---[]</td></tr><tr><td>rs6841258</td><td>4p14</td><td>4</td><td>40565426</td><td>0.85</td><td>C/T</td><td>0.179</td><td>0.039 (0.024, 0.054)</td><td>3.6 &#215; 10<sup>&#8722;7</sup></td><td>[RBM47]</td></tr><tr><td>rs78587638</td><td>2q14.2</td><td>2</td><td>119187509</td><td>0.98</td><td>A/G</td><td>0.842</td><td>&#8722;0.037 (&#8722;0.051, &#8722;0.023)</td><td>4.2 &#215; 10<sup>&#8722;7</sup></td><td>INSIG2---[]---EN1</td></tr><tr><td>rs12133641</td><td>1q21.3</td><td>1</td><td>154428283</td><td>&gt;0.99</td><td>A/G</td><td>0.395</td><td>0.028 (0.017, 0.038)</td><td>4.3 &#215; 10<sup>&#8722;7</sup></td><td>[IL6R]</td></tr><tr><td>rs2075533</td><td>9q32</td><td>9</td><td>117693631</td><td>&gt;0.99</td><td>A/G</td><td>0.572</td><td>0.027 (0.017, 0.038)</td><td>4.7 &#215; 10<sup>&#8722;7</sup></td><td>TNFSF8[]--TNC</td></tr><tr><td>rs921533</td><td>2q31.1</td><td>2</td><td>174551931</td><td>0.98</td><td>A/T</td><td>0.658</td><td>0.029 (0.018, 0.040)</td><td>5.2 &#215; 10<sup>&#8722;7</sup></td><td>CDCA7---[]---SP3</td></tr><tr><td>rs2963854</td><td>5q35.2</td><td>5</td><td>175083754</td><td>0.84</td><td>A/G</td><td>0.196</td><td>&#8722;0.034 (&#8722;0.047, &#8722;0.021)</td><td>5.3 &#215; 10<sup>&#8722;7</sup></td><td>SFXN1---[]-HRH2</td></tr><tr><td>rs112724722</td><td>7q21.3</td><td>7</td><td>93546386</td><td>&gt;0.99</td><td>A/G</td><td>0.998</td><td>&#8722;0.384 (&#8722;0.534, &#8722;0.234)</td><td>5.3 &#215; 10<sup>&#8722;7</sup></td><td>GNGT1-[]-GNG11</td></tr><tr><td>rs969584</td><td>8q24.13</td><td>8</td><td>126620429</td><td>0.99</td><td>C/G</td><td>0.351</td><td>&#8722;0.028 (&#8722;0.040, &#8722;0.017)</td><td>5.4 &#215; 10<sup>&#8722;7</sup></td><td>TRIB1---[]---FAM84B</td></tr><tr><td>rs71872522</td><td>1p31.1</td><td>1</td><td>77050728</td><td>0.73</td><td>D/I</td><td>1</td><td>&#8722;1.797 (&#8722;2.505, &#8722;1.089)</td><td>6.6 &#215; 10<sup>&#8722;7</sup></td><td>[ST6GALNAC3]</td></tr><tr><td>rs200872239</td><td>1p36.11</td><td>1</td><td>25250916</td><td>0.77</td><td>D/I</td><td>0.313</td><td>0.032 (0.020, 0.045)</td><td>6.8 &#215; 10<sup>&#8722;7</sup></td><td>[RUNX3]</td></tr></table>
bff23076e8335b4b7f39e449062bd2255dbcfde15b4c45c5916234aefcdbfd94.png
simple
<table><tr><td></td><td>Phase I - 2011 (<i>n</i> = 1054) %</td><td>Phase II - 2012 (<i>n</i> = 1105) %</td><td>Phase III - 2013 (<i>n</i> = 1854) %</td><td><i>P**</i></td></tr><tr><td>Location:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; Operating room</td><td>1.2</td><td>1.8</td><td>1.5</td><td></td></tr><tr><td>&#8226; Medical surgical unit</td><td>73.1</td><td>71.7</td><td>62.0</td><td></td></tr><tr><td>&#8226; Pharmacy</td><td>0.0</td><td>0.1</td><td>4.6</td><td></td></tr><tr><td>&#8226; Step Down Unit</td><td>10.9</td><td>8.3</td><td>20.7</td><td></td></tr><tr><td>&#8226; Emergency Department</td><td>0.0</td><td>2.6</td><td>0.0</td><td></td></tr><tr><td>&#8226; Intensive Care Unit</td><td>14.7</td><td>15.5</td><td>11.2</td><td></td></tr><tr><td>Time:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; Morning (7 am to 1 pm)</td><td>33.0</td><td>38.4</td><td>30.9</td><td></td></tr><tr><td>&#8226; Not identified</td><td>13.4</td><td>0.2</td><td>0.8</td><td></td></tr><tr><td>&#8226; Night (7 pm to 7 am)</td><td>23.5</td><td>31.0</td><td>47.1</td><td></td></tr><tr><td>&#8226; Afternoon (1 pm to 7 pm)</td><td>30.1</td><td>30.4</td><td>21.3</td><td></td></tr><tr><td>Order entry type:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; Electronic</td><td>38.4</td><td>40.4</td><td>73.7</td><td></td></tr><tr><td>&#8226; Manual</td><td>61.6</td><td>51.4</td><td>26.3</td><td></td></tr><tr><td>&#8226; Not Prescribed</td><td>0.0</td><td>8.2</td><td>0.0</td><td></td></tr><tr><td>Error class:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; A</td><td>29.2</td><td>14.1</td><td>2.2</td><td></td></tr><tr><td>&#8226; B</td><td>25.8</td><td>34.8</td><td>65.1</td><td></td></tr><tr><td>&#8226; C</td><td>35.7</td><td>35.2</td><td>27.5</td><td></td></tr><tr><td>&#8226; D</td><td>8.0</td><td>13.8</td><td>4.6</td><td></td></tr><tr><td>&#8226; E, F, H, G or I</td><td>1.3</td><td>2.1</td><td>0.5</td><td></td></tr><tr><td>Error accountability:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; Nursing</td><td>46.4</td><td>48.5</td><td>58.7</td><td></td></tr><tr><td>&#8226; Pharmacy</td><td>19.4</td><td>20.1</td><td>26.9</td><td></td></tr><tr><td>&#8226; Physician</td><td>32.4</td><td>22.9</td><td>10.8</td><td></td></tr><tr><td>&#8226; Other</td><td>1.7</td><td>8.5</td><td>3.6</td><td></td></tr><tr><td>Phase of medication use where error occurred:</td><td></td><td></td><td></td><td><i>p</i> &lt; 0.001</td></tr><tr><td>&#8226; Administering</td><td>35.5</td><td>43.1</td><td>55.6</td><td></td></tr><tr><td>&#8226; Dispensing</td><td>19.6</td><td>24.3</td><td>22.7</td><td></td></tr><tr><td>&#8226; Monitoring</td><td>3.4</td><td>0.9</td><td>0.2</td><td></td></tr><tr><td>&#8226; Prescribing</td><td>34.5</td><td>23.8</td><td>11.7</td><td></td></tr><tr><td>&#8226; Transcribing</td><td>6.9</td><td>8.0</td><td>9.9</td><td></td></tr></table>
b4d22e199d866e6baffd015a70fad986801e75455c3cdaa50570909526b3e7c6.png
complex
<table><tr><td rowspan="2">Variables</td><td rowspan="2">No. of cases.</td><td colspan="3">Univariate analysis</td><td colspan="3">Multivariate analysis</td></tr><tr><td>HR ratio</td><td>95%CI</td><td>P-value</td><td>HR ratio</td><td>95%CI</td><td>P-value</td></tr><tr><td>Age(years)</td><td></td><td>1.009</td><td>0.991-1.027</td><td>0.349</td><td></td><td></td><td></td></tr><tr><td> &lt;60</td><td>76</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> &#8805;60</td><td>49</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Gender</td><td></td><td>0.911</td><td>0.554-1.498</td><td>0.713</td><td></td><td></td><td></td></tr><tr><td> Female</td><td>59</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Male</td><td>66</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tumor diameter(cm)</td><td></td><td>0.566</td><td>0.3629-0.8826</td><td>0.012*</td><td>1.719</td><td>1.049-2.816</td><td>0.019*</td></tr><tr><td> &#8804;5</td><td>71</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> &gt;5</td><td>54</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Tumor location</td><td></td><td>0.996</td><td>0.609-1.628</td><td>0.987</td><td></td><td></td><td></td></tr><tr><td> Colon</td><td>69</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Rectum</td><td>56</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Depth of infiltration</td><td></td><td>1.055</td><td>0.749-1.485</td><td>0.761</td><td></td><td></td><td></td></tr><tr><td> Submucosa, musculeris propria</td><td>28</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Subserosa</td><td>66</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> To the surrounding tissue</td><td>31</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Histologic type</td><td></td><td>1.61</td><td>1.155-2.245</td><td>0.005**</td><td>1.615</td><td>1.138-2.293</td><td>0.007**</td></tr><tr><td> Well differentiated</td><td>56</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Morderately differentiated</td><td>49</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> Poorly differentiated</td><td>20</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>TNM staging</td><td></td><td>1.716</td><td>1.055-2.791</td><td>0.029*</td><td>1.849</td><td>1.119-3.057</td><td>0.007**</td></tr><tr><td> I/II</td><td>81</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> III/IV</td><td>44</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Lymph node metastasis</td><td></td><td>1.811</td><td>1.099-2.983</td><td>0.02*</td><td></td><td></td><td></td></tr><tr><td> NO</td><td>85</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> YES</td><td>40</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>CHRDL2 expression</td><td></td><td>1.956</td><td>1.188-3.221</td><td>0.008**</td><td>1.956</td><td>1.188-3.221</td><td>0.008*</td></tr><tr><td> Low</td><td>63</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td> High</td><td>62</td><td></td><td></td><td></td><td></td><td></td><td></td></tr></table>
3d97d5d57b9f6af7609ba4fc3cabca18552f5cb2439f2df3373e7efbebad134d.png
simple
<table><tr><td></td><td>MBA</td><td>LEBA</td></tr><tr><td>Deep squat</td><td>2.20 &#177; 0.79</td><td>2.50 &#177; 0.71</td></tr><tr><td>Hurdle step</td><td>1.80 &#177; 0.63</td><td>1.80 &#177; 0.79</td></tr><tr><td>Inline lunge</td><td>2.10 &#177; 0.74</td><td>2.70 &#177; 0.48 *</td></tr><tr><td>Shoulder mobility</td><td>1.40 &#177; 0.52</td><td>1.90 &#177; 0.57 <sup>&#8225;</sup></td></tr><tr><td>Active straight leg raise</td><td>1.80 &#177; 0.79</td><td>2.30 &#177; 0.67</td></tr><tr><td>Trunk stability pushup</td><td>2.30 &#177; 0.82</td><td>2.60 &#177; 0.52</td></tr><tr><td>Rotary stability</td><td>1.80 &#177; 0.79</td><td>1.60 &#177; 0.84</td></tr><tr><td>Total</td><td>13.40 &#177; 2.17</td><td>15.40 &#177; 1.90 *</td></tr></table>
89b272e26e7f07c84ec5445239f9122cd6faa1f632c9fc0612fbef0658900214.png
simple
<table><tr><td>Survey/Questionnaire</td><td>Scheduled at</td><td>Contents</td><td>Conducted by *</td><td>Consent/Reconsent</td></tr><tr><td>Women's Enrollment Survey</td><td>Beginning of trial</td><td>Baseline census of all women of reproductive age, enrollment into surveillance</td><td>FD</td><td>Y</td></tr><tr><td>Newly Married Woman Survey</td><td>Ongoing, 5- weekly</td><td>Allows enrollment of eligible, newly married women</td><td>FD</td><td>Y</td></tr><tr><td>Pregnancy Surveillance Survey</td><td>Ongoing, 5- weekly</td><td>Urinary hCG-based identification of new pregnancies</td><td>FD</td><td>Y, for urine test</td></tr><tr><td>Women's ConsentInterview</td><td>Pregnancy identification</td><td>Informing women about the trial, obtaining consent for interviews and supplementation</td><td>TL</td><td>Y</td></tr><tr><td>Pregnancy Dosing Visits</td><td>Weekly</td><td>Weekly supplementation of enrolled pregnant women</td><td>FD</td><td>N</td></tr><tr><td>Pregnancy Enrollment Questionnaire</td><td>First week after consent</td><td>Baseline characteristics, pregnancy history, 7 d diet, 7 d/30 d morbidity, exposures</td><td>FI</td><td>N</td></tr><tr><td>Socioeconomic Status Questionnaire</td><td>First week after consent</td><td>Education, employment of self and husband, household assets</td><td>FI</td><td>N</td></tr><tr><td>Family History Questionnaire</td><td>First week after consent</td><td>Parental vital status, cause of death, chronic morbidity</td><td>FI</td><td>N</td></tr><tr><td>Late Pregnancy Questionnaire</td><td>At 28 weeks gestation</td><td>7 d diet, 7 d/30 d morbidity, exposures</td><td>FI</td><td>N</td></tr><tr><td>Three-Month Postpartum Questionnaire</td><td>At 12 weeks postpartum</td><td>Complications of labor and delivery, 7 d diet, 7 d/30 d morbidity, exposures</td><td>FI</td><td>N</td></tr><tr><td>Six-Month Postpartum Questionnaire</td><td>At 24 weeks postpartum</td><td>7 d diet, 7 d/30 d morbidity, exposures</td><td>FI</td><td>N</td></tr><tr><td>Miscarriage/Stillbirth Questionnaire</td><td>4 weeks after event</td><td>Complications of labor and delivery, care-seeking</td><td>FI</td><td>Y</td></tr><tr><td>Verbal Autopsy - Infant</td><td>4 weeks after event</td><td>Enhanced from WHO standard instrument</td><td>FI</td><td>Y</td></tr><tr><td>Verbal Autopsy - Mother</td><td>4 weeks after event</td><td>Enhanced from WHO standard instrument</td><td>RP</td><td>Y</td></tr></table>
400e7849e6f7a74551c28474b110f7a1914941d09b51f5eadd3462869efc6a78.png
simple
<table><tr><td> </td><td>70 OR patients(<i>n</i>, %)</td><td>49 EVAR patients (<i>n</i>, %)</td><td><i>p</i></td></tr><tr><td>In-hospital</td><td> </td><td> </td><td> </td></tr><tr><td> Reintervention</td><td>1, 1.4</td><td>2, 4</td><td>0.36</td></tr><tr><td> Mortality</td><td>0, 0</td><td>0, 0</td><td>NA</td></tr><tr><td>30-day</td><td> </td><td> </td><td> </td></tr><tr><td> Reintervention</td><td>0, 0</td><td>2, 4</td><td>0.16</td></tr><tr><td> Mortality</td><td>0, 0</td><td>0, 0</td><td>NA</td></tr><tr><td>1-year</td><td> </td><td> </td><td> </td></tr><tr><td> Reintervention</td><td>1, 1.4</td><td>2, 4</td><td>0.36</td></tr><tr><td> Mortality</td><td>0, 0</td><td>0, 0</td><td>NA</td></tr><tr><td>Long-term</td><td> </td><td> </td><td> </td></tr><tr><td> Reintervention</td><td>8, 11.4</td><td>4, 8.1</td><td>0.39</td></tr><tr><td> Mortality</td><td>3, 4.2</td><td>4, 8.1</td><td>0.38</td></tr></table>
8429ea52468625bcddee453360339adef31fe9ec37aab284a7b31896d1d3a3c2.png
simple
<table><tr><td>Characteristics</td><td>Number (%)</td></tr><tr><td>Number of patients</td><td>112</td></tr><tr><td>Tissue samples analyzed</td><td>224</td></tr><tr><td>Sex</td><td></td></tr><tr><td> male</td><td>27</td></tr><tr><td> female</td><td>85</td></tr><tr><td>Age</td><td></td></tr><tr><td> &lt; 45y</td><td>49</td></tr><tr><td> &#8805; 45y</td><td>63</td></tr><tr><td>Tumor size<sup>*</sup></td><td></td></tr><tr><td> T1</td><td>63</td></tr><tr><td> T2</td><td>36</td></tr><tr><td> T3</td><td>8</td></tr><tr><td>Multifocality</td><td>34 (30%)</td></tr><tr><td>Lymph node metastasis</td><td>41 (38%)</td></tr><tr><td>Distant metastasis</td><td>0</td></tr><tr><td>Tumor mutation status</td><td></td></tr><tr><td>BRAF V600E</td><td>69 (63%)</td></tr></table>
56948a3b41e9a38c87352b9e3011a171bc9e9dcbb5a19bc70cdefc335cd3bcf7.png
complex
<table><tr><td>Outcome</td><td>Controls: no transfusion in ED group (<i>n</i> = 204)</td><td>Cases: transfusion group (<i>n</i> = 204)</td><td>Odds ratio or between-group difference (95% CI)</td><td><i>P</i> value*</td></tr><tr><td>Primary composite outcome, <i>n</i> (%)</td><td>26 (12.7)</td><td>28 (13.7)</td><td>0.91 (0.48&#8211;1.72)</td><td>0.77</td></tr><tr><td> &#8226; Respiratory failure</td><td>17 (8.3)</td><td>19 (9.3)</td><td>1.13 (0.57&#8211;2.24)</td><td>0.73</td></tr><tr><td> &#8226; ICU admission</td><td>8 (3.9)</td><td>7 (3.4)</td><td>0.87 (0.31&#8211;2.45)</td><td>0.79</td></tr><tr><td> &#8226; ARDS</td><td>9 (4.4)</td><td>14 (6.9)</td><td>1.60 (0.68&#8211;3.78)</td><td>0.28</td></tr><tr><td colspan="4">Secondary outcomes (days)</td><td></td></tr><tr><td> Ventilator-free</td><td>24.7 (9.4)</td><td>23.7 (10.3)</td><td>1.0 (&#8722;0.9&#8211;2.9)</td><td>0.30</td></tr><tr><td> ICU-free</td><td>24.7 (8.3)</td><td>23.7 (9.0)</td><td>0.9 (&#8722;0.8&#8211;2.6)</td><td>0.30</td></tr><tr><td> Hospital-free</td><td>20.0 (8.5)</td><td>18.6 (9.1)</td><td>1.4 (&#8722;0.3&#8211;3.1)</td><td>0.11</td></tr><tr><td> RRT, <i>n</i> (%)</td><td>18 (8.8)</td><td>7 (3.4)</td><td>0.37 (0.15&#8211;0.90)</td><td>0.02</td></tr><tr><td> Mortality, <i>n</i> (%)</td><td>18 (8.8)</td><td>22 (10.8)</td><td>1.25 (0.65&#8211;2.41)</td><td>0.51</td></tr></table>
f8954e158c7b0fba57a74fa675db3a203e0cbd63cf47769b47b4e902feea9756.png
complex
<table><tr><td></td><td colspan="2">Training</td><td colspan="2">Development</td><td colspan="2">Test</td></tr><tr><td>Year</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td><td>Tit./Abs.</td><td>Full</td></tr><tr><td>2009</td><td>800</td><td>0</td><td>150</td><td>0</td><td>260</td><td>0</td></tr><tr><td>2011</td><td>800</td><td>108</td><td>150</td><td>109</td><td>260</td><td>87</td></tr><tr><td>2013</td><td>0</td><td>222</td><td>0</td><td>249</td><td>0</td><td>305</td></tr></table>
303085ec0b3aba5150058adba56440079272e41cef53ae1eb5be34cdd89347a8.png
simple
<table><tr><td> </td><td>All PCa</td><td>Sign PCa</td><td>Insig PCa</td></tr><tr><td>Sensitivity</td><td>96</td><td>98</td><td>91</td></tr><tr><td>Specificity</td><td>32</td><td>22</td><td>13</td></tr><tr><td>NPV</td><td>75</td><td>92</td><td>83</td></tr><tr><td>PPV</td><td>78</td><td>56</td><td>23</td></tr></table>
654ed62e6b7d73fd0bc18c62ad3c2f6e3cc67a07ebb8e6ac8a5d7e579b8a04c5.png
complex
<table><tr><td rowspan="2">Trait</td><td colspan="2">Transgene (T)</td><td colspan="2">Genotype (G)</td><td colspan="2">Planting (C)</td><td colspan="2">T * B</td><td colspan="2">T * C</td><td colspan="2">G * C</td><td colspan="2">T * G * C</td></tr><tr><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td><td>df</td><td><i>F</i></td></tr><tr><td>Number of tillers per plant</td><td>1</td><td>4.4*</td><td>4</td><td>19.1**</td><td>1</td><td>0.1</td><td>4</td><td>1.2</td><td>1</td><td>1.2</td><td>4</td><td>1.2</td><td>4</td><td>2.0</td></tr><tr><td>Number of panicles per plant</td><td>1</td><td>27.3**</td><td>4</td><td>17.3**</td><td>1</td><td>28.8**</td><td>4</td><td>0.4</td><td>1</td><td>0.1</td><td>4</td><td>1.8</td><td>4</td><td>1.0</td></tr><tr><td>Number of filled seeds per plant</td><td>1</td><td>112.5**</td><td>4</td><td>6.1**</td><td>1</td><td>0.2</td><td>4</td><td>1.5</td><td>1</td><td>0.0</td><td>4</td><td>1.3</td><td>4</td><td>0.9</td></tr><tr><td>Ratio of seed set</td><td>1</td><td>14.8**</td><td>4</td><td>3.8*</td><td>1</td><td>1.9</td><td>4</td><td>1.3</td><td>1</td><td>0.3</td><td>4</td><td>1.3</td><td>4</td><td>1.3</td></tr><tr><td>1000&#8208;seed weight</td><td>1</td><td>8.3*</td><td>4</td><td>12.5**</td><td>1</td><td>1.4</td><td>4</td><td>1.2</td><td>1</td><td>0.1</td><td>4</td><td>2.2</td><td>4</td><td>0.2</td></tr></table>
9ac2817057237e0d195a9990b9ff51a11795aa432fd200ac6269cef13cfc2ca2.png
complex
<table><tr><td rowspan="2"></td><td colspan="2">All</td><td colspan="2">African American Female</td><td colspan="2">African American Male</td><td colspan="2">Caribbean Black Female</td><td colspan="2">Caribbean Black Male</td></tr><tr><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td><td>B</td><td>95% CI</td></tr><tr><td>Ethnicity (Caribbean Black)</td><td>&#8722;0.01 *</td><td>&#8722;0.03&#8211;0.00</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Gender (Female)</td><td>0.00</td><td>0.00&#8211;0.01</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td><td>-</td></tr><tr><td>Age (Years)</td><td>0.01 <sup>#</sup></td><td>0.00&#8211;0.02</td><td>0.13</td><td>&#8722;0.23&#8211;0.48</td><td>0.61 ***</td><td>0.38&#8211;0.83</td><td>0.27</td><td>&#8722;0.13&#8211;0.66</td><td>&#8722;0.09</td><td>&#8722;0.66&#8211;0.48</td></tr><tr><td>SES (Income to needs ratio)</td><td>0.00</td><td>&#8722;0.01&#8211;0.01</td><td>0.12</td><td>&#8722;0.06&#8211;0.31</td><td>0.20 *</td><td>0.02&#8211;0.37</td><td>0.35 ***</td><td>0.17&#8211;0.53</td><td>0.35</td><td>&#8722;0.25&#8211;0.95</td></tr><tr><td>Intercept</td><td>&#8722;0.06</td><td>&#8722;0.14&#8211;0.02</td><td>2.43</td><td>&#8722;2.91&#8211;7.76</td><td>&#8722;4.53 **</td><td>&#8722;7.82&#8211;&#8722;1.25</td><td>&#8722;1.11</td><td>&#8722;7.29&#8211;5.07</td><td>5.89</td><td>&#8722;2.17&#8211;13.96</td></tr></table>
d1879d4ef3bcfa5425a8f3fdb4db3cae5e36e76714bfcf19e59cd3da3cd35769.png
simple
<table><tr><td></td><td>Free State Department of Health ART course (Standard training)</td><td>PALSA PLUS training (Standard training)</td><td>STRETCH Training (Additional training in intervention clinics)</td></tr><tr><td>Description</td><td>Two- week training course comprising one week of lectures and one week of practical training</td><td>One- to two-hour sessions weekly or fortnightly of case scenario-based interactive training in use of PALSA PLUS guidelines (six to eight sessions in total)</td><td>One- to two-hour sessions weekly or fortnightly of case scenario-based interactive training in use of PALSA PLUS STRETCH guidelines (four sessions in total)</td></tr><tr><td>Trainers</td><td>Senior doctors, pharmacists dieticians and social workers working in ART programme</td><td>Middle level nurse managers trained as PALSA PLUS trainers</td><td>Middle level nurse managers trained as PALSA PLUS and STRETCH trainers</td></tr><tr><td>Trainees</td><td>Doctors, professional nurses enrolled nurses pharmacists and social workers involved in providing primary care services at hospitals and clinics across the province</td><td>Professional and enrolled nurses and ancillary staff at all intervention and control clinics and primary care clinics throughout the province.</td><td>All professional nurses (whether appointed to ART or primary care posts) at 16 intervention sites only</td></tr><tr><td>Setting</td><td>Local classrooms located throughout the province to which lectures are broadcast.Local ART sites during practical training</td><td>Training sessions held at the clinic</td><td>Training sessions held at the clinic</td></tr><tr><td>Mode of delivery</td><td>Lectures broadcast live from central studio with limited telephone interaction.Face-to-face with staff at ART sites during practical training</td><td>Face-to-face small group facilitative work</td><td>Face-to-face small group facilitative work</td></tr><tr><td>Intensity and duration</td><td>Full day training for one week of lectures and one week of practical training</td><td>One to two hours once every week or two weeks for two to three months</td><td>One to two hours once every week for four weeks</td></tr></table>
6bc0bb808e20820c2c5bdec338819421b54f46b46991ae58da5cd164d9d09a60.png
simple
<table><tr><td>Variable</td><td>Serum zinc &#956;g/dl (mean+/-sd)</td><td>ZD+</td><td>ZD-</td><td>Crude OR (95% CI)</td></tr><tr><td>One-way walking distance from nearby health facility (<i>n </i>= 700)</td><td></td><td></td><td></td><td></td></tr><tr><td>0-30 min</td><td>52.5 (9.9)</td><td>311</td><td>287</td><td>0.76 (0.50-1.16)</td></tr><tr><td>Longer than 30 min</td><td>51.6 (10.2)</td><td>60</td><td>42</td><td>1<sup>r</sup></td></tr><tr><td>Frequency of ANC follow up (<i>n </i>= 700)</td><td></td><td></td><td></td><td></td></tr><tr><td>0</td><td>53.4 (9.9)</td><td>184</td><td>180</td><td>1<sup>r</sup></td></tr><tr><td>1-2</td><td>51.3 (9.8)</td><td>171</td><td>136</td><td>1.23 (0.48-2.20)</td></tr><tr><td>&#8805; 3</td><td>50.6 (9.5)</td><td>16</td><td>13</td><td>1.20 (0.56-2.58)</td></tr><tr><td>Received nutrition education during the pregnancy (<i>n </i>= 700)</td><td></td><td></td><td></td><td></td></tr><tr><td>Yes</td><td>51.4 (10.2)</td><td>99</td><td>76</td><td>1.21 (0.86-1.71)</td></tr><tr><td>No</td><td>52.7 (9.8)</td><td>272</td><td>253</td><td>1<sup>r</sup></td></tr></table>
89777d8e04ef8ea170842b157e80d9d13d518ae49fe6be3c750b6362301ed31b.png
complex
<table><tr><td colspan="2"></td><td>Men (<i>n</i> = 74)</td><td>Women (<i>n</i> = 199)</td></tr><tr><td colspan="2">Age (years)</td><td>46.2 &#177; 14.2</td><td>46 &#177; 13.5</td></tr><tr><td colspan="2">BMI (kg/m<sup>2</sup>)</td><td>40.4 &#177; 8.3</td><td>34.8 &#177; 6.2</td></tr><tr><td rowspan="10">Obesity-related diseases (%)</td><td>Type 2 Diabetes</td><td>14.9</td><td>12.6</td></tr><tr><td>Thyroid diseases</td><td>6.8</td><td>35.2</td></tr><tr><td>Gastrointestinal diseases</td><td>23</td><td>19.6</td></tr><tr><td>Cardiovascular diseases</td><td>16.2</td><td>5.0</td></tr><tr><td>Hypertension</td><td>45.9</td><td>36.2</td></tr><tr><td>Osteaorticular diseases</td><td>25.7</td><td>22.1</td></tr><tr><td>Respiratory diseases</td><td>21.6</td><td>16.6</td></tr><tr><td>Psychiatric diseases</td><td>14.9</td><td>12.1</td></tr><tr><td>Dyslipidemia</td><td>16.2</td><td>12.6</td></tr><tr><td>Insulin resistance</td><td>10.8</td><td>15.1</td></tr><tr><td rowspan="4">Level of education (%)</td><td>Primary school</td><td>2.7</td><td>5</td></tr><tr><td>Middle school</td><td>20.3</td><td>25.3</td></tr><tr><td>High school</td><td>60.8</td><td>55.1</td></tr><tr><td>University degree</td><td>16.2</td><td>14.6</td></tr><tr><td rowspan="7">Occupation (%)</td><td>Housewife</td><td>1.4</td><td>32,7</td></tr><tr><td>Employee</td><td>21.9</td><td>29.6</td></tr><tr><td>Freelance worker</td><td>17.6</td><td>10.1</td></tr><tr><td>Factory worker</td><td>14.9</td><td>8.5</td></tr><tr><td>Retiree</td><td>12.2</td><td>9.5</td></tr><tr><td>Unemployed</td><td>6.8</td><td>5.5</td></tr><tr><td>Student</td><td>5.4</td><td>4</td></tr></table>
e49706b7d3b8743bc912ac27e49852ad417be6f6a8693878e553476b13c82e45.png
simple
<table><tr><td>&#947;-rays</td><td>#</td><td>X-rays</td><td>#</td><td>UV-A</td><td>#</td><td>UV-B</td><td>#</td><td>UV-C</td><td>#</td></tr><tr><td>RAD54</td><td>30</td><td>ATLIG4</td><td>28</td><td>AT2G21970.1</td><td>2</td><td>UVH3</td><td>32</td><td>TED4</td><td>3</td></tr><tr><td>AT4G14970</td><td>30</td><td>MIM</td><td>7</td><td></td><td></td><td>RPA70B</td><td>7</td><td>MC4</td><td>2</td></tr><tr><td>RPA1A</td><td>27</td><td>SMC6A</td><td>6</td><td></td><td></td><td>RPA70D</td><td>5</td><td>MC7</td><td>2</td></tr><tr><td>MSH5</td><td>23</td><td></td><td></td><td></td><td></td><td>XPB1</td><td>4</td><td>MC5</td><td>2</td></tr><tr><td>RAD51</td><td>18</td><td></td><td></td><td></td><td></td><td>XPB2</td><td>4</td><td>MC6</td><td>2</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>AT3G48900</td><td>1</td><td>MC8</td><td>2</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>HO4</td><td>1</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>HO3</td><td>1</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>ETL1</td><td>1</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>PCC1</td><td>1</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>PAD4</td><td>1</td></tr></table>
1401d902089fc612383567335ffbf57c9ddf59743cd33e7f89ad1ddecb949225.png
complex
<table><tr><td>ROI</td><td>cluster size</td><td>peak t-value</td><td colspan="3">MNI coordinates</td><td>p-value</td></tr><tr><td></td><td></td><td></td><td>x</td><td>y</td><td>z</td><td></td></tr><tr><td>temporal pole R</td><td>12091</td><td>7.27</td><td>56</td><td>8</td><td>-38</td><td>&lt;0.001</td></tr><tr><td>paracentral lobule</td><td>7873</td><td>5.84</td><td>-2</td><td>-34</td><td>44</td><td>&lt;0.001</td></tr><tr><td>orbitofrontal cortex L</td><td>1825</td><td>4.76</td><td>-20</td><td>52</td><td>-22</td><td>0.004</td></tr></table>
d60da9326915c5cf5bcdd5d1f8f54fa7d6b39499b1e9c878d01793aacefd3e42.png
complex
<table><tr><td rowspan="2">Treatment -seeking behavior for malaria</td><td>VMW village</td><td> </td><td>HC village</td><td> </td><td> </td></tr><tr><td>n</td><td>%</td><td>n</td><td>%</td><td>p</td></tr><tr><td>Patients who sought treatment outside home*</td><td>n=110</td><td> </td><td>n=126</td><td> </td><td>0.101</td></tr><tr><td>Yes</td><td>104</td><td>94.6</td><td>124</td><td>98.4</td><td> </td></tr><tr><td>No</td><td>6</td><td>5.5</td><td>2</td><td>1.6</td><td> </td></tr><tr><td>Treatment source*</td><td>n=104</td><td> </td><td>n=124</td><td> </td><td>&lt;.0001</td></tr><tr><td>VMW</td><td>42</td><td>40.4</td><td>0</td><td>0</td><td> </td></tr><tr><td>HC</td><td>29</td><td>27.9</td><td>117</td><td>94.4</td><td> </td></tr><tr><td>Private clinic</td><td>21</td><td>20.2</td><td>4</td><td>3.2</td><td> </td></tr><tr><td>Drug seller</td><td>5</td><td>4.8</td><td>1</td><td>0.8</td><td> </td></tr><tr><td>Other</td><td>7</td><td>6.7</td><td>2</td><td>1.6</td><td> </td></tr><tr><td>Blood test for malaria*</td><td>n=104</td><td> </td><td>n=124</td><td> </td><td>0.570</td></tr><tr><td>Yes, Dipstick/Sldie</td><td>88</td><td>84.6</td><td>98</td><td>79.0</td><td> </td></tr><tr><td>Not tested</td><td>15</td><td>14.4</td><td>24</td><td>19.4</td><td> </td></tr><tr><td>Don&#8217;t know</td><td>1</td><td>1.0</td><td>2</td><td>1.6</td><td> </td></tr><tr><td>Place to get the blood test*</td><td>n=88</td><td> </td><td>n=98</td><td> </td><td>&lt;.0001</td></tr><tr><td>VMW</td><td>38</td><td>43.2</td><td>0</td><td>0</td><td> </td></tr><tr><td>HC</td><td>28</td><td>31.8</td><td>93</td><td>94.9</td><td> </td></tr><tr><td>Private clinic</td><td>18</td><td>20.5</td><td>3</td><td>3.1</td><td> </td></tr><tr><td>Other</td><td>4</td><td>4.6</td><td>2</td><td>2.0</td><td> </td></tr><tr><td>Result of the blood test*</td><td>n=88</td><td> </td><td>n=98</td><td> </td><td>1.000</td></tr><tr><td>Positive</td><td>70</td><td>79.6</td><td>78</td><td>79.6</td><td> </td></tr><tr><td>Negative</td><td>17</td><td>19.3</td><td>19</td><td>19.4</td><td> </td></tr><tr><td>Don&#8217;t know/don&#8217;t remember</td><td>1</td><td>1.1</td><td>1</td><td>1.0</td><td> </td></tr><tr><td>Time to receive first treatment&#8224;</td><td>n=104</td><td> </td><td>n=124</td><td> </td><td>&lt;.0001</td></tr><tr><td>Same day</td><td>24</td><td>23.1</td><td>13</td><td>10.5</td><td> </td></tr><tr><td>Next day</td><td>35</td><td>33.7</td><td>80</td><td>64.5</td><td> </td></tr><tr><td>2 days after the illness started</td><td>31</td><td>29.8</td><td>23</td><td>18.6</td><td> </td></tr><tr><td>3 or more days after the illness started</td><td>14</td><td>13.5</td><td>8</td><td>6.5</td><td> </td></tr><tr><td>Antimalarial drugs&#8224;</td><td>n=104</td><td> </td><td>n=124</td><td> </td><td>0.032</td></tr><tr><td>Yes</td><td>98</td><td>94.2</td><td>106</td><td>85.5</td><td> </td></tr><tr><td>No</td><td>6</td><td>5.8</td><td>18</td><td>14.5</td><td> </td></tr><tr><td>Type of antimalarial taken*</td><td>n=98</td><td> </td><td>n=106</td><td> </td><td>0.555</td></tr><tr><td>A+M</td><td>25</td><td>25.5</td><td>26</td><td>24.5</td><td> </td></tr><tr><td>Malarine</td><td>14</td><td>14.3</td><td>14</td><td>13.2</td><td> </td></tr><tr><td>Antimalalrial drugs not recommended</td><td>8</td><td>8.2</td><td>4</td><td>3.8</td><td> </td></tr><tr><td>Paracetamol</td><td>7</td><td>7.1</td><td>5</td><td>4.7</td><td> </td></tr><tr><td>Don&#8217;t know/don&#8217;t remember</td><td>44</td><td>44.9</td><td>57</td><td>53.8</td><td> </td></tr></table>
0bb795af53cb959bdd01bb5b272bbbe05780bc976d9b27d98f1f5ec51ce31deb.png
complex
<table><tr><td rowspan="2"> </td><td rowspan="2">Controlsubjects</td><td colspan="3">Type 2 diabetic patients staged by neuropathy severity</td></tr><tr><td>Stage I</td><td>Stage II</td><td>Stage III</td></tr><tr><td>Corneal nerve fiber density (no/mm<sup>2</sup>)</td><td>30.6&#8211;34.1</td><td>25.6&#8211;29.4<sup><i>&#8727;</i></sup></td><td>24.9&#8211;28.1<sup>&#8224;</sup></td><td>21.6&#8211;25.7<sup>&#8224;</sup></td></tr><tr><td>Corneal nerve fiber length (mm/mm<sup>2</sup>)</td><td>12.1&#8211;13.3</td><td>10.6&#8211;12.0</td><td>10.1&#8211;11.5<sup><i>&#8727;</i></sup></td><td>8.95&#8211;10.4<sup>&#8224;,&#8225;</sup></td></tr><tr><td>Corneal nerve branch density (no/mm<sup>2</sup>)</td><td>12.0&#8211;15.6</td><td>10.7&#8211;13.0</td><td>8.7&#8211;11.2<sup><i>&#8727;</i></sup></td><td>8.4&#8211;11.0<sup><i>&#8727;</i></sup></td></tr><tr><td>Corneal nerve branch length (mm/mm<sup>2</sup>)</td><td>2.43&#8211;3.08</td><td>2.31&#8211;2.78</td><td>2.03&#8211;2.64</td><td>2.01&#8211;2.75</td></tr><tr><td>Tortuosity grade</td><td>1.86&#8211;2.04</td><td>2.40&#8211;2.64<sup>&#8224;</sup></td><td>2.39&#8211;2.58<sup>&#8224;</sup></td><td>2.47&#8211;2.68<sup>&#8224;</sup></td></tr><tr><td>Beading frequency (no/0.1 mm)</td><td>23.5&#8211;24.6</td><td>19.3&#8211;20.7<sup>&#8224;</sup></td><td>19.2&#8211;20.4<sup>&#8224;</sup></td><td>19.5&#8211;20.8<sup>&#8224;</sup></td></tr><tr><td>Bead size (<i>&#956;</i>m<sup>2</sup>)</td><td>7.89&#8211;8.25</td><td>9.80&#8211;10.2<sup>&#8224;</sup></td><td>9.90&#8211;10.3<sup>&#8224;</sup></td><td>10.0&#8211;10.4<sup>&#8224;</sup></td></tr></table>
1f3e2c3af6e7af5d04ddd1d1a34e47b53dec0361ef462214ad5380796aa1a04b.png
simple
<table><tr><td>Sugar</td><td>MIC</td></tr><tr><td>l-fucose</td><td>0.586 mM</td></tr><tr><td>Methyl-&#945;,l-fucoside</td><td>0.293 mM</td></tr><tr><td>Fuc(1,2)Gal (2-O-(l-fucosyl)-d-galactose)</td><td>0.293 mM</td></tr><tr><td>Fuc(1-3)GlcNAc (3-O-(l-fucosyl)-2-N-acetyl-d-glucosamine)</td><td>0.147 mM</td></tr><tr><td>Fuc(1-4)GlcNAc (4-O-(l-fucosyl)-2-N-acetyl-d-glucosamine)</td><td>0.147 mM</td></tr><tr><td>Fuc(1-6)GlcNAc (6-O-(l-fucosyl)-2-N-acetyl-d-glucosamine)</td><td>0.293 mM</td></tr><tr><td>l-galactose</td><td>4.69 mM</td></tr><tr><td>d-arabinose</td><td>9.375 mM</td></tr><tr><td>d-fructose</td><td>75 mM</td></tr><tr><td>d-mannose</td><td>150 mM</td></tr><tr><td>methyl-&#945;,d-mannoside, d-glucose, d-galactose, l-arabinose, d-xylose, d-lyxose, d-tagatose, l-rhamnose</td><td>NI*</td></tr></table>
a9e451bf094cac95ef4460f66820f737c95be809be3e4ebb5d407f76f2406753.png
simple
<table><tr><td></td><td>Range</td><td>N</td><td>Mean</td><td>SD</td><td>Response rates</td><td>Floor effects</td><td>Ceiling effects</td></tr><tr><td>EQ-5D-3 L (Utility)</td><td>&#8722;0.594 to 1</td><td>234</td><td>0.60</td><td>0.36</td><td>95.29 %</td><td>0.00 %</td><td>19.73 %</td></tr><tr><td>SF-6D (Utility)</td><td>0.345 to 1</td><td>218</td><td>0.66</td><td>0.16</td><td>93.16 %</td><td>0.92 %</td><td>0.92 %</td></tr><tr><td>SF-12 PCS</td><td>0 to 100</td><td>209</td><td>36.88</td><td>12.32</td><td>89.32 %</td><td>0.00 %</td><td>0.00 %</td></tr><tr><td>SF-12 MCS</td><td>0 to 100</td><td>209</td><td>43.43</td><td>13.30</td><td>89.32 %</td><td>0.00 %</td><td>0.00 %</td></tr><tr><td>SGRQ Symptoms Score</td><td>0 to 100</td><td>221</td><td>33.71</td><td>27.89</td><td>94.44 %</td><td>1.36 %</td><td>1.36 %</td></tr><tr><td>SGRQ Activity Score</td><td>0 to 100</td><td>193</td><td>46.04</td><td>31.80</td><td>82.47 %</td><td>7.77 %</td><td>7.77 %</td></tr><tr><td>SGRQ Impact Score</td><td>0 to 100</td><td>194</td><td>22.13</td><td>22.42</td><td>82.90 %</td><td>0.00 %</td><td>0.00 %</td></tr><tr><td>SGRQ Total Score</td><td>0 to 100</td><td>175</td><td>32.08</td><td>24.18</td><td>74.79 %</td><td>0.00 %</td><td>0.00 %</td></tr></table>
79f3129236baa6b25bf0cbe19ec746e25959230b3e1256ad8ebfdbae1de6ed2d.png
complex
<table><tr><td rowspan="2">Comparison</td><td rowspan="2">Studies</td><td colspan="3">Overall effect</td><td colspan="2">Heterogeneity</td><td colspan="2">Publication bias</td></tr><tr><td>OR</td><td>Z-score</td><td><i>p</i>-value</td><td>I<sup>2</sup></td><td><i>P</i>-value</td><td>Begg's test</td><td>Egger's test</td></tr><tr><td>tt vs TT</td><td>36</td><td>0.86 [0.73&#8211;1.01]</td><td>1.82</td><td>0.069</td><td>44.10%</td><td>0.004</td><td>0.382</td><td>0.363</td></tr><tr><td>Tt vs TT</td><td>36</td><td>0.92 [0.81&#8211;1.04]</td><td>1.35</td><td>0.176</td><td>60%</td><td>0.000</td><td>0.955</td><td>0.891</td></tr><tr><td>tt/Tt vs TT</td><td>36</td><td>0.89 [0.80&#8211;1.00]</td><td>1.96</td><td>0.05</td><td>56.20%</td><td>0.000</td><td>0.808</td><td>0.914</td></tr><tr><td>tt vs TT/Tt</td><td>36</td><td>0.90 [0.76&#8211;1.06]</td><td>1.29</td><td>0.197</td><td>54.20%</td><td>0.000</td><td>0.318</td><td>0.496</td></tr><tr><td>t vs T</td><td>36</td><td>0.91 [0.84&#8211;0.99]</td><td>2.18</td><td>0.03</td><td>56.90%</td><td>0.000</td><td>0.465</td><td>0.472</td></tr></table>
048abed8a20126a4b6cb8899b5c80f5db86cd4d696a97f3ef59035476ced6116.png
simple
<table><tr><td>HILP Group</td><td>G-A n (%)</td><td>G-B n (%)</td><td>G-C n (%)</td></tr><tr><td>Lymphocele</td><td>4 (6.6)</td><td>7 (9.4)</td><td>19 (17.5)</td></tr><tr><td>Bleeding necessitating surgery</td><td>-</td><td>1(1.3)</td><td>3(2.7)</td></tr><tr><td>Deep venous thrombosis</td><td>-</td><td>2(2.6)</td><td>3(2.7)</td></tr><tr><td>Pain</td><td>1(1.6)</td><td>1(1.3)</td><td>1(0.9)</td></tr><tr><td>Peripheral nerve palsy</td><td>-</td><td>1(1.3)</td><td>1(0.9)</td></tr><tr><td>ARDS</td><td>1(1.6)</td><td>-</td><td>1(0.9)</td></tr><tr><td>Pleural effusion</td><td>-</td><td>1(1.3)</td><td>-</td></tr><tr><td>Pulmonary microembolism</td><td>-</td><td>1(1.3)</td><td>-</td></tr><tr><td>Death (MOF or ARDS)</td><td>-</td><td>1(1.3)</td><td>2(1,8)</td></tr></table>
93365acfc78cd4d494ac9a8c121df8f5e5016ac1472783452cf4fded39b04766.png
complex
<table><tr><td>Schematic Name</td><td>Arabidopsis homologue CloneID</td><td>Normalized Expression Levels</td><td>Description</td><td>KEGGID</td></tr><tr><td colspan="4">Glycolysis - KEGG PATHWAY</td><td> </td></tr><tr><td>contig 763</td><td>At3g04120</td><td>4.1</td><td>Glyceraldehyde 3-phosphate dehydrogenase, cytosolic</td><td>Ac763</td></tr><tr><td>contig 251</td><td>At4g33070</td><td>3.4</td><td>Pyruvate decarboxylase 1</td><td>Ac251</td></tr><tr><td>contig 30</td><td>At2g36530</td><td>2.3</td><td>Enolase</td><td>Ac30</td></tr><tr><td>contig 1110</td><td>At1g77120</td><td>2.1</td><td>Alcohol dehydrogenase</td><td>Ac1110</td></tr><tr><td>contig 3191</td><td>At3g55440</td><td>2.1</td><td>Triose-phosphate isomerase</td><td>Ac3191</td></tr><tr><td>contig 441</td><td>At1g09780</td><td>1.6</td><td>Phosphoglycerate mutase</td><td>Ac441</td></tr><tr><td colspan="4">Cysteine and Methionine Metabolism</td><td> </td></tr><tr><td>contig 3189</td><td>At4g14880</td><td>2.3</td><td>Cysteine synthase</td><td>Ac3189</td></tr><tr><td>contig 117</td><td>At4g14710</td><td>1.7</td><td>ATARD2 acireductone dioxygenase2</td><td>Ac117</td></tr><tr><td>contig 113</td><td>At3g25570</td><td>1.6</td><td>S-adenosylmethionine decarboxylase</td><td>Ac113</td></tr><tr><td>contig 1009</td><td>At5g11520</td><td>1.5</td><td>Aspartate aminotransferase</td><td>Ac1009</td></tr><tr><td>contig 3350</td><td>At4g19710</td><td>1.5</td><td>Bifunctional aspartokinase/homoserine dehydrogenase</td><td>Ac3350</td></tr><tr><td colspan="4">Ubiquitin-Mediated Proteolysis - KEGG Pathway</td><td> </td></tr><tr><td>contig 1299</td><td>At2g02760</td><td>3.1</td><td>Ubiquitin conjugating protein</td><td>UBE2A</td></tr><tr><td>contig 154</td><td>At1g16890</td><td>1.6</td><td>Ubiquitin carrier protein E2 36</td><td>UBE2N</td></tr><tr><td>contig 861</td><td>At5g22920</td><td>1.6</td><td>Putative PGPD14 protein (pollen germination related protein)</td><td>PIRH2</td></tr><tr><td>contig 1793</td><td>At5g42190</td><td>1.5</td><td>SKP1-like protein 1B</td><td>SKP1</td></tr><tr><td>contig 1433</td><td>At1g64230</td><td>&#8722;2.0</td><td>Ubiquitin carrier protein E2 28</td><td>UBE2D_E</td></tr><tr><td>contig 153</td><td>At3g57870</td><td>&#8722;2.2</td><td>Ubiquitin carrier protein</td><td>UBE2I</td></tr></table>